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Development of an Injectable Methylcellulose Hydrogel System for Nucleus Pulposus 
Repair and Regeneration 
By Nada A. Haq-Siddiqi 
Advisor: Dr. Steven B. Nicoll 
Low back pain is the most common cause of disability in the world and is often caused by 
degeneration or injury of the intervertebral disc (IVD). The IVD is a complex, fibrocartilaginous 
tissue that allows for the wide range of spinal mobility. Disc degeneration is a progressive 
condition believed to begin in the central, gelatinous nucleus pulposus (NP) region of the tissue, 
for which there are few preventative therapies. Current therapeutic strategies include pain 
management and exercise, or surgical intervention such as spinal fusion, none of which address 
the underlying cause of degeneration. With an increasingly aging population, the socioeconomic 
impact of disability associated with low back pain and disc degeneration cannot be understated. 
Tissue engineering strategies are increasingly being investigated as an alternative therapy by which 
early-stage degeneration may be halted and reversed, thus restoring disc mechanics and inducing 
biological repair to prevent more painful long-term degeneration and disability. In order to prevent 
further injury to the IVD, an ideal therapeutic should be injectable via small gauge needle, be 
retained within the high-pressure intradiscal space, restore biomechanical properties, and deliver 
therapeutic agents and/or cells to drive tissue regeneration. Therefore, the overall objective of this 
thesis was to develop and characterize an injectable, bioactive, cellulose-based hydrogel system 
for NP replacement and repair. 
Methylcellulose (MC) is cellulose derivative that forms physically crosslinked gels at 
increasing temperatures. Methacrylation of MC allows for the formation of more robust, 
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chemically crosslinked hydrogels with lower effective macromer concentration. The first aim of 
this thesis investigated the influence of methacrylation on the thermoresponsive behavior of MC 
with implications for injectability and in situ retention. Results showed that increasing 
methacrylation percentage increased hydrophobic interactions that drive thermogelation, lowering 
the thermogelation onset temperature to within physiologic range, and produced robust, rapidly 
gelling, dual-crosslinked hydrogels when formed at physiologic temperature versus room 
temperature with redox initiators. The addition of anionic groups to MC would allow the polymer 
to mimic the sulfated glycosaminoglycan-rich matrix of the NP, enhancing water retention and 
sequestration of cationic proteins such as TGF-b3 that are critical for regenerative repair. Thus, 
the second aim was to develop an injectable, sulfonated MC hydrogel capable of forming stable 
gels in situ and electrostatically sequestering TGF-b3 to improve bioavailability of the therapeutic 
molecule. Findings showed that using sulfonated methacrylate monomers, negatively charged 
moieties could be incorporated into the MC hydrogels without sacrificing thermoresponsiveness 
below 37°C. Sulfonation was easily tunable by increasing monomer concentration, and TGF-b3 
sequestration was closely correlated with sulfonate concentration, resulting in a viable bioactive 
acellular biomaterial for NP replacement. Factorial design of macromer and sulfonate 
concentration allowed for selection of a sulfonated MC (sMC) formulation with optimal chemical 
and mechanical properties for injection into the NP. The third aim evaluated the bioactivity of the 
sMC hydrogels by encapsulating human bone-marrow derived mesenchymal stromal cells 
(hMSCs) with and without TGF-b3. Results demonstrated that sMC hydrogels with TGF-b3 were 
able to support NP-like matrix elaboration and maintained relevant mechanical properties. Overall, 
this work advanced the development of injectable cellulose-based hydrogels as potential bioactive 
NP replacements for IVD repair and regeneration. 
vii 
Acknowledgements 
First and foremost, the ultimate praise and thanks must go to Allah, 
whose presence and mercy have been constant both in times of my weakness and strength. 
 
اًمْلِع ِينْدِز َو ِيُنَعفَْنی اَم ِينّْمِلَع َو ِيَنتْمَّلَع اَِمب ِينَْعفْنا َّمُھَّللا  
Allaahumman fa’nee bima ‘allamtanee wa ‘allimnee ma yanfa’unee wa zidnee ‘ilma 
O Allah, make what You teach me beneficial, teach me what is beneficial, 
and increase me in knowledge 
 
This thesis marks the culmination of years of collaborative efforts, and this only begins to 
scratch the surface of the numerous contributions that have made its completion possible. Firstly, 
I would like to thank my thesis advisor, Dr. Steven Nicoll for his support and mentorship. Not only 
has he provided invaluable academic and professional guidance and helped me grow as an 
independent researcher, but has been understanding and supportive through setbacks, for which I 
am truly grateful. 
My thanks to my thesis committee, Dr. James Iatridis, Dr. Mitchell Schaffler, Dr. Sihong 
Wang, and Dr. Raymond Tu, who have all provided guidance, expertise, and a critical eye that has 
made this thesis and scientist better for it. 
My number one advice to anyone embarking on a Ph.D. has been: find your people. The work 
will have its ups and downs but “your people” will get you through it. In my doctoral experience 
I have been blessed with the best people. From day one, Michelle, Devika, Gittel, Anna, Fabrice, 
Jesse, and Dave have been more friends than colleagues, and made our lab a fun and dynamic 
place to work. All the graduate students in CCNY’s BME department, but in particular: Tanya, 
Shawn, Sean, Mykel, Kris, Karl, Anne Marie, Liz and Abbey, have made the graduate school 
experience infinitely easier and more fun by opening their lab doors, their homes, their knowledge 
viii 
and their hearts to me. The fact that I still regularly turn to them for support and guidance after 
they have moved on in their respective careers is a testament to the bonds we’ve built. Though not 
technically a part of our department, Tyler from the Iatridis lab has been a friend and motivator in 
my last few years, and I am so happy to be crossing this finish line together. 
Charles Darwin said, “It is the long history of humankind (and animal kind, too) those who 
learned to collaborate and improvise most effectively have prevailed.” At the risk of leaving 
someone out, I would like to thank the Tarbell lab, Schaffler lab, Barabino lab, Vasquez lab, Wong 
lab, Williams lab, and especially Dr. Majeska and Dr. Qui in BME, as well as the Morris Lab, Tu 
lab, Gilchrist Lab and Biddinger Lab in Chem E, and Dr. Pradhan from the Chemistry and NMR 
Facility, and the Iatridis Lab at Mount Sinai, without who’s generosity in materials, equipment, 
and expertise this research would not be possible. Thank you as well to my undergraduate mentees 
who have given me the opportunity to become a better scientist and a better mentor. 
The aforementioned people have made this dissertation what it is, but I must also acknowledge 
those who have made me what I am: My parents, who have supported me throughout this long 
journey. They taught me that nothing other than God and family was more important than a good 
education, and look where it got me. My brother, who has taught me about bravery and being my 
own advocate. My whole life, my grandparents have been an example to me and the highest bar 
that I have hoped to achieve. I am heartbroken to have lost three of them during this arduous 
process, but I know their prayers are still with me. Dadi, dekho maine thesis submit karli. My in-
laws, the Siddiqi family, there is nothing “in-law” about the love and support they have always 
given me, to say nothing of the greatest gift, Asad. It would not have been possible for me to 
complete this work without the help of Saba Iqbal, who has truly become a member of our family. 
ix 
Long hours for me often meant long hours for her. As painful as it has been to be away from 
Shahbaz, it has always been a comfort to know that he is in the most loving hands. 
“She is a friend of my mind. She gather me, man. The pieces I am, she gather them and give 
them back to me in all the right order. It's good, you know, when you got a woman who is a friend 
of your mind,” wrote Toni Morrison in Beloved. To Hinna, Sofia, Yumnah, Naethra, Kiran, and 
so many more dear friends I cannot begin to list, I am so grateful to have you to put me back 
together when the pieces come apart and giving me the opportunity to do the same in turn. 
I would need at least the full length of this thesis to begin to thank my husband Asad for 
everything he’s been for me throughout this time. This is as much his effort as it is mine. We have 
gone through the lowest lows and the highest highs together, and during the times that I doubted 
myself and wanted to quit, his faith in me is what kept me going. The best husband, best father, 
best brother, best friend, and best person I have ever known. 
Shahbaz Asad Siddiqi: my pride and joy, my sunshine, my hero. Every day I hope to be worthy 
of the honor of being your Amma. 
 
And finally, I would like to acknowledge myself. Through personal and professional 
challenges, I have persevered and have come out stronger because of it. 
  
x 
Table of Contents 
Abstract ....................................................................................................................v 
Acknowledgements ............................................................................................... vii 
List of Tables ........................................................................................................ xvi 
List of Figures ..................................................................................................... xvii 
List of Abbreviations .............................................................................................xx 
Chapter 1: Introduction to Intervertebral Disc – From Structure and 
Function to Regeneration and Repair ...................................................................1 
1.1 An Unmet Clinical Need: Low Back Pain and the Intervertebral Disc .............................. 2 
1.2 Intervertebral Disc Anatomy and Physiology ..................................................................... 4 
1.2.1 Anatomy and function ......................................................................................... 4 
1.2.2 Cells of the IVD ................................................................................................... 7 
1.3 Mechanics of the Disc ......................................................................................................... 8 
1.4 Development, Aging, and Degeneration ........................................................................... 11 
1.4.1 Development of the IVD .................................................................................... 11 
1.4.2 Degenerative Pathology .................................................................................... 13 
1.4.3 IVDD Associated Pain ...................................................................................... 17 
1.5 Current Clinical Repair Strategies .................................................................................... 18 
1.6 Polymeric Biomaterials for Nucleus Pulposus Replacement ............................................ 21 
1.6.1 Tunability .......................................................................................................... 23 
1.6.2 Injectability ....................................................................................................... 24 
xi 
1.7 Tissue Engineering and Biological Repair ....................................................................... 30 
1.7.1 Cell Source ........................................................................................................ 32 
1.7.2 Growth Factor Delivery .................................................................................... 34 
1.7.3 Biomaterials for NP Tissue Engineering .......................................................... 38 
1.7.4 Cellulosic Biomaterials ..................................................................................... 40 
1.7.5 Design Criteria and Functional Outcomes ....................................................... 49 
1.8 Motivation and Research Overview .................................................................................. 51 
1.9 Overview of Present Investigation .................................................................................... 56 
Chapter 2: Rheological Analysis of the Effect of Methacrylation on the 
Thermoresponsive Gelation of Methylcellulose in Aqueous Solutions .............59 
2.1 Introduction ....................................................................................................................... 60 
2.2 Materials and Methods ...................................................................................................... 63 
2.2.1 Macromer Preparation ..................................................................................... 63 
2.2.2 Nuclear Magnetic Resonance ........................................................................... 64 
2.2.3 Rheology ........................................................................................................... 64 
2.2.4 Statistical Analysis ............................................................................................ 68 
2.3 Results ............................................................................................................................... 68 
2.3.1 Structural Characterization .............................................................................. 68 
2.3.2 Determination of Thermogelation Onset Temperature ..................................... 68 
2.3.3 Thermoresponsive Gelation at Physiologic Temperature ................................ 70 
2.3.4 Strain Recovery ................................................................................................. 75 
2.3.5 Effect of Temperature on Redox-Initiated Crosslinking of Methacrylated MC 75 
2.4 Discussion ......................................................................................................................... 79 
xii 
2.5 Conclusion ........................................................................................................................ 89 
2.6 Acknowledgements ........................................................................................................... 89 
Chapter 3: Injectable Sulfonated Methylcellulose Hydrogels with Tunable 
Growth Factor Sequestration as Potential Nucleus Pulposus Replacements ..90 
3.1 Introduction ....................................................................................................................... 91 
3.2 Materials and Methods: ..................................................................................................... 95 
3.2.1 Methacrylation of Methylcellulose ................................................................... 95 
3.2.2 Proton Nuclear Magnetic Resonance Spectroscopy (1H-NMR) ....................... 97 
3.2.3 Hydrogel Fabrication ....................................................................................... 97 
3.2.4 Sulfonation Quantification ................................................................................ 97 
3.2.5 Mechanical Testing ........................................................................................... 98 
3.2.6 Swelling Properties and Hydrogel Network Characterization ......................... 98 
3.2.7 Gelation Properties ......................................................................................... 100 
3.2.8 Thermogelation Onset Temperature ............................................................... 100 
3.2.9 Redox-Initiated Gelation ................................................................................. 100 
3.2.10 In Situ Gelation ............................................................................................... 101 
3.2.11 In Vitro Stability .............................................................................................. 102 
3.2.12 Cytocompatibility ............................................................................................ 102 
3.2.13 Protein Adsorption .......................................................................................... 103 
3.2.14 Growth Factor Release ................................................................................... 103 
3.2.15 Statistics .......................................................................................................... 104 
3.3 Results ............................................................................................................................. 105 
3.3.1 Spectroscopy and Methacrylation Quantification .......................................... 105 
xiii 
3.3.2 Sulfonation Quantification .............................................................................. 105 
3.3.3 Compressive Properties .................................................................................. 106 
3.3.4 Equilibrium Swelling and Hydrogel Mesh Characterization ......................... 106 
3.3.5 Gelation Properties ......................................................................................... 108 
3.3.6 In Situ Gelation ............................................................................................... 109 
3.3.7 In Vitro Stability .............................................................................................. 110 
3.3.8 Cytocompatibility ............................................................................................ 111 
3.3.9 Protein Adsorption .......................................................................................... 111 
3.3.10 Growth Factor Release ................................................................................... 112 
3.4 Discussion ....................................................................................................................... 114 
3.5 Conclusions ..................................................................................................................... 126 
3.6 Acknowledgements ......................................................................................................... 126 
Chapter 4: TGF-b3 Sequestering, Sulfonated Methylcellulose Hydrogels 
Support Nucleus Pulposus-Like Matrix Elaboration by Encapsulated Human 
MSCs .....................................................................................................................127 
4.1 Introduction ..................................................................................................................... 128 
4.2 Materials and Methods .................................................................................................... 131 
4.2.1 Macromer Preparation ................................................................................... 131 
4.2.2 Human Mesenchymal Stromal Cell (hMSC) Culture ...................................... 132 
4.2.3 Hydrogel Preparation and Culture ................................................................. 133 
4.2.4 TGF-b3 Release .............................................................................................. 134 
4.2.5 Cell Viability ................................................................................................... 135 
4.2.6 Biochemical Analysis ...................................................................................... 135 
xiv 
4.2.7 Histological/Immunohistochemical Evaluation .............................................. 136 
4.2.8 Swelling Behavior ........................................................................................... 137 
4.2.9 Mechanical Testing ......................................................................................... 137 
4.2.10 Statistical Analysis .......................................................................................... 138 
4.3 Results ............................................................................................................................. 138 
4.3.1 Growth Factor Release from Sequestering Hydrogels ................................... 138 
4.3.2 Cell Viability, Distribution, and Morphology ................................................. 139 
4.3.3 NP Matrix Elaboration and Distribution ........................................................ 140 
4.3.4 Material Properties of Constructs .................................................................. 144 
4.4 Discussion ....................................................................................................................... 145 
4.5 Conclusion ...................................................................................................................... 158 
4.6 Acknowledgements ......................................................................................................... 159 
Chapter 5: Conclusions, Limitations, and Future Directions .........................160 
5.1 Overview ......................................................................................................................... 161 
5.2 Rheological Analysis of the Effect of Methacrylation on the Thermoresponsive Gelation 
of Methylcellulose in Aqueous Solutions (Chapter 2) .................................................... 163 
5.3 Injectable Sulfonated Methylcellulose Hydrogels with Tunable Growth Factor 
Sequestration as Potential Nucleus Pulposus Replacements (Chapter 3) ....................... 166 
5.4 TGF-b3 Sequestering, Sulfonated Methylcellulose Hydrogels Support Nucleus Pulposus-
Like Matrix Elaboration by Encapsulated Human MSCs (Chapter 4) ........................... 168 
5.5 Limitations and Future Directions .................................................................................. 170 
5.6 Final Conclusions ........................................................................................................... 178 
Appendix: Detailed Protocols .............................................................................180 
xv 
Methacrylated Methylcellulose Macromer Synthesis ................................................................. 181 
Methylcellulose Acid Hydrolysis ............................................................................................... 183 
1H-NMR Analysis ....................................................................................................................... 184 
Rheometry ................................................................................................................................... 186 
Differential Scanning Calorimetry .............................................................................................. 189 
Hydrogel Mechanical Testing ..................................................................................................... 190 
Bovine Tail Motion Segment Injury and Repair ......................................................................... 193 
Live/Dead Staining of Hydrogels ............................................................................................... 194 
Pepsin Digest .............................................................................................................................. 195 
Collagen ELISA .......................................................................................................................... 196 
PicoGreen Assay ......................................................................................................................... 199 
DMMB Assay ............................................................................................................................. 202 
Hematoxylin and Eosin (H&E) Staining (Paraffin Embedded Slides) ....................................... 204 
Alcian Blue Staining (Paraffin Embedded Slides) ...................................................................... 205 




List of Tables 
Table 1.1: Summary of native tissue mechanics benchmarks of the NP. ..................................... 50 
Table 2.1: Methacrylation percentage and degree of methacrylate substitution .......................... 68 
Table 2.2: Yield strain (gyield) from strain sweeps performed at 4°C and 37°C (1 Hz) ................ 71 
Table 2.3: Onset and completion times of thermogelation at 37°C (1%, 1 Hz). .......................... 71 
Table 3.1: Swelling ratio and related physical properties of sulfonated MC hydrogels. ............ 107 
Table 3.2:  Rheological properties of redox-polymerized sulfonated MC hydrogels. ................ 109 





List of Figures 
Figure 1.1: Schematic of the anatomy of the IVD and surrounding tissues. .................................. 5 
Figure 1.2: Pathways of nutrient supply in the healthy IVD. ......................................................... 6 
Figure 1.3: Forces acting on the IVD. ............................................................................................. 9 
Figure 1.4: Complex physical changes that may be transduced as mechanical stimuli to the cells.
........................................................................................................................................... 11 
Figure 1.5: Sagittal sections of human lumbar discs in various stages of degeneration. .............. 14 
Figure 1.6 Human NP collagen II fibril and aggrecan proteoglycan composition with age. ....... 15 
Figure 1.7: The degenerative cycle of IVD degeneration. ............................................................ 16 
Figure 1.8: Schematic of the progression of IVD degeneration highlighting the traditional timing 
of interventions. ................................................................................................................ 19 
Figure 1.9: Schematic of hydrogel structure. ................................................................................ 23 
Figure 1.10 Schematic representation of various injectable in situ curing chemical crosslinking 
systems. ............................................................................................................................. 26 
Figure 1.11: Geometric relationship between G* and its components G’ and G”. ...................... 28 
Figure 1.12: The tissue engineering paradigm: Cells, Scaffold (Tissue Architecture), and Signals 
(Niche Properties). ............................................................................................................ 30 
Figure 1.13: Schematic representation of growth factor delivery mechanisms from hydrogels. . 36 
Figure 1.14: A) Cellulose and B) its ether derivatives. ................................................................. 43 
Figure 2.1: Reaction scheme of the esterification of methylcellulose with methacrylic anhydride, 
and subsequent 1H- NMR spectra. .................................................................................... 65 
Figure 2.2: Methods of determining thermogelation temperature via rheometric analysis. ......... 67 
Figure 2.3: Temperature-dependent gelation of MC formulations with increasing temperatures.69 
xviii 
Figure 2.4: Temperature-dependent gelation and strain behavior of MC formulations in H2O. .. 72 
Figure 2.5: Temperature-dependent gelation and strain behavior of MC formulations in PBS. .. 73 
Figure 2.6: Behavior of thermogelling MC solutions at storage and physiologic temperatures (1% 
strain, 1 Hz). ...................................................................................................................... 74 
Figure 2.7: Representative graph of gel recovery under cyclic strain. ......................................... 75 
Figure 2.8: Free-radical polymerization of MC formulations with redox initiators APS and 
TEMED (10 mM each) in PBS at room temperature (20ºC) versus physiologic 
temperature (37ºC). ........................................................................................................... 78 
Figure 2.9: Continued increase in storage modulus G’ after completion of free-radical 
polymerization reaction. ................................................................................................... 79 
Figure 3.1: Synthesis and characterization of sulfonated methylcellulose (sMC) hydrogels. ...... 96 
Figure 3.2: Quantification of sulfonation. ................................................................................... 106 
Figure 3.3 Equilibrium mechanical properties of MC and sMC hydrogels. ............................... 107 
Figure 3.4: Gelation kinetics and in situ gelation. ...................................................................... 110 
Figure 3.5: In vitro stability of 3% MC hydrogels of varying 2SEM concentration (0, 1, 5, 10 
mM) over 8 weeks. ......................................................................................................... 111 
Figure 3.6:  Cytocompatibility of 3% MC hydrogels with varying concentrations of 2SEM (0, 1, 
5, 10 mM) with encapsulated human dermal fibroblasts (hDFs). ................................... 112 
Figure 3.7: Protein adsorption and TGF-b3 release from 3% MC hydrogels of varying sulfonate 
concentration (0, 1, 5, and 10 mM 2SEM). .................................................................... 113 
Figure 4.1: Schematic of hydrogel formulations, culture conditions and outcome measures .... 134 
Figure 4.2: Daily A) and cumulative B) release of encapsulated TGF-b3 from hMSC-laden 
hydrogels. ........................................................................................................................ 140 
xix 
Figure 4.3: Viability and survival of hMSCs encapsulated within MC and sMC hydrogels. .... 142 
Figure 4.4: Hematoxylin & Eosin staining of hMSC-laden hydrogels at day 7 and day 42. ..... 143 
Figure 4.5: Biochemical content of hMSC-laden MC hydrogels over time. .............................. 143 
Figure 4.6 ECM localization within hMSC-laden MC hydrogels at 42 days. ............................ 144 
Figure 4.7: Material properties of hMSC-laden MC hydrogels over time. ................................ 145 
  
xx 
List of Abbreviations 
AC: Articular Cartilage 
AF: Annulus Fibrosus 
ANOVA: Analysis of Variance 
APS: Ammonium Persulfate 
ATR-FTIR: Attenuated Total Reflection – Fourier Transform Infrared Spectroscopy 
BC: Bacterial Cellulose 
CEP: Cartilaginous Endplate 
CMC: Carboxymethyl Cellulose 
CNC: Cellulose Nanocrystals 
Col II: Type II Collagen 
CS: Chondroitin Sulfate 
DP: Degree of Polymerization 
DS: Degree of Substitution 
DSC: Differential Scanning Calorimetry 
ECM: Extracellular Matrix 
GAG: Glycosaminoglycan  
HA: Hyaluronic Acid 
hMSC: Human Mesenchymal Stromal Cell 
1H-NMR: Proton Nuclear Magnetic Resonance 
HEMC: Hydroxyethyl Methylcellulose 
HPMC: Hydroxypropyl Methylcellulose 
IVD: Intervertebral Disc 
xxi 
IVDD: Intervertebral Disc Degeneration 
Ma-CMC: Methacrylated Carboxymethylcellulose 
Ma-MC: Methacrylated Methylcellulose 
MC: Methylcellulose 
MFC: Microfibrillated Cellulose 
MMP: Matrix Metalloproteinase 
MSC: Mesenchymal Stem Cell 
NC: Notochordal Cell 
NFC: Nanofibrillated Cellulose 
NP: Nucleus Pulposus 
NPC: Nucleus Pulposus Cell 
PG: Proteoglycan 
sGAG: Sulfated Glycosaminoglycan 
sMC: Sulfonated Methylcellulose 
TEMED: N,N,N’,N’-Tetramethylethylenediamine 












Chapter 1:   Introduction to Intervertebral Disc – From Structure 
and Function to Regeneration and Repair 
  
2 
1.1   An Unmet Clinical Need: Low Back Pain and the Intervertebral Disc 
The intervertebral disc (IVD) is a fibrocartilaginous tissue that exists between vertebral bones 
within the spinal column. Its primary function is loadbearing, as it provides crucial shock 
absorption to the spine during motion (Neidlinger-Wilke et al. 2013). The IVD is a composite 
organ made up of three primary tissues: the nucleus pulposus (NP), annulus fibrosus (AF), and 
cartilaginous endplates (CEP), which together provide support and range of motion to the spine 
(Humzah and Soames 1988). Injury and degeneration of the IVD critically impair the IVD’s ability 
to perform that function (Raj 2008).  Intervertebral disc degeneration (IVDD) is linked to chronic 
low back pain and neck pain, the leading cause of disability worldwide (Hartvigsen et al. 2018). 
Although IVDD and low back pain are not life threatening, the personal and economic burdens of 
chronic pain are enormous; in 2016 low back and neck pain accounted for the highest amount of 
healthcare spending in the US, totaling approximately $134.5 billion in total spent on care, and is 
responsible for 60.1 million disability adjusted life years (DALYs) globally, which translates to 
hours of lost work opportunities and lost wages (Dieleman et al. 2020).  
Degeneration generally begins in the NP, where altered loading or injury can initiate aberrant 
cellular catabolism and breakdown of the proteoglycan-rich matrix that mediates NP hydration 
and hydrostatic pressure (Urban, Roberts, and Ralphs 2000). Loss of hydration and pressure leads 
to altered loading on the total disc, placing increased stress on the AF, giving rise to bulging, 
fissures, and even herniation of the NP out of the AF, as well as calcification and fracture of the 
CEP, and osteophyte formation (Iatridis et al. 2013; Setton and Chen 2006; Urban, Roberts, and 
Ralphs 2000). Pain management and physical therapy remain the standard of care for early to mid-
stage symptomatic degeneration, while eventually late-stage degeneration can necessitate a 
complete discectomy and spinal fusion (Desmoulin, Pradhan, and Milner 2020). Because the IVD 
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is mainly avascular, it has little to no capacity for repair, and so IVDD is a progressive condition 
for which there remains no effective treatment that addresses the cause of the degeneration or 
prevents progression of the disease. 
Tissue engineering solutions aim to address this issue by combining cell therapy with a 
scaffold that will both restore IVD mechanics and support further tissue repair. Because IVDD is 
understood to begin in the NP, the degenerate NP and mid-stage degeneration are the preferred 
targets for early intervention. The ideal tissue engineering construct attempts to recapitulate nature 
in an engineered implant by mimicking the environmental cues (i.e. mechanical and chemical) 
found in the natural tissue, to promote the differentiated phenotype of the incorporated cells. The 
construct must withstand the mechanical loads of the native NP, as well as allow for fluid and 
nutrient transport in a manner similar to the native IVD. Additionally, delivery of a tissue-
engineered system must be minimally invasive; injury to the AF can further IVDD by causing a 
reduction in the pressurization of the IVD, and therapeutic delivery must be injectable through a 
fine gauge needle to prevent further disruption of the AF. The combination of mechanical 
demands, limited nutritional and regenerative capacity, and need for minimally invasive and 
disruptive delivery present unique challenges for tissue engineering repair of the IVD. In the 
current chapter, physiology of the healthy and pathological IVD will be discussed, with emphasis 
on the NP as the therapeutic target, and current existing and investigative solutions for NP 
replacements will be outlined. Components of traditional tissue engineering – scaffold materials, 
cell source, and instructive signaling cues – will then be reviewed, in addition to the critical design 
criteria for evaluating success in NP tissue engineering. Finally, the scope and aims of the present 
investigation will be introduced. 
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1.2   Intervertebral Disc Anatomy and Physiology 
1.2.1   Anatomy and function  
The spinal column is made up of repeating vertebral bones separated by a unique connective 
tissue of the IVD that allows for a broad range of motion (Figure 1.1.A). The function of the IVD 
is mechanical, as it transmits loads through the spine. The IVD allows for 6 degrees of freedom in 
motion: compression, anterio-posterior and lateral shear, flexion, and torsion (Buckwalter et al. 
2000; Neidlinger-Wilke et al. 2013; Iatridis et al. 2013). It does so by virtue of its composite 
structure: the NP, a gel-like structure, resists vertical compression via hydrostatic pressure, and is 
surrounded by the annulus fibrosus (AF), which resists the radial stress from the expanding NP via 
circumferential tension. The NP and AF are sandwiched superiorly and inferiorly by the CEP, thin 
strips of cartilage which provide adhesion to the adjacent vertebral bodies and allow nutrition 
transport (Buckwalter et al. 2000; Raj 2008). The healthy IVD is avascular and mostly aneural.  
The NP is a highly hydrated, gelatinous structure. Water makes up approximately 80% of the 
wet weight of the NP; the rest of the wet weight is made up of proteoglycans (PGs) (15%), 
collagens (4%), and other extracellular matrix proteins (Raj 2008; Buckwalter et al. 2000). It is 
similar to hyaline cartilage in that the major collagen in the NP is collagen type II, and the most 
common PGs in the NP are aggrecan and versican (Raj 2008; Hayes, Benjamin, and Ralphs 2001). 
Aggrecan is high in chondroitin sulfate and keratan sulfate glycosaminoglycans which are 
covalently attached to its protein core in an arrangement that resembles a bottlebrush formation. 
The high negative charge of the sulfated glycosaminoglycan (sGAG) chains promote the influx of 
positive ions and water into the NP, creating hydrostatic pressure within the tissue (Buckwalter et 
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al. 2000; Hayes, Benjamin, and Ralphs 2001; Pattappa et al. 2012). The arrangement of fibers 
within the NP is isotropic, which enables uniform distribution of compressive loads.  
Figure 1.1: Schematic of the anatomy of the IVD and surrounding tissues. 
A) The spinal segment consisting of two vertebral bodies and an intervertebral disc sandwiched 
between them. B) A sectioned portion of a normal human disc, displaying the location of the NP, 
lamellae of the AF, and vertebral endplate (CEP). Adapted from Raj, (2008). 
 
Surrounding the NP is the AF, which consists of circumferential lamellae comprising the outer 
region of the IVD. The AF is also highly hydrated, although less so than the NP, with water making 
up 70% of the wet weight. Collagen is the next most abundant component of the AF, making up 
15% of the wet weight of the AF (70% of the dry weight). The AF contains both type I and type 
II collagen, with type I being more abundant in the outer AF, and elastin between lamellae. PGs 
make up only 5% of the wet weight of the AF (Raj 2008; Hayes, Benjamin, and Ralphs 2001; 
Bruehlmann et al. 2002). The lamellae of the AF are highly anisotropic and are arranged in 
concentric rings which maintain circumferential hoop stresses that resist the outward pressure 
created by the compressed NP (Figure 1.1.B). The collagen fibers in the lamellae are arranged 
parallel within each lamella and approximately 60° to the vertical axis, and alternate in direction 
between lamellae, which allow it to resist crack propagation in the case of injury (Raj 2008; Iatridis 
et al. 2013; Bruehlmann et al. 2002). The CEPs form the superior and inferior interface of the disc 
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and the vertebral bones. Thin strips of hyaline cartilage, the CEPs are also composed mainly of 
water (58% of total tissue weight), although less than each of the other two IVD tissues. 
Additionally, the CEP contains collagen and PGs at different weight percentages than the NP and 
AF, containing 60-80% collagen/dry weight and only 17%/dry weight of PGs (Roberts, Menage, 
and Urban 1989). Viscous fluid flow through the CEP allows for nutrient exchange via diffusion 
and convection from capillary beds in the subchondral plate through the CEP to the central portions 
of the disc and back (Urban, Smith, and Fairbank 2004). 
Figure 1.2: Pathways of nutrient supply in the healthy IVD. 
A) Cells of the avascular NP and inner AF are supplied by nutrients via capillary beds emerging from the 
vertebrae. B) The center of the disc has the lowest level of nutrients and highest amount of metabolites. 
C) Schematic of the nutrient gradients from endplate (0) to endplate (1). Adapted from Huang et. al. 
(2014). 
 
The IVD is mostly avascular, and blood supply in the healthy IVD is restricted to the 
subchondral plate and the outermost portions of the AF that experience only a few millimeters of 
capillary penetration from the surrounding tissue (Figure 1.2.A) (Huang, Urban, and Luk 2014). 
Because nutrient and metabolite exchange occurs primarily via diffusion, concentration gradients 
exists as a product of the rate of supply and consumption within the IVD, leading the IVD, and in 
particular the NP, to be generally a hypoxic, acidic environment with low glucose (Figure 1.2.B-
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C) (Horner and Urban 2001; Raj 2008). Even though the cells of the disc are uniquely 
differentiated to thrive in this environment (Guehring et al. 2009), a critical threshold exists beyond 
which cells will not remain active or viable, as well as a limit to the number of cells that can be 
supported within the tissue. 
1.2.2   Cells of the IVD 
The adult IVD has a very low cell density, at approximately 0.25-0.5% total tissue volume 
(Urban, Roberts, and Ralphs 2000). The NP contains ~4 x 106 cells/cm3 and the AF has a slightly 
higher cell density at ~9 x 106 cells/cm3 (Pattappa et al. 2012; Raj 2008). The cells of the outer AF 
are fusiform and fibroblast-like and are aligned with the collagen fibers in the AF lamellae. Moving 
towards the center of the IVD, the AF cells become more oval shaped (Bruehlmann et al. 2002; 
Johnson and Roberts 2003). The cells of the NP are rounded and are often referred to as 
chondrocyte-like cells, or IVD-chondrocytes; however, despite many similarities between NP cells 
and articular chondrocytes, there are key differences. The NP structure originates from the 
notochord in development, and the young NP is populated with large, highly vacuolated 
notochordal cells (NCs) (Urban, Roberts, and Ralphs 2000; Rodrigues-Pinto, Richardson, and 
Hoyland 2014); by approximately 10 years, these cells are replaced by smaller, more chondrocyte-
like NP cells (NPCs) (Rodrigues-Pinto, Richardson, and Hoyland 2014; Yang et al. 2009). There 
has been debate as to whether the NCs differentiate into NPCs or if they simply disappear and are 
replaced by the NPCs through an unknown mechanism (Rodrigues-Pinto, Richardson, and 
Hoyland 2014). Histological observations have shown chondrocyte migration from the endplate 
towards the central regions of the IVD (Yang et al. 2009; Kim et al. 2003; Kim et al. 2009). 
However, recent fate mapping experiments have shown that throughout the aging process of the 
NP, the cells within the NP remain notochordal in lineage (Choi and Harfe 2011; Choi, Cohn, and 
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Harfe 2008; McCann et al. 2012). It has been hypothesized that the phenotypic shift from highly 
vacuolated notochord-like cells to smaller, chondrocyte-like cells contributes to aging and 
degeneration of the disc (Risbud and Shapiro 2011; Chen, Yan, and Setton 2005). 
The cells of both the NP and AF exist within a dense pericellular matrix (PCM) high in 
collagen type VI, similar to the cells of articular cartilage (AC) (Cao, Guilak, and Setton 2007; 
Wilusz, Sanchez-Adams, and Guilak 2014). This matrix is both biochemically and 
morphologically distinct from the surrounding territorial matrix. NPCs exist both alone and in 
groups of 2 to 4 in the NP, and in longitudinal arrangements of up to 10 in the AF. The PCM is 
thought to have a mechanoregulatory function, and studies suggest that the pericellular matrix 
plays a critical role in both transmitting and attenuating mechanical forces experienced by the 
whole IVD to the cells (Cao, Guilak, and Setton 2011; Cappello et al. 2006; Cao, Guilak, and 
Setton 2009).  
1.3   Mechanics of the Disc 
The role of the IVD is purely mechanical: it functions to allow support and motion to the 
body. IVDs, along with small amounts of hyaline cartilage between the facets (the zygapophyseal 
joint) of two adjacent vertebral bodies, compose a motion segment that allows bending and 
twisting of the neck, torso, and waist. The disc thus must withstand compressive loads from both 
body weight and muscle tension. While standing, the posterior spinal muscles exert force to 
balance the flexion moment caused by body weight (Neidlinger-Wilke et al. 2013). In the healthy 
IVD, compressive loads are evenly borne and distributed by the NP. Hydrostatic pressure in the 
adult human NP measures at about 0.1-0.2 MPa while in supine position at rest, around 0.5 MPa 
when standing, and as high as 2.3 MPa while carrying a weight in a flexed position (Figure 1.3.A) 
(Neidlinger-Wilke et al. 2013). The wide range of motion allowed by the spine combined with 
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carrying extra weight can significantly alter the load on the spine and create much more complex 
loads on the disc (Hsieh and Twomey 2010; Wilke et al. 1999). 
Figure 1.3: Forces acting on the IVD. 
A) In vivo values of intradiscal pressure at different postures and daily activities. B) Representative 
stress profiles in the lumbar IVDs in healthy and degenerative conditions. Adapted from Neidlinger-
Wilke et al. (2013). C) Schematic representation of the multiscale architecture of the IVD and the axes of 
force distribution. Adapted from Nerurkar, Elliott, & Mauck (2011). 
 
Load distribution in the IVD is dependent on its composition (Figure 1.3.C). The high 
hydrostatic pressure within the NP resists compression from body weight and motion. As the NP 
undergoes compression, the AF stretches in tension and provides resistance to expansion, thereby 
maintaining high pressure within the NP.  The AF also resists strains during twisting and bending 
(Buckwalter et al. 2000; Iatridis et al. 2013; Neidlinger-Wilke et al. 2013). When the NP 
degenerates and loses hydration, it also loses height, which shifts abnormal loads to the AF, 
creating stress peaks which further promote disc degeneration and fissures (Figure 1.3.B). The 
figure is simplified in that it represents the stress distribution measured in vitro and does not 
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consider the varied loading conditions involved in vivo. It also only represents compressive stress 
and not tensile or shear stress. 
There is a wide range of both organization and composition of the ECM environment within 
the IVD; this contributes to the wide variety of forces experienced by the cells within the IVD. 
The cells in the NP are exposed to predominantly uniform hydrostatic stress (Figure 1.4). 
Conversely, the cells of the AF lie along collagen fibers in the lamellae and are exposed to tensile 
strain and shear stress as a result of the stretching and sliding of the fibers within the lamellae. NP 
cells also undergo compressive stress and fluid shear stress caused by convective flow of water 
during loading (Neidlinger-Wilke et al. 2013). The cells of the IVD have been shown to be 
sensitive to both magnitude and frequency of stimuli, in what is known as a threshold effect (Setton 
and Chen 2006). For example, static compression (0.4-1.3 MPa) has been shown to promote disc 
degeneration in a dose-dependent fashion, whereas cyclic loading (0.01- 0.1 Hz) has shown to 
balance anabolic and catabolic processes within the disc at the same peak stresses (Lotz et al. 
2002). Static compressive load has been reported to increase PG and collagen synthesis in IVD 
cells at low stresses of 0.2-0.4 MPa, and gene expression for matrix proteins is stimulated at 
stresses even lower than that (~0.1 MPa) (Ohshima, Urban, and Bergel 1995; Chen, Yan, and 
Setton 2004). Cellular response to hydrostatic pressure is much the same, with an increase in 
synthesis of collagen, PG, and tissue inhibitor of metalloproteinase 1 (TIMP1) under low to 
moderate hydrostatic pressures (<0.3MPa), while higher pressures were shown to inhibit PG 
synthesis and increase nitric oxide (NO) and matrix metalloproteinase 3 (MMP-3) production 







Figure 1.4: Complex physical changes that may be transduced as mechanical stimuli to the cells. 
Axial compressive loading (represented by the large arrow) of the disc is shown to induce shearing 
and tensile stresses as well as radial expansion that results in compression in both axial and radial 
directions. These loads will be distributed to the PG-collagen extracellular matrix (inset, bottom left) and 
the interstitial fluid phase that undergoes changes in hydrostatic pressure. The physical effects may be 
transduced from the matrix and contained fluid to cells that re-side in and interact with the extracellular 
matrix (inset, top left). Adapted from Setton & Chen (2006). 
 
1.4   Development, Aging, and Degeneration 
1.4.1   Development of the IVD 
During vertebrate embryonic development, the cells of the early embryo arrange into three 
distinct germ layers, the ectoderm, the mesoderm, and the endoderm, in a process known as 
gastrulation, and together they give rise to all the various tissues of the body. The mesoderm is the 
germ layer from which most connective tissues are derived. The mesoderm further separates into 
subdivisions: the axial mesoderm, paraxial mesoderm, intermediate mesoderm, and lateral plate 
mesoderm.  The notochord develops from the axial mesoderm while somites form from the 
paraxial mesoderm, and together they go on to form the primitive skeleton. The notochord is a rod-
shaped structure in the developing embryo of vertebrates that defines the primitive axis of the 
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embryo. This notochord eventually becomes segmented and forms the NP (Sivakamasundari and 
Lufkin 2012; Pattappa et al. 2012; Rodrigues-Pinto, Richardson, and Hoyland 2014). 
When the embryo begins to undergo organogenesis, the notochord directs the somites to 
migrate. Some of these cells differentiate into sclerotome and migrate towards and encircle the 
notochord and neural tube to begin to form the spine (Rodrigues-Pinto, Richardson, and Hoyland 
2014; Pattappa et al. 2012). These cells begin to condense around the notochord, forming a peri-
notochordal sheath (Pattappa et al. 2012). Internal pressure within the vacuolated notochordal cells 
causes the structure to elongate along the midline axis. The sclerotome begins to condense in 
segmented areas, and will eventually become the AF, while the non-condensed sclerotome forms 
the cartilaginous precursor to the vertebral bodies and the CEPs. The segmentation and 
condensation of the sclerotome causes the notochord to segment and expand, forming the NP 
(Pattappa et al. 2012; Rodrigues-Pinto, Richardson, and Hoyland 2014). Hedgehog signaling is 
responsible for pattern regulation and cell proliferation in the developing IVD (Sivakamasundari 
and Lufkin 2012; Risbud and Shapiro 2011; Choi and Harfe 2011; Dahia et al. 2009a). 
Development of the notochordal sheath depends on this signaling to provide mechanical constraint 
to the notochord and aid in its segmentation into distinct discs.  
Postnatally, the cells of the NP are notochordal in phenotype, being relatively large (~30 µm 
diameter) and containing large vacuoles which enable the cells to generate a large osmotic swelling 
pressure within the NP. The matrix of the infant IVD is highly gelatinous, with a clearly 
demarcated border between the NP and AF. Within 10 years of birth, the IVD undergoes numerous 
changes in matrix composition and cell phenotype (Raj 2008; Roughley 2004). The NCs decline 
in number and slowly give way to the more chondrocyte-like NPCs (Rodrigues-Pinto, Richardson, 
and Hoyland 2014; Dahia et al. 2009b). Furthermore, there is a reduction in cell clusters, which 
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may have an impact on cell-cell signaling and matrix maintenance (Hunter, Matyas, and Duncan 
2003; 2004). How this vacuolated NC population is lost to a smaller, chondrocytic phenotype is 
still under investigation; elucidation of the mechanism of change might give insight into the 
process of NP degeneration (Risbud and Shapiro 2011; Chen, Yan, and Setton 2005; 
Sivakamasundari and Lufkin 2012). Blood vessels which populated the CEP and AF regress in the 
first two years postnatally as well, minimizing the capacity for nutrient exchange and waste 
removal, and thus also cell proliferation and matrix production (Nerlich, Schleicher, and Boos 
1997). NPCs are adapted to the low oxygen environment; however, buildup of waste increases the 
concentration of lactic acid, making the IVD, and in particular the NP, a more acidic environment. 
This acidity enhances proteolytic activity, driving enzymatic breakdown of the matrix (Roughley 
2004). While these processes are a normal process of IVD aging, degeneration of the IVD is 
characterized as an accelerated progression of this breakdown, mediated by an aberrant cellular 
response (Smith et al. 2011). 
1.4.2   Degenerative Pathology 
The IVD undergoes enormous physiological changes throughout the aging process. Discs 
begin to degenerate far earlier than most other skeletal tissues. Signs of structural changes in the 
lumbar discs of humans can be found as early as 10 years of age; by 50 years, 10% of discs show 
signs of severe degeneration, and this increases to 60% by 70 years of age (Nerlich, Schleicher, & 
Boos, 1997; Raj, 2008; Urban et al., 2000). The causes of IVDD can be a multifactorial 
combination of aging, trauma, and lifestyle influences (high fat diet, smoking) (Adams and 
Roughley 2006; Hartvigsen et al. 2018). Altered loading, either via injury or aging, is strongly 
implicated in the degenerative cascade within the IVD. Injury may be dramatic, like disc 
herniation, or subtle, such as annular fissures. Studies have shown that violation of the AF as small 
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as a needle puncture can induce degenerative changes as a result of loss of IVD pressurization 
(Korecki, Costi, and Iatridis 2008; Iatridis et al. 2013). End plate fracture and radial fissures are 
also subsequent injuries of the IVD that can occur due to degeneration. Altered loading in one disc 
affects the surrounding tissue as well; osteophytes begin to grow in the vertebrae neighboring the 
degenerate disc, and ligamentous thickening can contribute to spinal stenosis (Figure 1.5). 
Figure 1.5: Sagittal sections of human lumbar discs in various stages of degeneration. 
Adapted from Galbusera et al. (2014). 
 
Change in matrix components are the most characteristic changes, as matrix composition 
dictates mechanical function. Both normal aging and pathologic degeneration are characterized by 
a loss of hydration and height. GAG content in the NP at 40-60 years of age is half that of what it 
was as a toddler; similar trends are seen in progressive stages of degeneration. Loss in % of water 
content is strongly correlated with loss of sGAGs, and as aging and degeneration progress, the 
distinction between both sGAG and hydration of the NP and AF blurs (Antoniou et al. 1996). PGs 
are aggregate molecules made up of sGAGs around a core protein, making a bottle-brush structure, 
which allows for maximal exposure of negatively charged sulfates for interaction with positively 
charged ions and water molecules. Aggrecan is the primary PG of the NP as well as AC and is 
often bonded to hyaluronic acid via link proteins, forming large proteoglycan aggregates. 
Throughout the aging process, these aggregates break down, reducing the compressive strength of 
the NP (Sivan, Wachtel, and Roughley 2014).  Along with the decrease in hydration, the NP also 
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becomes more fibrotic, with increasing collagen content. Although type II collagen is the 
predominant collagen in the NP, it is highest in absolute value/dry weight in the inner AF, giving 
way to type I collagen in the outer AF; age-related changes see a reduction in type II collagen as 
well as an increase in type I collagen, further blurring the distinction between NP and AF. 
Nonenzymatic glycation causes cross-linking of collagens, which stiffens the usually gelatinous 
material, and further stimulates enzyme and cytokine release in  the degenerating disc (Weber et 
al. 2015; Rodrigues-Pinto, Richardson, and Hoyland 2014). This transition in matrix composition 
is illustrated in Figure 1.6, where the shift in ECM from mostly PGs to increasing collagen is 
accompanied by the temporal break down of PG aggregates (Roughley, 2004). 
Figure 1.6 Human NP collagen II fibril and aggrecan proteoglycan composition with age. 
(CS – Chondroitin Sulfate, KS – Keratin Sulfate, LP – Link Protein, HA – Hyaluronic Acid). 
Adapted from Roughley (2004). 
 
In the healthy disc, there is a constant balance of matrix degradation and synthesis by the IVD 
cells. It is still not clear what causes the phenotypic shift that throws off the balance between the 
two. Altered loading conditions have been shown to increase the catabolic response of NP cells, 
with an increased production of matrix metalloproteinase (MMPs), cathepsins, and aggrecanases 
(Rodrigues-Pinto, Richardson, and Hoyland 2014; Urban, Roberts, and Ralphs 2000). 
Mechanotransduction is the process by which cells sense mechanical stimuli and convert it to 
electrochemical activity (Discher, Janmey, and Wang 2005). Given the complex mechanical loads 
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experienced in the disc, numerous studies have investigated how the cells of the IVD sense and 
respond to their environment (Fearing et al. 2018; Hsieh and Twomey 2010).  Guehring et al. 
(2010) showed that NCs are less resistant to mechanical loading than NPCs, suggesting that the 
increased loading during growth and aging may contribute to the disappearance of NPCs. Both 
integrin binding with the ECM (Gilchrist and Chen 2007; Le Maitre et al. 2009; Nettles, 
Richardson, and Setton 2004) and cadherin-mediated traction forces between cells (Hwang, Jing, 
et al. 2014) have been implicated in IVD mechanotransduction. The reduction in cell-cell 
interactions and subsequent loss of direct cell communication as the NP decreases in cellularity 
may be associated with further aberrant cell responses to stress. Indeed, the appearance of 
protrusions from the usually round cell bodies of NPCs may be indicative of cells both responding 
to increased matrix tension as well as attempting to respond to neighboring cells (Errington et al. 
1998; Johnson and Roberts 2003). 
 
Figure 1.7: The degenerative cycle of IVD degeneration. 
A) Homeostasis of the intervertebral disc is dependent on the interaction of cells, extracellular 
matrix and biomechanical stress, and alterations to the balance at any point can set off a degenerative 
cascade. B). Additional factors impacting the degenerative cycle including genetic predisposition to 
IVDD, infection, and alterations in nutrition. Adapted from Vergroesen et al. (2015). 
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It is becoming increasingly evident that disc degeneration creates a “vicious cycle” wherein 
cell-mediated catabolism causes fundamental changes in the matrix, which results in altered loads 
on the IVD, and further stimulates cellular pathology (Vergroesen et al. 2015). Because these 
factors are connected and amplify each other, researchers have proposed a model wherein these 
interrelated factors exist in a cycle that can be entered at any point, all leading to the same 
pathology (Figure 1.7).  
1.4.3   IVDD Associated Pain 
Degenerative changes to the disc are strongly correlated with low back pain (Adams and 
Roughley 2006). Vascularized granulation tissue extending from the NP to fissures in the AF have 
been associated with low back pain (Peng 2013). Inflammation has also been linked to 
symptomatic and painful IVDD (Molinos et al. 2015; Khan et al. 2017). Release of inflammatory 
cytokines from within the disc has been implicated in painful neural ingrowth into the AF (Ohtori, 
Miyagi, and Inoue 2018). Additionally, dynamic loading of the IVD has been shown to drive the 
influx of inflammatory cytokines, such as TNFa, into the disc, furthering cell-mediated 
degeneration (B. A. Walter et al. 2015; Molladavoodi, McMorran, and Gregory 2020). Non-
discogenic sources of pain are also common. Hypermobility of the disc subsequent to degeneration 
destabilizes the entire spine and requires the local musculature to overwork in compensation 
(Iatridis et al. 2013; Ohtori, Miyagi, and Inoue 2018). Furthermore, radicular pain and 
radiculopathy (also known as sciatica) frequently occurs due to spinal stenosis, itself a result of  
loss of disc height, osteophyte formation, facet joint hypertrophy, and disc herniation (Hartvigsen 
et al. 2018; Vassilaki and Hurwitz 2014). Interestingly, IVDD is not always symptomatic. Medical 
imaging in the form of magnetic resonance imaging (MRI) is still the standard mode of identifying 
IVD injury or degeneration, and usually only called for with symptomatic pain. This presents a 
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challenge in timing when disc degeneration is addressed, and the conservativeness or 
aggressiveness of the proposed therapy (Wu, Kim, and Jang 2020; Adams, Stefanakis, and Dolan 
2010). 
1.5   Current Clinical Repair Strategies 
Low back pain is a nearly ubiquitous condition, affecting up to 80% of the world’s adult 
population, and is highly associated with IVDD (Hoy et al. 2014) and results in $134.5 billion in 
healthcare spending in the US alone (Dieleman et al. 2020); IVDD is implicated in nearly 40% of 
these patients (Ohtori, Miyagi, and Inoue 2018; L. Zhao et al. 2019). Early non-surgical treatment 
strategies usually involve pain management via oral analgesics or non-steroidal anti-inflammatory 
drugs (NSAIDs) and physical therapy (Raj 2008; Adams, Stefanakis, and Dolan 2010). However, 
discogenic pain is often not noticeable until the disease has progressed considerably. The extent 
of intervention varies with the severity of the condition (Figure 1.8). Intradiscal steroid injections 
used to suppress inflammation and reduce pain has gone out of favor due to associated chondral 
degradation, but epidural injections of steroid are still commonly used for pain management and 
inflammation reduction (Nguyen et al. 2017; Schoenfeld and Weiner 2011). Intradiscal 
electrothermal annuloplasty (IDEA) and biacuplasty are minimally invasive thermal treatments for 
radiofrequency ablation of nociceptive nerve ingrowth, but have shown limited efficacy, and are 
focused strictly on resolving discogenic pain (L. Zhao et al. 2019). 
Surgical intervention becomes necessary in the case of severe, unremitting symptoms. 
Discectomy, or the removal of all or part of the NP, is the most common procedure for 
symptomatic herniation, but does not replace the NP, and so does not restore disc height or 
mechanics, leaving the AF vulnerable to further degradation (Kim, Park, and Kim 2009). AF 
defects are associated with 5-25% of post-operative re-herniation (Ambrossi et al. 2009; Long et 
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al. 2016; Shepard and Cho 2019). AF closure and repair is performed in cases of high risk for 
reherniation but the quest for a successful biomaterial AF sealant is still undergoing investigation 
(Bouma et al. 2013; H. J. Wilke et al. 2013; Thomé et al. 2018; Hom et al. 2019; Likhitpanichkul 
et al. 2014; Distefano et al. 2020).  
Figure 1.8: Schematic of the progression of IVD degeneration highlighting the traditional timing of 
interventions. 
Adapted from Hudson et al.(Hudson et al. 2013) 
 
Severe degeneration in which the integrity of the AF has been obliterated may be treated by 
spinal fusion, in which the whole disc is removed, and adjacent vertebral bodies are fused together. 
These interventions alter the range of motion and consequently negatively impact the mechanics 
of the adjacent discs (Iatridis et al. 2013; Yang, Langrana, and Lee 1986; Nunley et al. 2013). 
Prosthetic disc replacement of either the nucleus or whole disc has been explored as an alternative 
to spinal fusion. NP replacements require the AF to remain intact, while late-stage degeneration 
may require total disc replacement (TDR) or disc arthroplasty (Brophy and Hoh 2018). The 
efficacy of TDR is still under consideration; while some studies have shown TDR to be safe and 
effective, with greater patient satisfaction regarding mobility and short-term efficacy at least equal 
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to fusion (Bai et al. 2019; Ding et al. 2017), there have been reports of prosthetic induced osteolysis 
(Serhan et al. 2006). 
As the origin of IVD degeneration is generally understood to begin in the NP, repair or 
replacement of the NP has garnered increased therapeutic interest, with the goal of restoring 
biomechanics, thereby interrupting the degenerative cascade. Prosthetic implants such as 
Prosthetic Disc Nucleus (PDN-SOLO, Raymedica, Inc., Bloomington, MN) and 
NeuDisc™ (Replication Medical Inc., New Brunswick, NJ), fully formed implantable hydrogels, 
have shown promise in restoring disc mechanics, but do not sufficiently integrate with the complex 
geometry of the NP void space, and ultimately fail by device migration (Di Martino et al. 2005). 
DASCOR™ in situ forming polyurethane “balloon” showed promise in restoring disc height and 
motion segment stability, but has a preformed shape that does not integrate with the remaining 
tissue that surrounds it (Ahrens et al., 2009). Some of these materials have received CE Mark for 
marketing in Europe but have yet to receive FDA approval due to safety concerns. 
Research efforts have increasingly shifted towards biomaterial and regenerative engineering 
strategies for NP repair. As pre-formed NP replacements have largely failed due to device 
migration, in situ curing injectable materials are increasingly of interest as they can successfully 
integrate with the surrounding tissue and resist migration and extrusion (Lewis, 2012). Acellular 
injectable biomaterials focus on the restoration of disc height, mechanics, and hydration, and can 
also be used to deliver therapeutics directly to the disc for pain management or biological repair ( 
Bowles and Setton 2017). Biologic therapy is an appealing alternative to end-stage surgical 
treatment, as it attempts to address early and mid-stage degeneration and mitigate further 
degeneration before the effects become too severe and spread to adjacent structures (Hudson et al. 
2013). Such therapies can include drugs or biomolecules to stimulate anabolic repair processes in 
21 
the remaining native cells or introduce cells in hydrogel carriers in order to drive tissue 
regeneration. Current ongoing clinical trials involving both cellular and acellular hydrogels for NP 
replacement have focused on patients with symptomatic discogenic pain without bulging or 
herniation (indicating gross AF damage) and moderate loss in disc height (30-50%), as more 
advanced damage would likely result in extrusion and failure of the implanted material 
(Amirdelfan et al. 2021; Ceylan et al. 2019). The subsequent sections will thus focus on injectable 
biomaterial-based strategies for NP replacement and repair. 
1.6   Polymeric Biomaterials for Nucleus Pulposus Replacement 
Biomaterial replacement of the NP aims to repair the IVD by recapitulating the mechanical 
behavior of the healthy NP. Hydrogels are a class of biomaterials with high swelling capacity and 
highly tunable properties. The high water content in hydrogels allows them to behave like many 
natural soft tissues (Peppas et al. 2006). As such, hydrogels have been investigated for a wide 
variety of applications, from contact lenses to drug depots and cell scaffolds (Censi et al. 2012; 
Gaharwar, Peppas, and Khademhosseini 2014; Lin et al. 2021; Muir and Burdick 2021; Anseth, 
Bowman, and Brannon-Peppas 1996; Kretlow, Klouda, and Mikos 2007) Hydrogels may be 
synthetic or natural polymers, but they are all characterized as mesh networks swollen with water, 
much like the proteoglycan rich network of the NP. The ability to form in situ, conform to the 
complex void space in a degenerated or injured IVD and resist migration are all key factors in the 
design of a potential NP replacement biomaterial. In addition, biocompatibility and long-term 
stability in an acellular scaffold are necessary if the replacement is to persist in the IVD and restore 
mechanical function. Biomaterials for cell-based therapies may be biodegradable, and the rate of 
degradation must be tuned to match the rate of de-novo tissue development to maintain structural 
stability of the repaired IVD; additionally, the degradation byproducts must not be cytotoxic. 
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Synthetic hydrogels that have been used include poly(ethylene glycol) (PEG) and poly(N-
isopropylacryl-amide) (PNIPAAm) (Yang and Li 2009; Francisco et al. 2014; Thomas et al. 2010). 
Synthetic polymers are generally bio-inert, in that they do not illicit an immune response. They 
are also very well controlled as there is minimal variation between batches, and so are easily 
characterized. While synthetic polymers are usually readily modified and can be delivered with 
other natural materials, they themselves are not bioactive. Some polymeric scaffolds, like 
PGA/PLA/PLGA are degradable through hydrolysis of the ester linkages (Sahoo et al. 2008; 
Jeong, Wang, and Gutowska 2001). Others, such as PEG are not readily degraded, but can be 
chemically modified to degrade (Vernengo et al. 2008; Zhu 2010; Buxton et al. 2007).  
Natural materials include animal-derived molecules that mimic the native structure of or are 
present in the IVD, such as collagen (types I or II) and hyaluronic acid (Neidlinger-Wilke et al. 
2005; Cloyd et al. 2007; Bian, Guvendiren, et al. 2013). Scaffolds have also been produced directly 
by decellularizing IVD tissue (Liu et al. 2014). Other natural materials have been derived from 
plant or animal sources, and are chosen based on their similarity to proteoglycans in the NP as well 
as their ability to create swollen networks, such as chitosan (Sukarto et al. 2012; J. Li et al. 2012), 
plant-derived agarose, alginate (DiMicco et al. 2007; Chang and Poole 1996; Horner and Urban 
2001), methylcellulose and carboxymethylcellulose (Reza and Nicoll 2010a; 2010b; Gupta, 
Cooper, and Nicoll 2011; Lin et al. 2016; Varma, DiNicolas, and Nicoll 2018), all of which are 
long-chain polysaccharides. Cellulose, chitosan, and alginate are naturally-derived 
polysaccharides that mimic the GAGs of the NP, but because they are not animal derived, they 
resist enzymatic degradation, unlike other natural hydrogels like hyaluronic acid and chondroitin 
sulfate. This characteristic is important as the degenerate disc space contains an increased amount 
of matrix metalloproteinases that can degrade animal-derived polymers. Additionally, animal-
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derived polymers can be immunogenic. Recently, peptide-based hydrogels have also come into 
investigation, as researchers use the very building blocks of native tissues to design highly 
specialized materials for many biomedical applications (Moss et al. 2011; Leckie et al. 2012).  
 
Figure 1.9: Schematic of hydrogel structure. 
A) Polymer chains connected at crosslink point or crosslinking polymers. Mc = Number average 
molecular weight between two adjacent crosslinks, directly related to n (degree of crosslinking). x = mesh 
size, related to the distance between crosslinks. B) Common hydrogel modifications in tissue engineering 
including cell-adhesive ligands, enzymatically degradable crosslinks, and immobilized or sequestered 
growth factors. Adapted from Zhu & Marchant, (2011). 
 
1.6.1   Tunability 
Hydrogels are highly tunable platforms in which scaffold stiffness, porosity (and thus 
permeability), and swelling properties can be easily tuned by molecular weight, macromer 
concentration and crosslinking density (Zhu and Marchant 2011). The creation of polymeric 
networks that can swell many times their dry weight is due to crosslinking between macromers. 
Crosslinks can be physical in nature, mediated by temperature, pH, or ionic stimuli, or chemical, 
in which permanent covalent bonds are made between macromers. Crosslinking density itself can 
be modified by adjusting the concentration and size of the macromer, (Jeon et al. 2009; Gupta and 
Nicoll 2014) or density of functional crosslinking moieties. Crosslinking efficiency is affected by 
molecular weight as well; longer polymer chains are more likely to form chain entanglements that 
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can aid or inhibit crosslink formations depending on the type of crosslinking occurring (Ferry 
1980). The theory of rubber elasticity states that the strength of a hydrogel increases with 
increasing crosslinking density, which also decreases the swelling ratio (Flory and Rehner 1943a; 
1943b; Rehmann et al. 2017). Swelling ratio and crosslinking density are directly related to the 
mesh size (x) (Figure 1.9) (Canal and Peppas 1989), which affects the diffusion of solutes into 
and out of the hydrogel, as well as influences the movement of cells through the gel (Brazel and 
Peppas 2000).  
Equilibrium swelling behavior is a balance between the elastic properties of the polymer and 
the water content of the hydrogel. As such, hydrogels are viscoelastic materials with mechanical 
behavior that is both like an elastic solid and viscous fluid (Anseth, Bowman, and Brannon-Peppas 
1996). The NP is a highly viscoelastic structure as well, in that it relaxes and behaves in a fluid-
like manner under transient loading, but under dynamic loading it behaves more like a solid 
(Iatridis et al. 1996). Thus, hydrogels are the ideal class of biomaterials for NP replacement, and 
polymer choice is dictated only by the extent of control available over each polymer’s properties. 
1.6.2   Injectability 
Of particular interest for NP replacement and IVD repair applications is the delivery 
mechanism. As mentioned earlier, an ideal NP replacement strategy would be deployed in an IVD 
where the AF was mostly intact. As such, in order to prevent further violation of the AF and 
exacerbate the degenerative cascade further, it is necessary that any intradiscal therapeutic be able 
to be delivered through a fine gauge needle (Korecki, Costi, and Iatridis 2008). Initial viscosity of 
a material will determine the ease of its delivery. Upon injection, it must begin crosslinking 
quickly, increasing in viscosity rapidly so as not to extravasate from the injection site, which is 
critical in the high-pressure disc space. If cells are being deployed within the hydrogel then an 
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ideal hydrogel would also protect cells from shear-induced damage (Marquardt and Heilshorn 
2016; Burdick, Mauck, and Gerecht 2016).  
In situ curing polymers that form covalently crosslinked hydrogels upon injection satisfy this 
description, as they have not gone through their crosslinking reaction prior to injection (Figure 
1.10). Free-radical polymerization is one of the most common methods for chemical crosslinking 
and produces strong and highly stable inter-chain bonds. Radical-initiated reactive groups 
commonly used include acrylate (Buxton et al. 2007), methacrylate (Stalling, Akintoye, and Nicoll 
2009; Erickson et al. 2009), methacrylamide (H. Shin, Olsen, and Khademhosseini 2012), and 
styrene moieties (Chen et al. 2009), all of which contain a vinyl group that is the target of free-
radical crosslinking (Muir and Burdick 2021). Photopolymerization, in which an initiator molecule 
is cleaved by light of a certain wavelength (UV, visible light) to generate the free radical, is widely 
used, however, does not lend itself to injectable applications due to the limited penetration of light 
through tissue. Oxidative-reductive (redox) reactions can be used to generate free radicals in 
injectable systems by separating the two initiators into separate barrels of a dual-barrel syringe and 
injecting via a mixing tip. As the reaction begins upon mixing, this is a very useful system for 
injectable applications. Still, the potential cytotoxicity of initiators, and in particular the leaching 
of unreacted initiators, should be monitored and titrated. Ammonium persulfate (APS) with 
N,N,N’,N’-tetramethylethylenediamine (TEMED) or ascorbic acid are common redox initiators 
for biomedical applications (Temenoff et al. 2003). Redox initiators can also be used to initiate 
“click” reactions, named thus because of the speed and specificity of the reactions. Thiol-ene 
radical crosslinking is one such mechanism that uses dithiol crosslinkers. The most common of 
these is norbornene, a bridged cyclic hydrocarbon with a vulnerable carbon-carbon double bond 
(Rehmann et al. 2017). Michael addition crosslinking occurs between thiol-enes without the need 
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for free-radical initiators. The elimination of redox initiators as a potential source of cytotoxicity 
makes these excellent crosslinking systems for injectable applications, however, are limited by the 
need for high macromer concentrations to produce efficient reactions. These reactions can take 
from seconds to hours, depending on their reactivity, and so the system needs to be tuned to the 
application (Liang et al. 2016). Tyramine crosslinking is another covalent crosslinking mechanism 
that lends itself well to injectable systems, where oxidation of the phenol group of tyramine is 
mediated by the enzymatic reaction between horseradish peroxidase (HRP) and H2O2 (Ren et al. 
2016). 
Figure 1.10 Schematic representation of various injectable in situ curing chemical crosslinking 
systems. 
A) Free-radical chain polymerization B) Thiol-ene radical addition C) Thiol-ene Michael addition 
and D) Tyramine-based enzymatic crosslinking. Adapted from Muir & Burdick, (2021). 
 
An alternative to chemical crosslinking systems for injectable hydrogels is physically 
crosslinked systems. Physically crosslinking hydrogels are stimuli responsive, forming crosslinks 






injection into the body where the environment has very specific cues. Thermogelling polymers are 
of specific interest for the disc because of their tunable gelation. Although ionic and pH- sensitive 
hydrogels have been studied in the context of the disc, since the pH and ionic quality of the IVD 
is highly variable depending on degenerative stage, as opposed to temperature which is relatively 
constant, they will not be explored here. Thermogelling polymers include naturally- derived 
chitosan, (Alinejad et al. 2019) and cellulose derivatives including methylcellulose (MC), (Choi 
et al., 2020) and hydroxypropylmethylcellulose (HPMC), (Buchtová et al. 2018), animal-derived 
gelatin, (Cheng et al. 2010) and synthetic poly N-isopropylacrylamide (pNiPAAm) (Ji et al. 2009). 
Thermogelling hydrogel systems exhibit a lower critical solution temperature (LCST) below which 
the polymers are soluble; as temperature rises above the LCST, the polymers become increasingly 
hydrophobic. Instead of coming out of solution altogether, the hydrophobic moieties form 
networks which trap water within the gel (Klouda and Mikos 2008). Tuning thermogelling 
polymers so that the transition from solution to gel, or sol-gel transition, occurs at or below 
physiologic temperature (37°C) is ideal for injection into the human body. The reversibility of 
physical crosslinks has pros and cons. Physically crosslinked hydrogels are more permissive to 
cell growth and matrix deposition, as their structure can change in response to cells. The most 
obvious con of physically crosslinked gels is that the crosslinks are reversible and sensitive to 
deformation. Because of this, physically crosslinked gels alone would not perform well as NP 
replacements. Physical crosslinking systems can, however, be combined with other systems to 
form dual-polymer networks (DPN) and dual crosslinking hydrogels, where the thermoresponsive 
nature of the physical gel works in conjunction with covalent crosslinks to form a stronger gel. 
Shear thinning is another material behavior that is highly sought after for injectable 
applications (Loebel et al. 2017). Materials that exhibit high viscosity or even gel like behavior in 
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the absence of deformation in shear, but quickly decrease in viscosity with increasing shear rates, 
hold great appeal for injectable systems. Such materials are less likely to cure and set within a 
mixing tip or needle upon delivery, and rapidly recover to their original gelled state once the force 
upon them is removed, a feature known as “self-healing” (Zhang et al. 2020; Yeo and Park 2021). 
Shear-thinning gels are frequently physically crosslinked, and lack sufficient mechanical integrity 
as previously mentioned. Therefore, secondary crosslinking is often applied to set the gel once it 
has been injected in the location and forms the desired shape.  These systems are also gaining 
interest as polymer inks for 3-D printing applications. 
Rheology is a critical tool in assessing the viscoelastic properties of materials, and in 
particular, the injectability and gelation kinetics of crosslinking hydrogels (Chen, Wen, Janmey, 
Crocker, & Yodh, 2010). Small amplitude oscillatory shear (SOAS) allows for stress and strain to 
be measured under controlled oscillations, where the complex modulus G* is given by 
 𝐺∗ = 𝜎"#$ 𝛾"#$⁄  (1.1) 
where smax is the maximum stress and gmax is the maximum strain. Purely elastic materials 
exhibit maximum stress at maximum strain, where both are in phase (dà0), and in a purely viscous 
material, the maximum stress occurs when the strain rate is greatest, and stress and strain are out 
of phase by 90°. Thus, the relationship between the complex modulus and its elastic and viscous 
components (G’ and G”, respectively) of a given viscoelastic material is given by the relationship 
in Figure 1.11: 
Figure 1.11: Geometric relationship between G* and its components G’ and G”. 
(Malvern Instruments 2016) 
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This fundamental concept allows us to utilize the rheometer to ascertain a large amount of 
information, including the complex viscosity, h*, from its relationship with G* and the angular 
frequency w: 
 𝜂∗ = 𝐺∗ 𝜔⁄  (1.2) 
The linear viscoelastic region (LVER), or region where stress and strain are proportional, can 
be determined via strain sweep. The point at which the material begins to yield, known as the yield 
strain (gyield), defines where G’ becomes strain dependent, and is the upper limit of the parameters 
for where most SAOS testing occurs. Strain sweeps, and the resulting gyield also determine strain 
yielding/shear-thinning behavior (Chen et al., 2017; Loebel et al., 2017). Materials that exhibit 
gradual yielding with increasing strain are more likely to be easily injected than those that 
“rupture” by exhibiting a precipitous drop in G’ at higher strains. This rupture indicates that a large 
shearing force is necessary to achieve material yielding, which likely translates to material bursting 
forth from the injection needle, and very limited control. While physically crosslinked biopolymers 
such as agarose and methylcellulose exhibit shear thinning, many biological polymers display 
strain stiffening and rupture (Zuidema et al. 2014). Cyclic strain tests in which the apparatus is 
rapidly switched between high and low strain regimes can also be performed to assess shear-
thinning behavior. Low viscosity or G’ measurements at high strains followed by rapid recovery, 
as well as high viscosity or G’ values at low strain, indicate not only that the material is shear 
thinning, but that it recovers quickly and is less likely to extravasate from the injection site once it 
has exited the syringe. 
Throughout these tests, the relationship between G’ and G” is indicative of whether the 
material is exhibiting mostly elastic or mostly viscous behavior, respectively, as the relationship 
G’>G” is traditionally considered the “gel point.” Subsequently, this point also corresponds to the 
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d=45°. Rheometry can also be used to determine the kinetics of free-radical polymerization over 
time (Temenoff et al. 2003; Gold et al. 2014), as well as thermoresponsiveness, both by measuring 
the response to steadily increasing temperatures (usually at a ramp rate of 1-2°C/min) to determine 
the temperature at which a polymer rapidly begins to aggregate into a gel (Bain et al. 2012; Nasatto 
et al. 2015), or to instantaneous thermoresponsiveness by rapidly increasing the platform 
temperature (usually to 37°C) and holding for a prescribed amount of time to measure the time 
course of gelation behavior when introduced to physiologic temperatures (Caicco et al. 2013).  
Figure 1.12: The tissue engineering paradigm: Cells, Scaffold (Tissue Architecture), and Signals 
(Niche Properties). 
Adapted from Moysidou, Barberio, & Owens (2021). 
 
1.7   Tissue Engineering and Biological Repair 
While acellular biomaterial approaches to IVD repair hold promise for restoring disc 
hydration and mechanics, biologic therapy is an increasingly appealing alternative to end-stage 
surgical treatment, as it attempts to mitigate the cause of IVDD before the effects become too 
severe and spread to adjacent structures. Partial or full NP replacement seeks to rehydrate the disc 
and restore hydrostatic pressure lost during nucleotomy. The goal of tissue-engineered disc 
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replacements is not only to restore hydration, pressure, and overall mechanical function, but also 
biological function, so that the replaced disc can maintain itself. 
Tissue engineering aims to combine cells with engineered environments in an attempt to 
replicate, heal, and/or replace injured or diseased tissues, and thus, is a promising strategy for 
alleviating the effects of IVDD (O’Halloran and Pandit 2007; Henry et al. 2018; Hudson et al. 
2013). Targeting the NP where IVDD begins, tissue engineering strategies attempt to address 
degeneration before the effects spread irreversibly to the surrounding tissues of the AF, CEP, and 
adjacent vertebral bodies. Depending on the severity of the disease state, various regenerative 
approaches may be taken. In early degeneration, direct growth factor delivery may be sufficient to 
stimulate matrix production in the native cells (Singh, Patel, and Singh 2021). Platelet-rich plasma 
(PRP) is an appealing therapy utilized by clinicians because it is an autologous treatment that 
requires little to no manipulation and can be produced quickly, avoiding many regulatory hurdles 
of regenerative therapies, however, clinical efficacy is highly variable and there is no strong 
consensus on whether the resultant effects are regenerative or palliative. (Urits, Viswanath, et al. 
2019). If the native cells are not responsive, or the existing matrix is too degenerated, a nucleotomy 
may be performed and the void space may be filled with cells in an engineered scaffold. Both of 
these treatments depend on the remaining structural stability of the AF; if the AF is damaged and 
can no longer provide mechanical support to withstand the pressure within the NP, then a whole 
disc replacement will be necessary, with both NP and AF portions of the IVD engineered (Bowles 
et al. 2011; Gullbrand et al. 2018). The traditional tissue engineering paradigm is a triad that 
consists of cells, scaffold, and signals (Figure 1.12): the appropriately terminally differentiated 
cells or stem cells with potential to differentiate to the target cell type must be delivered with a 
scaffold material to provide structure and mechanical cues, while soluble factors like growth 
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factors and cytokines, as well as bound factors such as integrin binding peptides can be utilized to 
further direct cell behavior. The following sections will outline the three traditional components 
of tissue engineering and the current state of the art of NP tissue engineering. 
1.7.1   Cell Source 
Cell source is one of the first questions that must be answered when tissue engineering the 
NP, as the unique characteristics of the cell will dictate what type of environment is necessary to 
produce a de novo healthy NP. Various animal sources of NP cells have been used in in vitro and 
preclinical in vivo studies, including rat (Bowles et al., 2011; Maidhof et al., 2012; O’Halloran & 
Pandit, 2007), and bovine cells (Chou and Nicoll 2009; Reza and Nicoll 2010a; 2010b; Feng et al. 
2014). While these cells are useful model systems, development of translational therapeutics has 
focused on allogeneic and autologous cells. Autologous or cadaveric NP cells have been 
considered as an option; however, their functionality and availability is problematic. Given that 
the loss of the large, vacuolated notochordal cells (NCs) and the rise of small, chondrocytic cells 
in the NP is regarded as a precipitator of degeneration, autologous adult NP chondrocytes are 
generally not used as a tissue replacement. Conversely, NCs are known to regulate NP matrix early 
in life and are an appealing option, however, cell density in the native disc is so low that harvesting 
enough cells to expand in culture and produce a clinically viable tissue-engineered construct is 
difficult. NCs almost entirely disappear from the human NP by 10 years of age, which also 
contributes to the problem of acquisition of cells (Chen, Yan, and Setton 2005). Still, NCs, and 
NC-conditioned media have been shown to promote NP matrix elaboration in other cells in co-
culture, which may be useful for in vitro organ development (Korecki et al. 2010; Aguiar, Johnson, 
and Oegema 1999). 
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Significant developments in stem cell research make such progenitor cells an appealing choice 
for NP tissue engineering. Potential sources of stem cells include induced pluripotent stem cells 
(iPSCs) (Tang et al. 2018) and adult mesenchymal stromal cells (MSCs). Embryonic stem cells  
(ESCs) from animal sources are available for study, however, human embryonic stem cells are 
difficult to obtain and face ethical and political challenges for use (Urits, Capuco, et al. 2019). 
Autologous adult MSCs have shown promise in differentiating into NP-like cells (Gou et al. 2014; 
Risbud et al. 2004; Steck et al. 2005).  These multipotent, non-hematopoietic progenitor cells have 
proven ability to differentiate into all connective tissue lineages, and are easily harvested from a 
patient, either from bone marrow (Zhang et al. 2021; Gupta and Nicoll 2014) or adipose tissue 
(Zhu et al. 2019; Minogue et al. 2010), and expanded in culture.  
Recently, a subset of mesenchymal stem cells within the IVD have been identified, showing 
nearly identical differentiation capabilities as bone marrow-derived MSCs (all except adipocytes) 
(Blanco et al. 2010; Henriksson et al. 2009). Although the population is likely too small to harvest 
and use for tissue engineering, they do have the potential for direct stimulation by growth factor 
delivery in the early stages of disc degeneration, as well as being target cells for cell-homing 
strategies that use diffusion of growth factors to induce chemotaxis, such that the local stem cell 
population will populate a cell-free scaffold themselves (Illien-Jünger et al. 2012; Sakai and Grad 
2015). 
Identifying the phenotype of the cells chosen for the tissue engineering construct is critical in 
determining the success of the biological therapy. Many attempts have been made at identifying 
NP specific gene and protein markers. The primary matrix components of the NP are similar to 
those of AC, namely proteoglycans (in particular, aggrecan) and type II collagen, although the 
proportions of proteoglycan to collagen (as well as total water content) differ. NP cells and AC 
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cells both highly express COL2A1, ACAN, and SOX9. Minogue et al. (2010) explored gene 
expression in NP and AC cells and identified a number of NP positive and NP negative (AC 
positive) genes. The NP-positive genes were PAX1, FOXF1, HBB, CA12, and OVOS2; the AC-
positive genes were GDF10, CYTL1, IBSP, and FBLN1. Lee et al. (2007) found that in rat NP, 
annexin A3, glypican 3 (GPS3), keratin 19 (K19), pleiotrophin (PTN), and vimentin (VIM) were 
expressed significantly more than in the AF and AC, while cartilage oligomeric matrix protein 
(COMP) and matrix gla protein (MGP) were higher in AC than NP; they did note, however, that 
there were no clear “on/off” markers to distinguish NP from AF or AC cells. Lv et al. (2014) 
reviewed many different studies on phenotypic markers in multiple species and concluded that N-
cadherin (CDH2) and keratin 19 (K19) are potential NP markers, as they distinguish healthy NP 
from AF, AC, and degenerate NP.  Although these and other genes have been described as NP 
markers because they identify NPCs in non-human species, Thorpe et al. (2015) have cautioned 
that KRT-19, KRT-18, CD24 and laminin genes, LAM-5 and LAM-11, do not distinguish between 
NPC and AC cells in humans. Gene expression is a useful tool in determining cell differentiation 
and lineage, however, protein expression has more direct functional application, as it is not only 
indicative of successful transcription of the genes but results in gross biological and mechanical 
changes in the tissue. 
1.7.2   Growth Factor Delivery  
When engineering new tissues, and particularly when using stem cells, growth factors are 
often necessary to direct cells towards the appropriate phenotype. These factors may influence the 
production of matrix molecules, decrease the production of catabolic enzymes, or a combination 
of both effects (Yang and Li 2009). Many of the growth factors used in engineering NP tissues are 
from the transforming growth factor-β (TGF-β) superfamily, including TGF-β1, TGF-β3, and bone 
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morphogenetic proteins-2, -7 and -12 (BMP-2, -7, -12) (Li et al. 2017), as well as others, such as 
insulin-like growth factor 1 (IGF-1) (Chon et al. 2013; Shim et al. 2016), and 
growth/differentiation factor-5 (GDF-5) (Yang and Li 2009; O’Halloran and Pandit 2007; S Chen 
et al. 2019). In particular, numerous studies have utilized TGF-β1 and TGF-β3 to differentiate 
stem cells towards a chondrogenic and NP-like phenotype in vitro (Steck et al. 2005; Cox et al. 
2014; Gupta, Cooper, and Nicoll 2011). Studies have shown that short term TGF-β3 treatment of 
encapsulated bone-marrow derived MSCs was sufficient to promote long-term differentiation and 
tissue maturation (Steck et al. 2005; Cox et al. 2014; Gupta, Cooper, and Nicoll 2011). Long-term 
efficacy of growth factor stimulation and delivery is limited, however, due to their short half-lives 
(Wang et al. 2017). Growth factor stimulation has been shown to be critical for the differentiation 
of encapsulated hMSCs; in the absence of growth factor stimulation, cells fail to clearly 
differentiate and synthesize new matrix (Madry et al. 2014; Johnstone et al. 2013; Gupta, Cooper, 
and Nicoll 2011). Various delivery vehicles have been developed to protect and prolong the 
bioavailability and bioactivity of growth factors for tissue engineering, with a particular focus on 
in vivo translation. 
In vivo, exogenous growth factor supplementation is not feasible, and so growth factor 
delivery mechanisms must be utilized to supply growth factors with the injectable scaffold material 
and sustain their bioavailability long enough to direct stem cell differentiation. Prolonged growth 
factor delivery can be difficult to control and expensive to maintain. Direct loading of growth 
factors into hydrogels usually results in a burst release due to the rapid influx of water into the 
hydrogel pushing out the payload (Lin and Metters 2006; Silva et al. 2009). Sequestration or 
delivery of growth factor remains an area that many are attempting to address through such 
methods as modification of the scaffold material via covalent tethering (Mann, Schmedlen, and 
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West 2001; Schneider et al. 2019; McCall, Luoma, and Anseth 2012), encapsulated microparticles 
(Holland, Tabata, and Mikos 2003; Bian et al. 2011), and affinity-based sequestration (Figure 
1.13) (Benoit and Anseth 2005; Tae et al. 2006; Bian et al. 2011; Lee, Silva, and Mooney 2011). 
Covalent immobilization of growth factors or growth factor mimics can lead to sustained signaling, 
but can be susceptible to hinderance by steric factors, or conversely can provide permanent 
stimulation, which is not always desirable (Mann, Schmedlen, and West 2001). Secondary carriers 
such as microparticles have also been used in growth factor delivery, however, this approach 
requires multiple steps for particle and hydrogel preparation, and presents a less direct route for 
delivery since the factor must be released from the microparticles to reach encapsulated cells, 
potentially delaying stimulation (Bian et al. 2011). 
 
Figure 1.13: Schematic representation of growth factor delivery mechanisms from hydrogels. 
(Blue squares represent growth factors). Adapted from Censi et al. (2012). 
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Affinity-based growth factor sequestration is a promising method that utilizes affinity 
between molecules to attract and reversibly bind growth factors. These affinity molecules can be 
ligand mimetic peptides, guest-host interactions (cyclodextrin), or more fundamental 
intermolecular attractions like Van der Waals forces, hydrogen bonding, electrostatic and 
hydrophobic interactions (Wang & Von Recum, 2011). Electrostatic interactions are one such 
affinity sequestration mechanism of particular interest because it mimics the natural behavior of 
the native ECM. Specifically, negatively charged sulfates on GAGs, such as heparin and 
chondroitin sulfate, are known to act as depots for charged growth factors, maintaining their 
availability and prolonging their activity, with some growth factors showing greater resistance to 
proteolysis and thermal denaturation when bound to heparin or heparan sulfate (McCall, Lin, and 
Anseth 2011; Soares Da Costa, Reis, and Pashkuleva 2017).  Heparin-based growth factor delivery 
systems have been investigated due to the affinity of many growth factors such as BMP, bFGF, 
and TGF-β to heparin, thus enabling sustained release of the encapsulated growth factors (Jeon et 
al. 2011; Lei, Trevino, and Temenoff 2016; Lei et al. 2014; Nie et al. 2007; Liang and Kiick 2014; 
Hachim et al. 2019). 
Scaffolds that mimic the sulfation of native matrix GAGs by artificially incorporating sulfate 
groups have also been investigated (Purcell et al. 2014; Feng et al. 2017; Hintze et al. 2012; Yan 
et al. 2018; Portocarrero Huang et al. 2017; Waghmare et al. 2018). Sulfated alginate gels have 
shown to sequester heparin-binding proteins bFGF, VEGR, IGF and TGF-β1 (Freeman, Kedem, 
and Cohen 2008; Re’em et al. 2012). Many of these artificially sulfated polymers have been 
referred to as “GAG mimetics” as they aim to mimic highly sulfated GAG-rich matrices in a 
controllable fashion (Arslan, Guler, and Tekinay 2016; Sivan et al. 2014). These studies utilize 
SO3-dimethyl formamide complexes, pentosan sulfates, carbodiimide chemistry with sulfuric acid, 
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and other mechanisms for covalently sulfating the base polymer (Hintze et al. 2012; Frith et al. 
2013; Freeman, Kedem, and Cohen 2008). 
1.7.3   Biomaterials for NP Tissue Engineering 
Biomaterials under consideration for tissue engineering of the NP must satisfy the same 
requirements as acellular NP replacement biomaterials (injectability, in situ gelling, and swelling 
and mechanical properties matching the healthy NP) as described earlier in section 1.6. In addition, 
there are a number of considerations specific to carrying and supporting cell differentiation and 
tissue growth (Huang, Hu, Li, & Luk, 2018). Firstly, cytocompatibility of the material must extend 
beyond not releasing cytotoxic factors (the response to which is noticeable within 24-72 hours) 
but should promote cell survival and differentiation. Proliferation is often seen as a marker of cell 
health, however, studies have shown that proliferative phenotypes are different than “biosynthetic” 
phenotypes that lay down matrix, so increasing cell number may not be indicative of biomaterial 
success (Strehl et al. 2002). Secondly, ideally the scaffold should break down at a rate concurrent 
with matrix deposition by the cells, such that mechanical integrity of the construct is not lost, but 
void space is created within the gel to be permissive for neomatrix elaboration (Bryant and Anseth 
2003; Chung et al. 2009). 
Integrin binding moieties like RGD (fibronectin derived) or direct conjugation of cell 
attachment matrix proteins (like laminin) have been utilized to harness the cell’s responsiveness 
to its environment (Bridgen et al. 2017; Francisco et al. 2013). Immature NP cells preserve their 
phenotype and matrix-production on soft gels (Hwang, Chen, et al. 2014). Similarly, studies with 
both NPCs and hMSCs in chemically crosslinked carboxymethylcellulose (CMC) yield better 
results in NP gene expression and matrix elaboration on softer substrates, even in the absence of 
any cell-binding sites (Reza and Nicoll 2010a; Gupta and Nicoll 2014; Lin et al. 2016). Hyaluronic 
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acid and type II collagen-based hydrogels have been studied extensively for NP tissue engineering, 
as they are found natively in the NP, and provide an excellent mimic for the native tissue that 
promotes NP-like differentiation (Calderon et al. 2010; Cloyd et al. 2007). However, because they 
are animal derived and specifically found in the NP, these materials are susceptible to enzymatic 
degradation, which is upregulated in the degenerative disc. Hydrogels composed of alginate, a 
natural polysaccharide derived from kelp, have also shown the ability to support NP-like matrix 
elaboration (Chou and Nicoll 2009; Bron et al. 2009).  Nevertheless, these ionically crosslinked 
gels are not mechanically stable enough for long-term culture, and certainly less so for in vivo 
application. Synthetic materials have also been investigated for NP tissue engineering, although 
less so than naturally derived substrates. Synthetic hydrogels that are designed with hydrolytically 
degradable portions in particular, like poly(lactic-co-glycolic acid) (PLGA) have shown promise 
as they are permissive to NP-like matrix elaboration, although they are otherwise “bioinert” in that 
they do not directly interact with encapsulated cells (Fraylich et al. 2010). 
As stated in earlier sections, injectability is a critical factor for both acellular biomaterial and 
cell-based NP replacement materials. Injectability in the IVD possesses a unique challenge, not 
only because delivery must be through a fine gauge needle, but because the IVD and NP void 
space are naturally high-pressure regions, and the void space created by nucleotomy is irregular, 
all of which puts the injectable at risk for extravasation. This not only directly leads to failure of 
the NP replacement but can have deleterious effects to neighboring tissues in vivo. It is critical that 
“injectable” systems that pass injectability tests in the laboratory be validated, either in vivo or in 
ex vivo motion segment models. Work in our lab has shown very promising results for NP-like 
differentiation and matrix elaboration in soft, CMC-based hydrogels (Reza and Nicoll 2010b; 
Gupta, Cooper, and Nicoll 2011; Gupta and Nicoll 2014; Lin et al. 2016). Recently, we were able 
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to transition the photocrosslinked CMC hydrogel system to one that polymerizes in situ without 
the need for ultraviolet light exposure using a redox-initiated crosslinking system with 
APS/TEMED in dual-barrel syringes (Varma, DiNicolas, and Nicoll 2018). These scaffolds 
showed robust and uniform distribution of NP matrix components Col II and sGAGs. However, 
preliminary ex vivo motion segment studies showed that despite redox-initiated polymerization 
and rheological studies that indicated rapid gelation, the viscosity of the gel did not increase 
enough to resist extravasation from the disc upon injection. CMC was mixed with MC in order to 
combine the high swelling capacity of CMC and the intrinsic thermogelling capacity of MC to 
form an in situ gelling acellular NP replacement that restored disc height and range of motion 
(Varma et al. 2018). However, the effective macromer concentration of this system is 6%, which 
is far from the low macromer concentrations that are most permissive to cell differentiation (1.5-
2%). Thus, future work aims to shift the development of this cellulose-based hydrogel system, 
such that it maintains the ability to support cell differentiation and matrix production, while also 
providing translational potential of an in situ forming hydrogel. 
1.7.4   Cellulosic Biomaterials 
Cellulose is a naturally occurring polysaccharide and is the most abundant polymer on earth 
(Klemm et al. 2005). It is renewable and biodegradable, making it an ideal biomaterial in the age 
of sustainability. It is also easily chemically modified and is highly tunable, making it an ideal 
material for biomedical applications (Fox et al. 2011; Kamide 1977). Cellulose is primarily derived 
from the cell walls of plants but can also be synthesized by bacteria and tunicates (Klemm et al. 
2005; Gorgieva and Trček 2019). Consisting of repeating β(1,4) linked D-glucose units, each 
glucan ring has 3 hydroxyl groups, which allows for strong hydrogen bonding between cellulose 
chains. The hydrogen bonding makes cellulose resistant to dissolution in water and many other 
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organic solvents. However, cellulose can be solubilized in ionic solutions and processed by means 
such as casting, molding, or electrospinning. Degree of polymerization (DP), or the number of 
repeating monomeric units, is highly dependent on source, and can affect the mechanics and 
viscosity of the polymer solution (Klemm et al. 2005). 
The three hydroxyl groups on each glucan unit can easily be substituted with functional 
groups, changing the solubility of the polymer, and making it suitable for a variety of applications 
in biomedicine. Esterification of the hydroxyl groups is a common modification that results in a 
number of cellulose derivatives that have widely been used as biomaterials (Figure 1.14) (Fox et 
al. 2011). Methylcellulose (MC) is the simplest of these derivatives, in which hydroxyl groups are 
replaced by methoxy groups (Desbrières, Hirrien, and Ross-Murphy 2000; Nasatto et al. 2015). 
These methoxy groups create hydrophobic regions within the cellulose polymer while still 
rendering it water soluble (Nasatto et al. 2015; Haque and Morris 1993). The result is a 
thermosensitive polymer that can form reversable, physically crosslinked hydrogels upon heating. 
The addition of ionic salts and other components in solution can be used to tune the thermogelation 
temperature of MC, making it useful for injectable systems that go from lower ambient 
temperatures to physiologic temperatures (Caicco et al. 2013; Gupta, Tator, and Shoichet 2006; 
Zheng et al. 2004). Hydroxypropyl methylcellulose (HPMC) displays similar 
thermoresponsiveness that varies depending on the percentage of methoxyl and hydroxypropyl 
substitutions (Joshi 2011). CMC is another cellulose ether in which hydroxyl groups are replaced 
by highly negatively charged carboxylmethyl groups (Ogushi, Sakai, and Kawakami 2007; Reeves 
et al. 2010). The increased negative charge makes CMC highly hydrophilic, and an excellent 
material for applications in which a high affinity for water is critical. CMC is highly sensitive to 
pH and ionic concentration, which results in tunable swelling behavior. All these cellulose ethers 
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are commonly used in the pharmaceutical and food industries, are biocompatible and are FDA 
approved for several biological applications. Cellulose sulfates (CS) have also been investigated, 
both for their highly anionic character, like CMC, as well as their similarity to sulfated 
glycosaminoglycans found in many animal tissues ( Wang et al. 2007; Zhang, Lin, and Yao 2015; 
Portocarrero Huang et al. 2018; Portocarrero Huang et al. 2017) 
Cellulose microparticles are another form of cellulose that have also recently gained interest 
for biomaterial applications. They include microfibrillated and nanofibrillated cellulose (MFC and 
NFC, respectively), and cellulose nanocrystals (CNC). MFC and NFC are cellulose microfibers 
formed by defibrillation of plant cellulose and are noted to possess high stiffness and strength 
(Borges et al. 2011; Eyholzer et al. 2011). CNC is formed via acid hydrolysis of naturally occurring 
crystalline cellulose fibers (Bhat et al. 2019). The resulting material consists of rod-like crystals 
with unique rheologic properties. CNC is comprised of an isotropic suspension that then forms a 
liquid crystal structure depending on concentration, and is highly dependent on temperature, ionic 
strength, and pH of the solution (Qiao et al. 2016). Micro- and nano-celluloses can be used on their 
own or can be incorporated into hydrogels and other biomaterial matrices in order to increase their 
physical properties (McKee et al. 2014; Stevanic et al. 2012; Haghpanah et al. 2013; Dai et al. 
2019; Markstedt et al. 2015; Bhat et al. 2019). 
Cellulose-derived biomaterials have been used for a variety of applications, such as soft tissue 
fillers ( Varma et al. 2014; Gold et al. 2015; 2014), ophthalmic lubricants, and hemostats (Lewis 
et al., 2013). In addition to its tunability, cellulose is not enzymatically degradable by the human 
body, as humans do not naturally produce cellulose or the enzyme that degrades it (i.e., cellulase). 
This creates the potential for continuous structural support but may be undesirable in the case of 
tissue engineering solutions where the scaffold should eventually degrade at the approximate rate 
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of new tissue development. The introduction of functional groups can tune cellulosic susceptibility 
to hydrolytic degradation. Bacterial cellulose (BC) has become increasingly popular for various 
biomedical applications. Cellulose fibers formed by bacteria, particularly those formed by the 
genus Acetobacter, have high appeal due to their superior purity (they are not associated with other 
substances such as hemicellulose or lignin which are present in plant sources) and are able to 
achieve a much higher DP than plant cellulose, resulting in greater crystallinity as well as increased 
mechanical properties (Rajwade, Paknikar, and Kumbhar 2015).  
 
Figure 1.14: A) Cellulose and B) its ether derivatives. 
Available locations for ether modifications highlighted in green. Adapted from Kabir et al. (2018). 
 
The variety of sources, chemical and physical modifications, and micro- and nano- structures 
of cellulose make it an ideal material for a wide range of biomedical uses, including for IVD repair 
(Klemm et al. 2005; Courtenay, Sharma, and Scott 2018). 
1.7.4.1   Cellulosics for Disc Repair – Acellular Biomaterials 
Several forms of cellulose are being used to develop cell-free, structural reinforcement to the 
IVD, especially for early stages of the disease and post microdiscectomy. Acellular repair or 
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replacement of IVD tissue is a promising approach that faces much fewer regulatory hurdles than 
cell-based tissue engineering. These strategies focus on the mechanical strength of the material, 
their durability over repeated cycles of physiological loading and resistance to herniation during 
complex loading.  
 Borges et al. (2010, 2011) developed composite photocrosslinked hydrogels containing 
Tween 20 trimethacrylate, N-vinyl-2-pyrrolidone, and nanofibrillated cellulose (NFC) and 
assessed the gelling behavior, compressive mechanical properties, and swelling behavior along 
with the morphology and biocompatibility. Here, NFC was chosen as a component of the 
composite hydrogel due to its high water retention value as well as its previous use as a reinforcing 
additive in other polymer matrices. Inclusion of 1.6 wt% of NFC led to a 30-fold increase in the 
compressive strength of the hydrogels. However, despite NFC having a high water-retention value, 
it actually resulted in a lower swelling ratio compared to hydrogels without NFC included. To 
address this, the same group created carboxymethylated NFC (c-NFC), introducing negatively 
charged carboxymethyl groups to increase the hydrophilicity of the composite hydrogel. 
Increasing degree of carboxymethylation resulted in shear thinning behavior by the hydrogel 
mixture, which is promising for injectable applications. Swelling ratio increased within each 
concentration of NFC added, however, none were able to achieve the swelling ratio of the 
hydrogels without c-NFC. Similarly, static compression showed that while the addition of NFC 
increased compressive modulus of the hydrogels, carboxymethylation reduced the modulus within 
a respective % NFC, likely due to the same loosening of the polymer network. A dynamic 
compression protocol comprised of cyclic compression between 0.5-1 kPa using a testing protocol 
mimicking a 16-hour workday. Here, gels with NFC demonstrated highest stiffness and percent 
recovery post testing (Eyholzer et al. 2011). 
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More recently, similar implant strengthening behavior of NFC was also delineated in an ex 
vivo bovine motion segment model using polyethylene glycol dimethacrylate (PEGDMA) 
hydrogels (Khoushabi et al. 2015; Schmocker et al. 2016; Karami et al. 2018). Photopolymerized 
PEGDMA hydrogels were reinforced with NFC, increasing the stiffness 2-3.5-fold without 
compromising the toughness. The high crystallinity and aspect ratio of NFCs provided mechanical 
reinforcement to the hydrogels while lowering gelation time. Additionally, ex vivo biomechanical 
assessment of NFC-chitosan hydrogels implanted in porcine discs demonstrated disc height 
restoration along with relaxation parameters similar to native IVD (Doench et al. 2018). Currently, 
these NFC-chitosan gels form over an hour, which limits their ability to gel in situ for minimally 
invasive IVD procedures. Another interesting nano-sized form of cellulose consists of cellulose 
nanocrystals, which were recently tested in ionically crosslinked gellan gums for AF repair. 
Similar to NFCs, the nanocrystals increased hydrogel stiffness and complex modulus while also 
aiding the gelation process. However, the gelation kinetics of this platform is slow, requiring close 
to 10 minutes to obtain fully formed hydrogels. Further, degradation studies indicated poor 
stability of the gels, with 15% mass loss in 30 days of incubation in PBS (Pereira et al. 2018). 
CMC, a cellulose ester with high water absorbing capacity due to the substitution of anionic 
carboxyl groups for some of the hydroxyls on the cellulose backbone has been methacrylated to 
allow for free-radical crosslinking of the polymer chains resulting in hydrogels with tunable 
material properties (Varma et al. 2014; Gupta, Cooper, and Nicoll 2011). Recently, the Nicoll lab 
has combined methacrylated CMC with thermosensitive MC to obtain thermogelling, injectable, 
redox-polymerized hydrogels capable of forming rapidly (within 4 min.) in situ, with swelling and 
compressive mechanical properties akin to native NP tissue (Varma et al. 2018). Cyclic 
compressive loading of bovine motion segments injected with CMC/MC hydrogels restored a 
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range of compressive biomechanical parameters to healthy values, including the disc height, range 
of motion and neutral zone parameters. Additionally, fatigue testing of this formulation in bovine 
motion segments revealed that the CMC/MC hydrogel improved fatigue endurance of the discs 
compared to the injured condition, but performed similar to the nucleotomy control group, a 
clinical standard for IVD herniation. Although, the implanted and nucleotomy groups presented 
similar herniation risks during the failure test, a majority of the failure parameters (failure strength, 
subsidence to failure and stiffness) were similar between the implanted and intact discs (Lin et al. 
2019). 
1.7.4.2   Cellulosics for Disc Repair – Cell-based Strategies and Tissue Engineering 
While biomaterial-based acellular replacements may be able to relieve pain and partially 
restore mechanical functionality of the spine, lack of cells limits their use for biological repair of 
disc tissue. Therefore, in the long run, a cell-based therapy may serve as a better solution for disc 
degeneration (O’Halloran and Pandit 2007; Yang and Li 2009; Hudson et al. 2013).  Roughley et 
al. (2006) explored a composite hydrogel containing chitosan, glycerophosphate, and 
hydroxyethyl cellulose (HEC) for its potential as an NP tissue engineering scaffold. These 
hydrogels with encapsulated disc cells showed deposition and retention of GAGs. To the best of 
our knowledge, we are the only group to have successfully demonstrated the use of cellulose as 
the primary scaffold material for NP tissue engineering. Reza and Nicoll (2010a) demonstrated 
that photocrosslinked carboxymethylcellulose hydrogels can support NP-like matrix elaboration 
by encapsulated bovine NP cells, thus establishing CMC as a promising biomaterial for NP tissue 
engineering.  Gupta et al. (2011) further explored the utility of photocrosslinked CMC hydrogels 
for the encapsulation of human mesenchymal stem cells (hMSCs).  These cells showed NP-like 
differentiation under TGF-b3 treatment, as determined by assessment of gene expression and 
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relevant matrix macromolecular deposition. Furthermore, the resulting tissue engineered 
constructs possessed compressive mechanical properties similar to that of the human NP.  That 
study was a critical step forward as hMSCs are a more clinically relevant cell source compared to 
either autologous or allogeneic NP cells.  In subsequent studies, our group evaluated the impact of 
photocrosslinked CMC scaffold composition and TGF-b3 exposure duration on the NP-like 
differentiation of encapsulated hMSCs, further elucidating scaffold microenvironmental effects on 
hMSCs, leading to improved CMC hydrogel systems (Gupta and Nicoll 2015; Lin et al. 2016; 
Gupta and Nicoll 2014).  As UV light has limited tissue penetration, photocrosslinking restricts 
clinically relevant, minimally-invasive delivery of CMC hydrogels. Thus, the Nicoll group has 
recently been exploring redox-initiated crosslinking in CMC hydrogels to achieve in situ gelation 
with an injectable material, moving closer to clinical translation. (Varma, DiNicolas, and Nicoll 
2018) successfully demonstrated that redox-polymerized CMC hydrogels support NP-like 
differentiation of encapsulated hMSCs, leading to relevant matrix deposition and functional 
mechanics in vitro.  
Successful tissue engineering of whole IVDs will be a big step forward in the spine field, 
especially for patients who present late stage IVDD requiring full discectomy. The angle-ply 
architecture of the AF and integration of the inner AF to the NP are largely responsible for 
maintaining the disc pressure, height and preventing herniation of the NP in healthy discs, 
however, this complex structure is challenging to replicate in tissue-engineered constructs. Yang 
et al. (2018) presented an interesting approach to tissue engineer whole IVDs by micropatterning 
bacterial cellulose to re-create the angle-ply structure of the AF, further rolling the cellulosic sheets 
embedded with AF cells, and combining a central collagen gel to create disc-shaped organs. 
Integration of these tissue-engineered units with native tissue was evaluated in vivo in rat tails. The 
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resulting 3-month data demonstrated successful integration and inter-lamellar neo-tissue formation 
along with disc height and mechanical strength similar to native, healthy discs. This study utilized 
micropatterning to achieve aligned cells and matrix components - a novel, scalable approach to 
obtain tissue-engineered whole IVDs. Although successfully demonstrated in animal studies, the 
isolation and use of healthy human AF and NP cells poses several challenges, which can be 
countered by using adipose or mesenchymal stem cells. In addition, this strategy is also dependent 
on successful delivery of growth factors, either via scaffolds or gene-delivery. Growth factors, 
such as GDF-5, TGF-b1, are some of the most studied proteins for NP differentiation and identified 
as critical to sustain the differentiated state of stem cells in the NP. Henry et al. (2017) 
demonstrated the use of pullulan microbeads to enable sustained release of these growth factors in 
injectable silanized hydroxypropylmethylcellulose (HPMC) hydrogels. Further investigation of 
the microbead system in an ex vivo degenerative disc model showed that sequential release of the 
chemokine CCL-5, followed by TGF-b1 and GDF-5, could recruit MSCs into the NP and induce 
matrix elaboration, although they have not yet reported data on tissue elaboration within the HPMC 
hydrogels. 
Recently, an injectable hyaluronic acid-methylcellulose (HAMC) hydrogel carrier with 
Wharton’s jelly-derived MSCs (WJ-MSCs) was reported for repair of degenerate discs in a rat 
model (Choi et al., 2020). This hydrogel has been previously used for various neurological repair 
strategies, but this is the first report of its use in orthopedic tissues (Gupta, Tator, and Shoichet 
2006; Caicco et al. 2013). The hydrogel promoted retention and survival of the WJ-MSCs, and 
together showed superior matrix elaboration, restoration of disc hydration, and down regulation of 
catabolic enzymes that frequently matched that of the uninjured control. It should be noted, 
however, that the rat-tail model is extremely small, and retention within a disc of that size does not 
49 
necessarily translate to retention of cells or elaboration within larger species (i.e., human). 
Furthermore, mechanical properties were not reported, and from previous studies of physically 
crosslinked gels, it can be surmised that the HAMC hydrogel system would not likely contribute 
to the restoration of disc height or mechanics. 
1.7.5   Design Criteria and Functional Outcomes 
The goal of NP tissue engineering is to restore the mechanical function of the degenerate disc 
to healthy levels and promote the ability of the incorporated cells to actively maintain the healthy 
tissue. In addition, delivery of a tissue-engineered therapeutic for NP repair must minimize any 
disruption to the neighboring structures to limit further damage and disease progression. As such, 
the endpoints of the tissue-engineered construct should be clearly defined and aim to achieve 
characteristics as close to the native, healthy disc as possible.  
As the NP and IVD’s function is purely mechanical, a tissue-engineered NP replacement must 
attempt to meet the mechanical specifications of the NP (Nerurkar, Elliott, and Mauck 2011). 
Several studies have been conducted on the native tissue mechanics of the healthy IVD, as a 
composite structure, as well as the individual portions of the AF and NP. Table 1.1 below shows 
a summary of the mechanical benchmarks for the NP relevant for NP tissue engineering. 
Additionally, swelling behavior is a critical component of NP material behavior. Though to the 
best of our knowledge the equilibrium weight swelling ratio (Qw) of healthy human NP tissue has 
not been reported in the literature, our laboratory has previously measured Qw of healthy bovine 






Table 1.1: Summary of native tissue mechanics benchmarks of the NP. 
Modified from Nerurkar et al. (2011) 
Testing Modality Benchmark Native Value 
Confined Compression 
(Johannessen and Elliott 2005) 
Swelling Stress Psw 0.138 MPa 
Aggregate Modulus HAeff 1.01 ± 0.43 MPa 
Permeability ko 0.9x10-15 m4/Ns 
Unconfined Compression 
(Cloyd et al. 2007) 
Equilibrium Young’s modulus Ey 5 kPa 
Poisson’s ratio 0.62 
Percent relaxation ~65% 
Torsional shear 
(Iatridis et al. 1997) 
Complex shear modulus |G*| 7.4-19.8 kPa 
Phase shift δ 23º-30º 
 
The similarities between AC and the IVD are many, particularly in the make-up of the matrix. 
The cells of the mature IVD are so similar to articular chondrocytes that they are often referred to 
as NP chondrocytes. Still, the IVD and AC are two distinct tissues that have key differences to be 
mindful of while tissue engineering either one of them. The function of the IVD as a whole is to 
resist compression and allow motion; separately, the NP resists compression while the AF resists 
tension. Cartilage resists compression but also provides lubrication for articulating joints (Chen et 
al. 2017). Both AC and NP are characterized as having high proteoglycan content, particularly of 
aggrecan, as well as collagen type II. A critical difference lies in the ratio of these molecules, as 
the glycosaminoglycan to collagen ratio is 2:1 in cartilage, and 27:1 in the NP 
(GAG:Hydroxyproline) (Mwale et al. 2004; Yang and Li 2009). Absolute values of GAG and 
collagen in the NP are approximately 250 µg/mg dry weight and 525 µg/mg dry weight, 
respectively (Antoniou et al. 1996; Mwale et al. 2004). Type II collagen outnumbers type I in the 
NP 60:1 (Antoniou et al. 1996). The relative proportions of these matrix components are what 
distinguish NPCs from AC cells, however, it is not necessarily accurate to apply this proportion to 
gene expression (Mwale et al. 2004; Risbud et al. 2015). 
In addition to the functional outcomes of mechanics and biochemistry/matrix elaboration, 
clinical translation must be considered. Primary considerations include the material be sterilizable, 
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cytocompatible, injectable, and retained in situ upon injection. The ideal NP replacement delivered 
minimally invasively, to limit disruption of the AF. Low initial viscosity can allow for injection 
through fine gauge needles (Boyd and Carter 2006). Injectable dermal fillers, which similarly 
require delivery through a fine gauge needle (27-30 ga) have been reported to range in initial 
viscosity from 58-1199 Pa·s (Falcone and Berg 2008). In addition, because the center of the IVD 
is a high-pressure space, the injectable material must rapidly increase in viscosity and shear 
modulus as it cures in situ in order to resist extravasation from the void space. Previous work from 
our lab using a CMC-MC DPN system reported initial viscosity (within 30 seconds of injection) 
to be 440.7 Pa·s, followed by a rapid 10-fold increase in viscosity by gelation completion (Varma 
et al. 2018). Previous work with CMC alone achieved a final gelation viscosity of ~160 Pa·s, 
though this was found not to be retained within the disc when injected in an ex vivo bovine disc 
model. Thus, while rheological analysis can be used to quantify the viscosity and shear modulus, 
secondary validation in a constrained space, or better yet, an in vivo or ex vivo nucleotomy model 
is useful for qualitatively confirming gelation and retention (Frith et al. 2013; Varma et al. 2018). 
Gelation time should also be taken into consideration, such that the physician has enough time to 
work with the pre-gelled material and fill void spaces, but short enough that the material does not 
extravasate and the procedure time is not prolonged. The current ISO standard for injectable 
biomaterials is 4-15 minutes (ISO Standard 5833:2002).  
1.8   Motivation and Research Overview 
Tissue-engineered NP replacements are a promising solution that can address the immediate 
mechanical needs of a damaged disc; however, clinical translation is hindered by a number of 
factors. As the goal of tissue engineering repair is to minimize further injury to the degenerated or 
herniated disc, delivery of the constructs must remain minimally invasive. Injectability, in situ 
52 
formation and retention are necessary for any acellular or cell-laden biomaterial approach. CMC 
has been methacrylated to form stable, chemically-crosslinked hydrogels that support growth of 
NP cells (Reza and Nicoll 2010b; 2010a) and the differentiation of hMSCs towards an NP-like 
phenotype when treated with TGF-β3 (Gupta, Cooper, and Nicoll 2011; Gupta and Nicoll 2014; 
Lin et al. 2016). However, recent work has demonstrated that even when utilizing redox-initiated 
crosslinking methods, methacrylated CMC does not gel in situ in the disc space due to diffusion 
away from the injection site (Varma et al. 2018). Recently a dual-polymer network (DPN) 
hydrogel consisting of methacrylated CMC and MC was investigated as a potential acellular NP 
replacement. MC afforded the construct additional thermogelling capacity, which allowed for in 
situ retention and restoration of disc height and mechanics, however, the effective polymer 
concentration was too high to support encapsulated cell viability. To reduce the effective 
macromer concentration while maintaining injectability and intradiscal retention, the overall 
objective of this thesis was to identify a lower macromer concentration of a single polymer network 
consisting of MC that would be retained in situ while serving as a potential cell scaffold. MC 
hydrogels have been well characterized for their mechanical and material properties once 
chemically crosslinked and for rheological properties during redox-initiated gelation (Gold et al. 
2014; 2015), but the influence of this chemical modification on the intrinsic thermogelation of MC 
is unclear. Therefore, the first objective of this thesis was to investigate the effect of methacrylation 
on MC thermogelation and its role in the rheologic properties of a dual-crosslinked MC hydrogel 
network. Although methylcellulose is a water-soluble cellulose derivative, its thermosensitive 
nature is derived from the presence of hydrophobic methoxy groups on its backbone, which also 
results in a lower swelling capacity than CMC. Incorporation of negatively charged sulfonate 
groups to the polysaccharide backbone of MC would allow the polymer to mimic the charged 
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proteoglycan-rich matrix of the NP, which can enhance the water uptake and swelling capacity 
and potentially promote differentiation of stem cells towards an NP-like phenotype. Thus, the 
second objective of this thesis was to develop a sulfonated MC hydrogel and characterize its 
material properties relevant to NP replacement. Furthermore, matrix sulfation has been shown to 
promote sequestration and presentation of growth factors. Clinical translation of a potential 
injectable, cell-based scaffold material requires the ability to retain and deliver TGF-b3 (Purcell 
et al. 2014; Lei, Trevino, and Temenoff 2016; Merceron et al. 2012). Accordingly, we also aimed 
to characterize the sustained release or sequestration of encapsulated TGF-b3 from within these 
scaffolds. Multiple studies have now shown CMC hydrogels successfully support NP-like 
differentiation and matrix elaboration of hMSCs (Varma, DiNicolas, and Nicoll 2018; Lin et al. 
2016; Gupta and Nicoll 2014; Gupta, Cooper, and Nicoll 2011); however, methacrylated MC 
hydrogels have not been investigated as scaffolds for hMSCs. Thus, the final objective was to 
characterize hMSC survival, differentiation, and matrix elaboration within dual-crosslinked MC 
hydrogels. As matrix sulfation has been shown to be critical to the development of healthy skeletal 
tissues, the effect of added sulfonation to the matrix was also investigated (Cho et al. 2004; Mertz 
et al. 2012; Cortes, Baria, and Schwartz 2009; Klüppel et al. 2005). 
The tissue engineering paradigm centers on three factors: scaffolds, signals, and cells; 
previous studies have combined these in vitro using exogenous delivery of growth factors via cell 
culture media. A clinically translatable tissue engineering solution would need to deliver all three 
together, as exogenous growth factor is not clinically feasible. In addition, previous work in our 
lab has shown promise for robust acellular in situ gelling biomaterials that aim to restore disc 
mechanics, and for soft, cell-laden constructs that promote hMSC differentiation, but not materials 
that achieve both desirable outcomes. As such, the global hypothesis of this thesis is that an MC-
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based hydrogel system can be utilized as a thermogelling, injectable and in situ gelling system 
capable of serving as a clinically translatable method of tissue engineering NP repair. 
Specifically, chemical modifications of MC via controlled methacrylation percentage and 
sulfonation may be employed to direct injectability and sequestration of soluble factors to 
support hMSC differentiation towards an NP-like phenotype. 
The specific aims to test this hypothesis are as follows: 
Specific Aim 1: Investigate the influence of the degree of methacrylation modification 
on thermogelation and rheological properties of MC. 
MC polymer solutions will be modified with methacrylate groups resulting in varying 
methacrylation percentages, and the rheological properties of methacrylated MC without redox-
initiated chemical crosslinking (thermogelation onset temperature, storage and loss modulus, 
complex viscosity, phase angle, and shear thinning behavior) will be assessed in relation to varying 
temperature, shear rate, and time. Storage and loss modulus upon completion of redox-initiated 
chemical crosslinking and time to completion will also be investigated after gelation at room 
temperature (20ºC) and physiologic temperature (37ºC) to assess the role of the thermoresponsive 
behavior in chemically crosslinked hydrogel behavior, and to determine if gelation at physiologic 
temperature results in a dual-crosslinked hydrogel. 
Specific Aim 2: Develop sulfonated MC hydrogels for injectable NP replacement with 
tunable swelling and mechanical properties, as well as a means for retaining incorporated 
TGF-b3 to serve as a clinically relevant, tissue engineering scaffold. 
Negatively charged monomers, 2-sulfoethyl methacrylate (2SEM), will be covalently 
incorporated into MC hydrogels during free-radical polymerization. The effects of 2SEM 
incorporation on bulk material properties (equilibrium swelling, mechanics) and long-term 
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stability of acellular hydrogels will be assessed. Injectability will be evaluated by investigating 
thermogelation and redox-initiated gelation of sulfonated gels via rheometry, and in situ gelation 
will be assessed via injection into an ex vivo nucleotomized bovine motion segment model. The 
electrostatic interaction of sulfonated MC hydrogels with proteins will be characterized by 
quantifying serum protein adsorption, and more specifically, its ability to sequester incorporated 
TGF-b3 over the course of two weeks via electrostatic affinity will be interrogated. 
Specific Aim 3: Investigate the ability of redox-polymerized MC hydrogels (with and 
without the addition of sulfonates) to support human mesenchymal stromal cell (hMSC) 
differentiation towards an NP-like phenotype with TGF-b3 supplementation in cell culture 
media or direct incorporation into hydrogel constructs. 
Human MSCs will be encapsulated within MC hydrogels with and without sulfonates, and 
survival and differentiation will be assessed in vitro. TGF-β3 will either be incorporated directly 
into the hydrogels or supplemented exogenously via cell culture media to assess the impact of the 
hydrogel sulfonation on the bioavailability of TGF-β3 to encapsulated hMSCs. Human MSC 
viability and differentiation will be determined based on DNA content, ECM content (sGAGs and 
Collagen type II) and distribution and construct mechanical properties over the duration of the 
culture period. 
Successful completion of the above Specific Aims will result in the development of a fully 
self-contained, injectable system for tissue engineering repair of the injured or degenerate NP. This 
thesis work will provide greater insight into the influence of chemical modifications (i.e., 
methacrylation, sulfonation) on the thermoresponsive behavior of MC and functional network 
formation. Moreover, it will establish the feasibility of chemically-crosslinked MC hydrogels as 
cell-instructive scaffolds for minimally invasive, clinically-relevant, tissue engineering therapies. 
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1.9   Overview of Present Investigation 
The global objective of this thesis is to engineer an injectable MC-based hydrogel system as 
a functional NP replacement for both cell-based and acellular therapies for IVDD. Previous studies 
have shown successful NP-like differentiation of encapsulated hMSCs but were unsuccessful in 
forming gels directly in the disc, and the combination acellular cellulosic gel developed 
subsequently (CMC-MC) was not permissive for hMSC encapsulation and differentiation. It was 
found that the thermogelling capacity of MC combined with redox-initiated covalent crosslinking 
is necessary for in situ gel formation. Even though we have seen that the thermogelling behavior 
is preserved in methacrylated MC, the effect of methacrylate modification and percent 
modification on the thermoresponsive behavior of MC has not been investigated. Additionally, we 
have observed previously that methacrylation percentage surprisingly did not have a strong effect 
on swelling and network properties (i.e., mesh size, crosslinking density) of MC, contradictory to 
most polymer studies (including CMC), which showed increasing the availability of potential 
crosslinking sites leads to increased crosslink formation and modified physical properties. This 
motivated the more in depth rheometric investigation of MC at varying methacrylation 
percentages. Thus, thermogelation onset temperature, thermoresponsive gelation and shear 
thinning behavior at physiologic temperature, and redox-initiated crosslinking kinetics were 
investigated for various methacrylation percentages and are presented in Chapter 2. This study 
demonstrated that the addition of methacrylate groups lowers the thermogelation onset temperature 
and increases the thermoresponsiveness of MC hydrogels, potentially affecting the injectability 
and handling of MC solutions, but did not have a major additive effect on the complex modulus 
of redox-polymerized gels at room temperature or physiologic temperature. 
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Previous studies comparing CMC hydrogels to MC hydrogels favored CMC hydrogels 
because of the higher swelling capacity afforded by the negatively charged carboxyl groups. An 
additional translational challenge has been delivery of TGF-b3 within the hydrogel system. As 
such, Chapter 3 aimed to address both issues by incorporating sulfonates into the MC hydrogel 
system, with the goal of creating an in situ gelling GAG mimetic that increased MC swelling 
capacity and sequestered incorporated TGF-b3 for delivery in a single hydrogel system. Sulfonated 
MC hydrogels were investigated for injectability, swelling, mechanical behavior, long-term 
stability, and cytocompatibility in a factorial design comparing three macromer concentrations 
(2%, 3%, and 4%) and four sulfonate concentrations (0 mM, 1 mM, 5 mM, and 10 mM). Sulfonate 
incorporation did not increase the water capacity of MC hydrogels but did sequester TGF-b3 in a 
tunable fashion. In addition, ex vivo bovine motion segment models for injection and retention 
showed that a minimum of 3% MC crosslinked with 10 mM APS and TEMED each was necessary 
to form hydrogels in situ. Therefore, this formulation was used to investigate bioactivity and 
capacity to support hMSC differentiation in Chapter 4. 
The results of Chapter 3 demonstrated the successful creation of an in situ gelling, sulfonated 
MC that sequestered TGF-b3 in a tunable fashion. We selected 5 mM sulfonate concentration, as 
this afforded no significant difference in sequestration from 10 mM, both of which displayed the 
strongest sequestration of encapsulated TGF-b3 over 2 weeks.  Bone marrow-derived MSCs were 
encapsulated in redox-polymerized MC hydrogels with and without sulfonates, and TGF-b3 
delivery was administered either within the hydrogel or through media supplementation, and 
growth factor-free conditions served as controls. Over 6 weeks of culture, the MSC-laden 
constructs showed moderate matrix deposition, with clear superiority in the groups that were both 
sulfonated and received TGF-b3 stimulation, regardless of delivery route.  However, the measured 
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values of ECM content did not approach reported native NP levels. Mechanical and swelling 
properties did not change over time, indicating that MC remained resistant to hydrolytic 
degradation as previous studies had shown. Cell viability decreased over time in all groups except 
those with both sulfonate and TGF-b3 supplementation, indicating a potentially synergistic effect. 
Overall, the study showed that sulfonation and encapsulated TGF-b3 delivery hold promise for 
cellulose-based hydrogels for NP tissue engineering, but that the low swelling capacity and lack 
of scaffold breakdown may have prevented robust matrix elaboration and cell survival, and that 
further optimization is necessary to develop an in situ gelling cellulosic hydrogel that can repair 











Chapter 2:   Rheological Analysis of the Effect of Methacrylation on 
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2.1   Introduction 
Hydrogels are a broad class of biomaterials composed of highly hydrated polymer networks. 
These materials have a wide array of biomedical applications, due to their tunability and water 
content, from cell-laden tissue engineering scaffolds to cell-free prostheses and fillers (Peppas et 
al. 2006; Sivashanmugam et al. 2015; Raucci et al. 2020). In situ forming injectable hydrogels are 
increasingly necessary for a number of minimally invasive biomedical interventions, including 
soft tissue fillers (Gold et al. 2015; Varma et al. 2014; Li et al. 2019; Falcone and Berg 2008), 
orthopedic implants (Raucci et al. 2020; Lin et al. 2021), and drug delivery depots (Mathew et al. 
2018). These biomaterials must have a low starting viscosity in order to be easily injected through 
small gauge needles but must also exhibit an increase in viscosity upon injection in order to not 
lose mechanical integrity or extravasate from the injection site. Physical, ionic, and covalent 
crosslinking of polymeric biomaterials are all means by which an injectable material can form a 
gel in situ in order to be retained at the site of injection. Physical crosslinking of polymers is 
frequently mediated by environmental changes like temperature and pH. This is very useful in 
biological applications, where the introduction of physiological temperature (37°C) or pH (7.4) 
can direct the formation of gels. Physical crosslinks driven by environmental changes are also 
reversible, as they are dependent on specific environmental stimuli, which may fluctuate. 
Methylcellulose (MC) is one such polymer that exhibits temperature-dependent physical 
crosslinking to produce thermoreversible hydrogels. MC is a water-soluble derivative of cellulose, 
a naturally occurring plant-derived polysaccharide and the most abundant natural polymer on earth 
(Klemm et al. 2005). Cellulose is a linear polymer made up of repeating β(1,4) linked D-glucose 
units with three hydroxyl groups on each glucan ring, which allows for strong inter- and intra-
chain hydrogen bonding, resulting in a rigid crystalline structure and resistance to water solubility. 
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Substitution of the hydroxyl groups on cellulose by methoxy groups in MC disrupts the crystalline 
structure, thereby improving its affinity for water and  enabling it to be dissolved in aqueous 
solutions (Nasatto et al. 2015). The methoxy groups themselves are hydrophobic, and thus, while 
the polymer chain is made water-soluble, the methoxy groups form aggregations as temperature 
increases, resulting in a reversible, physically crosslinked hydrogel. Unmodified MC has been 
reported to show a thermogelation onset temperature ranging from 50°C to 70°C, depending on 
degree of substitution (DS) of cellulose hydroxyls by methoxy groups and weight % concentration 
(Haque and Morris 1993; Lin Li 2002). The ability to form hydrophobic aggregates in response to 
increasing temperature is dictated by the concentration of hydrophobic moieties. A DS of 1.7-1.9 
out of 3 possible substitutions of methoxy groups for hydroxyls on cellulose has been shown to be 
optimal for solubility and thermoresponsiveness; higher or lower than this limits the water 
solubility of MC (Sarkar 1979). Other additions to MC such as hydrophobic stearyl groups and 
hydrophilic carboxyl, amino, and acylamino modifications have been used to decrease and 
increase the thermogelation temperature, respectively (Wu et al. 2021; Lee, Cho, and Park 2005; 
Li et al. 2012).  
Although MC readily forms thermoreversible hydrogels, the mechanical properties of the gels 
are generally not sufficient to withstand the forces experienced in many biomedical applications 
(i.e., movement, touch, load-bearing joints). As such, MC is frequently used as an additive in dual 
polymer networks to provide thermogelling capacity, but not on its own as a primary scaffold 
material (Gupta, Tator, and Shoichet 2006; Payne et al. 2017; Choi et al. 2020; Oğuz and Ege 
2018; Jung, Kim, and Ho Park 2019; Mihardja et al. 2013). In order to enhance the mechanical 
properties of MC, we previously coupled methacrylate groups to the MC backbone to allow for 
free-radical crosslinking and the formation of mechanically stable hydrogels via 
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photopolymerization (Stalling, Akintoye, and Nicoll 2009). The injectability of methacrylated MC 
(Ma-MC) hydrogels was later achieved by introducing redox initiators to form covalently 
crosslinked hydrogels in situ (Gold et al. 2014; 2015). In that prior work, Ma-MC hydrogels were 
formed in vitro using redox-initiated, free radical polymerization at room temperature, but the 
influence of temperature on Ma-MC gelation, was not explored. Methacrylate groups are strongly 
hydrophobic and have been shown to decrease the cloud point temperature of the cellulose 
derivative, hydroxypropyl cellulose, in a manner proportional to the degree of methacrylate 
substitution (Marsano, Bianchi, et al. 2000).  Thus, it was hypothesized that methacrylation would 
augment the hydrophobically-driven physical crosslinking of MC, thereby lowering the 
thermogelation onset temperature and enhancing the chemical crosslinking of methacrylate 
moieties, leading to more robust, dual-crosslinked hydrogels. 
Numerous studies have also shown that the solvent constitution of the MC solution (i.e., water 
versus saline) can alter the thermogelation temperature of MC (Zheng et al. 2004; Xu, Li, et al. 
2004; Xu, Wang, et al. 2004). Ionic solutes in aqueous MC solutions can modify both the 
temperature and strength of thermogelation by altering the water solubility of the polymer in 
“salting-out” or “salting-in” effects, depending on the ion(s), in accordance with the Hofmeister 
series (Xu, Wang, et al. 2004; Hofmeister 1888). The effect is tunable and can be seen to vary 
depending on the mixture and concentration of ions, including those in physiologically relevant 
solutions (Xu, Li, et al. 2004; Zheng et al. 2004).  This is particularly relevant for MC hydrogels 
containing cellulose nanocrystals, which require specific solvents (i.e., water) for complete 
resuspension and dispersion in MC solutions (Hynninen et al. 2018). Therefore, in this study the 
effect of methacrylate pendant groups on the thermoresponsive behavior of MC in water and saline 
solutions, and the effect of gelation temperature on redox-initiated polymerization were 
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characterized. This investigation has important implications for surgical implementation of the 
injectable biomaterial, interrogating how the rate of thermogelation and strength of physical 
crosslinks formed at physiologic temperature impact the efficiency of redox-initiated chemical 
crosslinking.  
2.2   Materials and Methods 
2.2.1   Macromer Preparation  
Methylcellulose was methacrylated by esterification of hydroxyl groups with methacrylic 
anhydride (Sigma-Aldrich) according to previously described protocols (Figure 2.1) (Gold et al. 
2014; Stalling, Akintoye, and Nicoll 2009; Varma et al. 2018). Briefly, 15kDa (15 cP viscosity at 
2 wt%, 20°C) and 41kDa (400 cP viscosity at 2 wt%, 20°C) MC powder (Sigma-Aldrich, degree 
of substitution of methoxy groups 1.8) was mixed 1:1 and then added to deionized H2O (diH2O) 
at 1% (w/v) at 80°C until it was evenly disbursed, after which the temperature was lowered to 4°C 
and allowed to continue to dissolve fully for ~24 hours. The mixture of low and medium viscosity 
MC was used for optimal viscosity and handling, as previously described for injectable  tissue 
replacement applications (Varma et al. 2018; Lin et al. 2019). The solution was then reacted with 
methacrylic anhydride with a molar excess of 20 at 4°C with periodic adjustments of pH between 
8-9 for 48 hours. The reaction product was purified by dialysis (Spectra/Por, MWCO 6-8 kDa) 
over 3 days to remove unreacted methacrylic anhydride. Purified solution was lyophilized and 
stored at -20°C. Unmodified MC was treated in the same method as Ma-MC, by dissolving 1:1 





2.2.2   Nuclear Magnetic Resonance 
Polymer samples were acid hydrolyzed as previously described for 1H NMR analysis (500 
MHz, Varian Mercury 500) (Stalling, Akintoye, and Nicoll 2009; Reza and Nicoll 2010a). Percent 
methacrylation was determined via relative integrations of methacrylate protons to carbohydrate 
protons: 
 %	𝑚𝑒𝑡ℎ𝑎𝑐𝑟𝑦𝑙𝑎𝑡𝑖𝑜𝑛 = %&!"#$%& '!"#$%&
⁄ )
(&!' '!'⁄ )
× 100 (2.1) 
 𝐷𝑆, = %	𝑚𝑒𝑡ℎ𝑎𝑐𝑟𝑦𝑙𝑎𝑡𝑖𝑜𝑛	 × 	3 (2.2) 
where AMethyl is the peak area of the protons (PMethyl = 3) in the methyl of the methacrylate group 
and AMC is the peak area of the protons (PMC = 14) on the disaccharide subunit of MC, and degree 
of methacrylate substitution (DSM) was determined based on a maximum DS of 3 (Gold et al. 
2015). 
2.2.3   Rheology 
Methacrylated methylcellulose and unmodified methylcellulose (uMC) were dissolved in 
either diH2O or Dulbecco’s Phosphate Buffered Saline (DPBS) at 3% w/v and stored at 4ºC until 
use. All rheometric analyses were performed on an AR2000ex Rheometer (TA Instruments) with 
a cone and plate geometry (2º, 20mm) under oscillatory conditions. Preliminary strain and 
frequency sweep measurements on non-gelled methacrylated MC polymer solutions established 
the optimal test parameters (1% strain, 1 Hz) based on the linear viscoelastic region (Gold et al. 
2015; Varma et al. 2018). A solvent trap apparatus with diH2O was used to prevent sample 
dehydration. Results were analyzed using the TA Data Analysis software (Advantage v.5.4.0). 
Shear storage modulus (G’), shear loss modulus (G”), and phase angle (d) were measured against 
temperature, time, and strain % (g) (Kim et al. 2016; Gold et al. 2015; 2014). 
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Figure 2.1: Reaction scheme of the esterification of methylcellulose with methacrylic anhydride, 
and subsequent 1H- NMR spectra. 
 
2.2.3.1   Determination of Thermogelation Onset Temperature 
A temperature ramp was performed from 4ºC to 80ºC with a ramp rate of 1ºC/min to determine 
the temperature of thermogelation onset.  Onset temperature was measured using three different 
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2002; Arvidson et al. 2013; Knarr and Bayer 2014). Method 1 employed the most commonly used 
definition of gelation onset as the point at which G’>G”, indicating the elastic component of the 
complex modulus was dominant over the viscous component (Desbrières, Hirrien, and Ross-
Murphy 2000; Winter and Chambon 1986; Payne et al. 2017; Caicco et al. 2013; Oğuz and Ege 
2018). Method 2 defined thermogelation as the point at which the rate of increase in G’ was greater 
than 2% for 4 or more consecutive points, used to determine the inflection point of G’ which 
corresponds to a rapid increase in stiffness (Xu and Li 2005; Haque and Morris 1993; Tate et al. 
2001; Xu, Li, et al. 2004; Almeida, Rakesh, and Zhao 2018). The final method defined 
thermogelation onset by the local maximum of the first derivative of log(G’) with respect to 
temperature, corresponding to the steepest slope in the curve of G’, indicating rapid gel formation 
(Zheng et al. 2004; Li et al. 2002; Wang and Li 2005). 
2.2.3.2    Strain Sweep and Timed Temperature Hold at Physiologic Temperature 
The response to instantaneous increase in temperature, as is experienced during injection into 
the body, was determined via time sweep at physiologic temperature, 37ºC. Polymer solution was 
equilibrated at 4ºC for 5 minutes, after which the temperature was immediately raised to 37ºC and 
held for 15 minutes (1 Hz, 1% strain). Logarithmic strain sweeps from 0% to 100% were performed 
at 4ºC and 37ºC, before and after the timed temperature hold, respectively.  
2.2.3.3    Strain Recovery 
Recovery of the MC formulations after cyclic deformation was investigated by applying strain 
and cyclically switching from low strain (0.2%) to high strain (500%) for 2 minutes each over the 




Figure 2.2: Methods of determining thermogelation temperature via rheometric analysis. 
A) Log plot and B) standard plot of the same data set (G’ and G”) with three commonly used 
methods for defining thermogelation onset marked accordingly. Method 1 uses the Winter-Chambon 
criteria of G’>G” and equates the formation of a gel with thermogelation. Method 2 selects the point of 
sharp increase in G’ (corresponding to an increase in G’ of greater than 2% for 4 consecutive points over 
30 seconds). Method 3 displays the derivative of logG’ with respect to T, exhibiting a clear maximum at 
the inflection point of logG’, where increase in G’ is at its maximum. 
 
2.2.3.4   Thermogelation Effect on Redox-Initiated Crosslinking of Methacrylated MC  
The influence of temperature during redox-initiated crosslinking of injectable MC hydrogels 
was measured via time sweep. MC solutions were dissolved as previously described in in dual-
barrel syringes, at a final concentration of 3% w/v (Gold et al. 2014). Redox initiators ammonium 
persulfate (APS) (Sigma) and N,N,N,N-tetramethylethylenediamine (TEMED) (Sigma) were each 
added in opposing sides of the dual-barrel syringe (Pac-Dent) at 10 mM final concentration for 
free-radical polymerization. Mixing tips (1:1) were used to mix polymer precursors during ejection 
onto the pre-warmed (20ºC or 37ºC) peltier plate. T=0 was defined as the point at which 10 mM 
TEMED was added to the MC/10 mM APS solution. Gelation onset, determined by oscillation 
time sweep, was identified at the point at which G’>G”. Gelation completion was established as 
A B
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the first time at which four consecutive data points exhibited less than a 2% change in the growth 
of G’ (Gold et al. 2014; Temenoff et al. 2003).  
2.2.4   Statistical Analysis 
All analyses were performed in triplicate unless otherwise noted. Data are represented as mean 
± standard deviation. A two-way ANOVA was used to determine the effect of methacrylation 
percentage and solvent on thermogelation onset temperature, and the effect of methacrylation 
percentage and temperature on the properties of redox-polymerized gels.  A three-way ANOVA 
was used to determine the effect of methacrylation percentage, solvent, and temperature on 
rheological properties of thermally crosslinked gels. Significance was set at p<0.05. 
2.3   Results 
2.3.1   Structural Characterization 
1H-NMR confirmed the methacrylation of MC via the presence of methylene and methyl 
protons of the methacrylate at d ≈ 6.1 and 5.7 ppm and d ≈1.9 ppm respectively, which are not 
present on the unmodified MC (Figure 2.1). The broad stretch from ~2.8-4.6 ppm corresponding 
to protons on the disaccharide MC subunit was integrated with respect to the methyl peak, and 
relative methacrylation calculated based on the relative ratio of methyl protons (3) to disaccharide 
protons (14).  
Table 2.1: Methacrylation percentage and degree of methacrylate substitution 
 % Methacrylation Degree of Substitution by Methacrylates 
uMC 0% 0 
mMC2 2.44% 0.07 
mMC5 5.84% 0.18 
mMC9 9.54% 0.29 
 
2.3.2    Determination of Thermogelation Onset Temperature  
Thermogelation curves of MC of varying methacrylation percentage from 4ºC to 80ºC 
(Figure 2.3A) showed a wide range of moduli (G’, G”) as well as rates of increase (Figure 2.3C). 
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The effect of methacrylation percentage on thermogelation onset temperature was significant 
across all three methods of calculation, with gelation onset temperature decreasing with increasing 
methacrylation percentage (Figure 2.3B). The effect of the solvent on thermogelation was only 
statistically significant when measured by the first derivative of log(G’) or by the sharp increase 
of G’; for thermogelation onset temperature measured by G’>G”, the effect of the solvent was not 
considered significant. For mMC9, G’ was greater than G” from the onset of the experiment, and 
therefore, onset temperature was calculated as 0ºC. 
Figure 2.3: Temperature-dependent gelation of MC formulations with increasing temperatures. 
A) Representative temperature ramp curves of various Ma-MC (and unmodified MC) formulations 
in H2O and PBS. B) Gelation onset temperatures as determined by differing mathematical criteria. C) 
Determination of thermogelation rate and comparison of slopes. # — Significant difference between 
solvents. * — Significantly different from all other methacrylation % within the same solvent. a,b,c,d,e,f 
—  Significantly different from other methacrylation % within the same solvent. Significance set at p < 
0.05. 








































































































































































































2.3.3   Thermoresponsive Gelation at Physiologic Temperature 
Strain sweeps were conducted at 4ºC and 37ºC to simulate the behavior of the polymer 
solutions at refrigerated storage temperature and physiologic temperature, respectively. 
Representative curves of each group are shown in Figure 2.4 for polymer solutions in H2O and 
Figure 2.5 for polymer solutions in PBS. Quantitative values for each group were taken at 1% 
strain (Figure 2.6). Strain sweeps at 4ºC showed that G” was consistently greater than G’ for 
almost all methacrylation percentages, indicating the polymer solutions were more viscous than 
elastic. Only mMC9 showed G’ as slightly greater than G’ until the yield strain was reached. This 
was corroborated by the phase angle (d) which was near 90º for most groups at 4ºC, characteristic 
of viscous fluid-like behavior, while mMC9 had a phase angle less than 45° in both solvents. At 
37ºC, all groups had achieved “gelation” in that G’>G” from the onset of the strain sweep. Only 
mMC9 exhibited G’ and |h*| significantly greater than groups of lower methacrylation percentage 
at 4ºC (Figures 2.6A, B). At physiologic temperature, all groups underwent thermogelation as 
shown by d less than 45º indicating more elastic than viscous behavior (Figure 2.6C). All samples 
displayed d significantly lower than those at 4ºC. Despite this, uMC and mMC2 showed no 
significant change in G’ or |h*| in either solvent, while mMC5 and mMC9 displayed significantly 
higher G’ and |h*|, with solutions in PBS resulting in even stiffer/more viscous gels. 
Physical crosslinks are reversible and can break under deformation and then reform when the 
force is released. This can be observed by the decrease in G’ with increasing g (Figures 2.4 and 
2.5). Yield strain (gyield) is typically described as the strain at which G’ becomes less than G”, 
indicating the strain-dependent gel-sol transition (Shih, Shih, and Aksay 1999). Unmodified MC 
mMC2 and mMC5 did not display yield according to this definition, although a decrease in G’ can 
be observed between 1 and 10% strain. Yield strains were observed for uMC and mMC2 (H2O and 
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PBS) at 37ºC (Figures 2.4 and 2.5, Table 2.2). mMC5 and mMC9 displayed strain stiffening 
behavior rather than thinning as shown by an increase in both G’ and G”, which for mMC9 resulted 
in rupture of the gel at high g, as shown by a sharp drop in both G’ and G” (Figures 2.4 and 2.5). 
Table 2.2: Yield strain (gyield) from strain sweeps performed at 4°C and 37°C (1 Hz) 
  Yield Strain 
  4ºC gyield (%) 37ºC gyield (%) 
uMC H2O — 15.25 ± 21.50 PBS — 12.88 ± 6.38 
mMC2 H2O — 18.64 ± 15.24 PBS — 14.84 ± 15.43 
mMC5 H2O 0.097 ± 0.12
a — 
PBS — — 
mMC9 H2O 5.51 ± 3.48
a — 
PBS 6.26 ± 0.82 — 
a – Significantly different from other yield strain within the same solvent. Significance set at p < 0.05. 
 
Between strain sweeps, temperature was increased from 4ºC to 37ºC rapidly and held for 15 
minutes to simulate the temperature change upon injection. Onset of gelation here was defined as 
the time at which G’>G” (sol-gel transition) and completion of the thermogelling process at 37ºC 
was defined as the point at which G’ increased by less than 2% for 4 or more consecutive points, 
corresponding to a plateauing of the increase in G’. Thermogelation onset time ranged from 0:13 
± 0:05 to 0:45 ± 0:22 minutes; thermogelation completion was achieved between 2:40 ± 0:20 and 
6:09 ± 1:12 minutes (Table 2.3). 
Table 2.3: Onset and completion times of thermogelation at 37°C (1%, 1 Hz).  
  Thermogelation Onset Time (min) Thermogelation Completion Time 
uMC H2O 00:19 ± 00:22 03:25 ± 01:08 PBS 00:43 ± 00:04 02:55 ± 00:39 
mMC2 H2O 00:40 ± 00:42 03:12 ± 01:08 PBS 00:36 ± 00:28 02:42 ± 01:26 
mMC5 H2O 00:28 ± 00:15 02:40 ± 00:20
# 
PBS 00:45 ± 00:22 06:09 ± 01:12* 
mMC9 H2O 00:13 ± 00:05 03:00 ± 00:10 PBS 00:17 ± 00:04 02:50 ± 00:04 
* - Significant difference from all other methacrylate percentages. # - Significant difference from PBS 
with the same methacrylation % and temperature. Significance set at p < 0.05. 
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Figure 2.4: Temperature-dependent gelation and strain behavior of MC formulations in H2O. 
MC formulations were equilibrated at 4°C and then underwent a strain sweep, followed by an 
immediate ramp up to 37°C that was held for 15 minutes, after which a subsequent strain sweep at 37°C 
was conducted, displaying time, temperature, and deformation-dependent mechanical behavior of 
physically crosslinked MC gels. 
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uMC Strain Sweep 37°C












mMC2 Strain Sweep 37°C












mMC5 Strain Sweep 37°C





























 Figure 2.5: Temperature-dependent gelation and strain behavior of MC formulations in PBS. 
MC formulations were equilibrated at 4°C and then underwent a strain sweep, followed by an 
immediate ramp up to 37°C that was held for 15 minutes, after which a subsequent strain sweep at 37°C 
was conducted, displaying time, temperature, and deformation-dependent mechanical behavior of 
physically crosslinked MC gels. 
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uMC Strain Sweep 37°C
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Figure 2.6: Behavior of thermogelling MC solutions at storage and physiologic temperatures (1% 
strain, 1 Hz). 
A) Storage modulus G’, B) complex viscosity |h*| and C) phase angle d for varying MC formulations at 
4ºC and 37ºC. * - Significant difference from all other macromer % within the same solvent and 
temperature. # - Significant difference between solvents within the same methacrylation % and 
temperature. † - Significant difference from 4°C within the same methacrylation % and solvent. 
a,b,c,e,f,g,h – Significant difference between the same letters. Significance set at p < 0.05. 
 
 



























































2.3.4   Strain Recovery 
The rapid breaking and recovery of physical crosslinks was demonstrated via cyclic strain 
time sweep. Application of extremely high strain (500%) resulted in fluid-like behavior where 
G’<G” and immediate removal of the high strain (strain % of ~0.2%) returned the MC solution to 
a “gel” with G’>G” (Figure 2.7). Recovery at low strain included characteristic thixotropic 
behavior, wherein a gradual increase in G’ is attributed to the time-dependent reordering of 
hydrophobic aggregate crosslinks within the MC chains. The recovery profile for mMC9 in H2O 
is shown in Figure 2.7 as a representative profile; all other groups showed similar results. 
Figure 2.7: Representative graph of gel recovery under cyclic strain. 
 
 
2.3.5   Effect of Temperature on Redox-Initiated Crosslinking of Methacrylated MC 
Gelation of methacrylated MC hydrogels with redox initiators APS and TEMED was 
performed at 20ºC and 37ºC to compare the gelation kinetics and modulus of thermosensitive, 
chemically crosslinked gels. Characteristic gelation curves (Figure 2.8A) showed a toe region 
where chemical crosslinking and polymerization was not dominant within the gel system at 20ºC 
that lasted an average of 3:39 ± 0:36 minutes across all methacrylated groups (not significantly 



























different). This lag time was eliminated when gelation occurred at 37ºC. Gelation initiation time 
was significantly different across all methacrylation percentages at 20ºC (Figure 2.8B), with 
gelation onset occurring more rapidly with increasing methacrylation, ranging from 0:34 ± 00:06 
to 04:37 ± 00:32 minutes for all methacrylated groups. With mMC9, gelation onset was nearly 
instantaneous even at 20ºC, however, there was still a toe region.  There was no significant 
difference between gelation onset time for all groups at 37ºC, with G’>G” occurring at or prior to 
the first recorded point, ranging from 26 ± 4 seconds to 42 ± 14 seconds. Unmethacrylated MC 
was mixed with redox initiators and prepared exactly as the methacrylated MC to investigate any 
effect the redox initiators might have on gelation characteristics of the unmodified polymer. 
Unmodified MC did not achieve consistent gelation initiation at 20ºC, as G’ became equal to G” 
at a few points but never crossed over. Gelation completion, defined as the point at which G’ 
increased by less than 2% for 4 or more consecutive points (Figure 2.8A, dotted red line) and 
coinciding with a plateauing of the gelation reaction, was significantly different between 20ºC and 
37ºC for all methacrylated MC, with an average difference of 5:33 ± 00:51 minutes between 
temperatures.  
Initial G’ ranged from 0.773 ± 0.271 to 16.416 ± 4.786 Pa and was significantly influenced 
by both methacrylation percentage and temperature. Upon gelation completion, G’ was two orders 
of magnitude greater in the methacrylated MC gels (1,046.63 ± 139.84 to 3,722.67 ± 474.21 Pa) 
than uMC (0.842 ± 0.093 to 8.383 ± 6.169 Pa), due to the formation of chemical crosslinks by the 
redox initiation of methacrylate crosslinking. Viscosity behaved similarly, with initial |h*| for 
mMC9 higher than all other groups, although values were on the same order of magnitude for all 
samples (under 5 Pa•s), and |h*| at completion ranging from 166.60 ± 22.30 to 592.5 ± 75.54 Pa•s.  
G’ and |h*| were higher in all gels formed at 37ºC than those formed at 20ºC except for mMC9. 
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Although gelation completion had been achieved as defined previously by the plateauing of G’, 
gels continued to stiffen as the final remnants of free radicals and methacrylates reacted to form 
crosslinks, and by the true end of the reaction, each methacrylated MC group was significantly 
stiffer than at “completion.” Gels from mMC2 and mMC5 formed at 20ºC were no longer 
significantly softer than those formed at 37ºC, as the reactions had essentially “caught up” with 
those at 37ºC. However, while mMC9 gels also continued to increase in G’, the increase at 20ºC 
was significantly higher than at 37ºC (Figure 2.9). The phase angles for all chemically crosslinked 
gels were less than 1 (0.341º ± 0.065 to 0.856º ± 0.033) indicating the formation of strongly 
crosslinked elastic solids, while uMC reached a d of 65.553º ± 8.095 at 20ºC and 20.190º ± 8.072 





Figure 2.8: Free-radical polymerization of MC formulations with redox initiators APS and 
TEMED (10 mM each) in PBS at room temperature (20ºC) versus physiologic temperature (37ºC). 
A) Representative gelation curves over 20 minutes. B) Values measured from gelation curves for 
gelation onset and completion time, and storage modulus G’ and complex viscosity |h*| at the initiation 
and completion of the redox polymerization reactions. (uMC included for comparison but did not react 
with redox initiators as it does not have methacrylate groups). * - Significant difference from other 
methacrylation % within temperature # - Significant difference between temperature within the same 
methacrylation %. Significance set at p < 0.05. 
 






































































































































































































































Figure 2.9: Continued increase in storage modulus G’ after completion of free-radical 
polymerization reaction. 
# - Significant difference between gelation temperature within the same methacrylation %. † - 
Significant difference from “reaction completion” within the same methacrylation % and temperature. 
Significance set at p < 0.05. 
 
2.4   Discussion 
Thermogelling hydrogels have immense utility in biomedical applications, as they take 
advantage of the difference between ambient temperatures and physiologic temperatures to form 
gels in situ, allowing minimally invasive delivery of therapeutics, drug depots and cell-laden 
scaffolds. In order to achieve robust mechanical properties that withstand physiological stresses 
and strains in situ, high macromer concentrations may be necessary, however, rendering 
injectability more difficult, as increased macromer concentration even at low temperatures is often 
accompanied by high viscosity. We have previously shown that MC, a thermogelling derivative 
of cellulose, can be chemically modified with methacrylate groups to enable the formation of 
stable, chemically crosslinked hydrogels via photopolymerization (Stalling, Akintoye, and Nicoll 
2009). The use of redox initiators in a dual-barrel syringe system further enables injectability of 
these chemically crosslinking gels, which have been characterized extensively for their material 
properties including swelling, compressive mechanics, long-term stability, and cytocompatibility 
























(Gold et al. 2014; 2015). Here, we investigated the influence of hydrophobic methacrylate 
substitutions on the thermogelation of MC via rheometric analysis. It was found that the 
combination of thermally mediated physical crosslinks and redox-initiated chemical crosslinks 
influences the rate and efficiency of gel formation as well as the final gel strength in relation to the 
percent methacrylation of MC. This has implications for ease of use in surgical implementation, 
as well as tuning hydrogel formulations for a variety of indications.  
Physiologic applications for thermogelling polymers require a threshold of 37ºC for onset of 
gelation, above which a polymer solution is generally considered less than ideal for biomedical 
applications, because it implies that the change in temperature upon injection would not elicit a 
gelation response. There is, however, no consensus in the literature for determining the 
temperature of thermogelation. Rheology has widely been used as a tool to measure the gelation 
properties of MC. While other analytical methods like differential scanning calorimetry (Haque 
and Morris 1993; Li et al. 2002) and turbidimetry (Arvidson et al. 2013; Zheng et al. 2004) have 
also successfully been used to measure thermogelation onset temperature, rheology provides data 
relevant to the physical behavior of the material, such as shear modulus, phase angle, and viscosity, 
which are of particular interest in the characterization of an injectable material for clinical 
applications. Within the available rheometric studies of thermogelling materials, numerous 
definitions of thermogelation onset temperature have been used, making comparison across studies 
difficult. The most common and traditional definition for gelation is point at which G’ becomes 
greater than G”, indicating the elastic component of the modulus dominating over the viscous 
component (Desbrières, Hirrien, and Ross-Murphy 2000; Winter and Chambon 1986; Payne et al. 
2017; Caicco et al. 2013; Oğuz and Ege 2018; Almdal et al. 1993). This method works reasonably 
well where the difference between G’ and G” grows rapidly, however, frequently there is no 
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physical significance as both G’ and G” remain within an order of magnitude of each other for a 
considerable range of temperature increase beyond that point, and the rapid increase in G’ 
indicative of molecular aggregation has not yet been reached (Figure 2.3B). This is particularly 
evident at lower concentrations of MC. The temperature at which G’ exhibits a sharp increase has 
also frequently been used as the definition of thermogelation onset, although there is no consensus 
on a numerical method to identify it (Knarr and Bayer 2014; Xu and Li 2005; Haque and Morris 
1993; Tate et al. 2001; Xu, Li, et al. 2004; Almeida, Rakesh, and Zhao 2018). Here, we have 
proposed a method of defining the rapid increase in G’ by identifying the point at which G’ 
consistently increases by greater than 2% for 4 or more consecutive points (at a sampling rate of 
6.5 s), thus resulting in a more physically relevant increase in G’. Zheng et al. (2004) have 
previously showed that the first derivative of LogG’ with respect to temperature, T, is a reliable 
mathematical method for rheologically determining the sol-gel transition of thermally gelling MC, 
as it represents the highest rate of increase in G’. This has also been shown to correspond with the 
endothermic peak in calorimetric measurements of MC thermogelation and the cloud point 
measured by turbidimetry (Li 2002; Wang and Li 2005). 
Temperature ramps of MC samples showed that “thermogelation onset temperature” 
decreased with increasing methacrylation percentage across all methods of determination. The 
derivative of LogG’ gave the most consistent results both with respect to the effect of saline 
solution and the effect of methacrylation percentage on reduction of thermogelation temperature. 
It was observed that due to the initial decrease in G’ at increasing temperatures of unmodified MC, 
the >2% increase in G’ occurred at a much lower temperature than dLogG’. This initial decrease 
in G’ with increasing temperature is characteristic of most liquids, and the disappearance of that 
behavior from methacrylated MC samples is indicative of the increased intermolecular aggregation 
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between macromolecular chains in the presence of methacrylate groups even at low temperatures. 
The crossover point where G’ > G”, which is most commonly used as an indicator of gelation, was 
shown to have the greatest variability between groups. Indeed, mMC9 and occasionally mMC5 in 
PBS never displayed such a crossover, as G’ began higher than G” even at 4ºC. As the polymer 
solution was able to flow and be extruded through a micropipette, the material had not formed a 
strong gel despite meeting the technical definition of having achieved sol-gel transition, thus 
supporting the conclusion that G’>G” is not a fully accurate physically descriptive criterion for 
identifying thermoresponsive aggregation, particularly at low concentrations. Here, it can be 
observed that between the three criteria, a given sample may or may not meet the threshold for 
thermogelation at physiologic temperature: if dLogG’/dT is used, none of the samples achieve 
thermogelation at 37ºC, however, the other criteria show that the thermal response does begin at 
or below 37ºC. The Winter-Chambon criterion describes the point at which the elastic component 
of the shear modulus becomes dominant over the viscous component, thus behaving in a more 
“gel-like” manner. Nevertheless, this does not necessarily correlate with the thermal response of 
the material, as some formulations displayed gel-like behavior at the lowest temperature recorded, 
indicative of strong inter-chain bonds, but the rapid response of G’ to increasing temperatures did 
not occur until later in the temperature sweep. As such, the thermoresponsive behavior of polymer 
solutions and particularly thermogelation onset should be clearly regarded as distinct from the 
Winter-Chambon criteria for the shift to more gel-like behavior of viscoelastic materials.  
To examine the thermoresponsive behavior of MC in a physiologically relevant test, MC was 
equilibrated at 4ºC and then the temperature was rapidly raised to 37ºC and held constant for 15 
minutes, simulating the rapid increase in temperature from refrigerated storage to injection in vivo 
and its development over time. Despite the fact that not all groups achieved a thermogelation onset 
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temperature of 37ºC or less (according to any of the aforementioned definitions), all MC 
formulations underwent some thermogelation when the temperature was raised to 37ºC (Figure 
2.3). This indicates that the temperature-dependent gelation response of MC is not binary, in that 
the solution can display thermoresponsive behavior below the “thermogelation onset temperature”. 
All groups started at 4ºC with G’<G” and rapidly increased in G’, undergoing sol-gel transition 
before plateauing. Thermogelation at 37ºC did not result in strong gels, however; across all groups, 
G’ increased by only one order of magnitude, with the maximum storage modulus achieved by 
mMC9 in PBS at 146.27 ± 8.29 Pa (Figures 2.4-2.6). These values are on the order of other 
reported MC thermogels at 37ºC including those of higher macromer percentage, further exhibiting 
that increasing methacrylate percentage increases hydrophobic interactions, thereby strengthening 
the gels (Shin et al. 2020; Jung, Kim, and Ho Park 2019; Gupta, Tator, and Shoichet 2006; Caicco 
et al. 2013; Stabenfeldt, Garcia, and LaPlaca 2006).  
There was also a marked effect of solvent on the temperature-dependent, strain response of 
the gels (Figures 2.4-2.6, Table 2.2).  In both H2O and PBS, mMC9 formed very weak gels even 
at 4ºC, which displayed shear thinning behavior. Interestingly, uMC and mMC2 gels exhibited 
shear thinning behavior at 37ºC, while mMC5 and mMC9 did not. In H2O, mMC5 briefly yielded 
and decreased in G’ at increased strain but then underwent strain stiffening and did not experience 
a gel-sol transition, while in PBS, it did not yield at all and only displayed strain stiffening. In H2O, 
very transient strain stiffening behavior in mMC9 was followed immediately by rupture of the gel; 
there was no stiffening prior to rupture in PBS. The formulations that underwent true strain 
yielding experienced it at moderate strain percentages (1.53 ± 2.64% to 12.88 ± 6.38%) whereas 
the rupture of mMC9 occurred at much higher strains (21.22 ± 2.84% and 51.49 ± 9.178% in PBS 
and H2O, respectively). As has been previously shown, PBS likely strengthened the hydrophobic 
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interactions at the higher methacrylation percentages, rendering the gels more brittle, and for 
mMC9, resulting in rupture at a lower strain percentage than in H2O (Thirumala, Gimble, and 
Devireddy 2013; Zheng et al. 2004). Similar strain stiffening behavior is seen in many 
biopolymers, including type I collagen, actin, and fibrin (Erk, Henderson, and Shull 2010; Motte 
and Kaufman 2013).  
Concern over whether strain stiffening could potentially make injectability more difficult for 
an in situ polymerizing biomaterial motivated investigating the recovery behavior of the MC 
thermogels. These tests showed that MC deformed and recovered under rapidly cycling changes 
at high strains (Figure 2.7).  The strain stiffening seen in the sweep experiments, in which a graded 
increase in strain was applied, can be attributed to the gradual ordering of the polymer chains and 
associated increases in chain alignment and polymer crystallinity. In contrast, the rapid recovery 
at high cyclic strains likely did not allow for increased chain organization, with the material 
retaining its amorphous structure. 
Having shown the effect of methacrylates on the thermal response of physically crosslinked 
gels, further studies focused on characterizing the influence of the thermal response on chemically 
crosslinked gels. MC solutions were mixed with redox initiators APS and TEMED in dual-barrel 
syringes and extruded via mixing tips onto the rheometer peltier plate at either 20ºC or 37ºC. 
Unmodified MC was used as a control to assess the influence of the redox initiators on 
thermogelation, as the absence of methacrylates prevents any chemical crosslinking from 
occurring. As was expected, uMC did not undergo thermogelation at 20ºC in H2O but did undergo 
thermogelation at 37ºC; there was no significant difference when compared to the behavior of 
uMC in PBS as presented in Figure 2.5, suggesting that 10 mM concentrations of APS and 
TEMED do not strongly influence the thermoresponsiveness of the base polymer (data not shown). 
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Redox-initiated gelation resulted in shear moduli 1-2 orders of magnitude greater than physically 
crosslinked gels alone, without raising the macromer concentration (Figure 2.8). Increasing the 
macromer concentration increases viscosity, which would make injection of high macromer 
concentration cellulosic solutions difficult for minimally invasive procedures using fine gauge 
needles.  
The ability to rapidly transition from a viscous fluid to an elastic solid at physiologic 
temperature is a highly appealing feature that combines ease of delivery with structural stability. 
It was shown that redox-initiated chemical gelation was accelerated at 37ºC versus 20ºC across all 
methacrylated groups (Figure 2.8A).  The toe region of the gelation curves observed at 20ºC 
appear to indicate where physical interactions were dominating the reaction, as the MC polymer 
chains intermixed and arranged in such a way that free radicals produced by the initiators had yet 
to substantially crosslink the methacrylates at that point. Thermogelation onset temperature 
measurements shown in Figure 2.4 demonstrated that the G’>G” point occurred prior to 20ºC for 
mMC9 (< 4ºC) and mMC5 (5.20 ± 5.64ºC), and that for mMC2, 20ºC was within one standard 
deviation of the mean (28.26 ±11.46ºC). The gelation onset time of redox-polymerized gels at 
20ºC reflected that pattern, with the onset time for mMC2 > mMC5 > mMC9, confirming that the 
methacrylate contribution to thermogelation plays a role even when redox initiators are present 
(Figure 2.8B). At 37ºC, all formulations began gelation instantaneously, which could be a result 
of both thermogelation onset at 37ºC (which occurred within 1 minute for nearly all formulations) 
and heat-mediated acceleration of the redox-initiated chemical reaction. Once the redox reaction 
began to dominate, there was no effect of the interplay between methacrylation percentage and 
thermogelation on completion. 
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Redox-polymerized gels increased in stiffness with increasing methacrylation percentage at 
20ºC, which is not unexpected (assuming complete conversion of all available methacrylates 
during crosslinking), as the theory of rubber elasticity states that hydrogel strength and stiffness 
increase with increasing crosslinking density (Flory and Rehner 1943a). Interestingly, this pattern 
was not evident at 37ºC, with mMC9 exhibiting lower G’ at completion than mMC5. Additionally, 
by gelation completion, all groups except mMC9 achieved higher G’ at 37ºC vs 20ºC. Although 
gelation was complete by the accepted definition of reaction completion (Temenoff et al. 2003; 
Gold et al. 2014), gels continued to stiffen, and by the end of the reaction, there was no significant 
difference in G’ between gels made at 20ºC and 37ºC for both mMC2 and mMC5 (Figure 2.9). 
However, the difference between the moduli of gels formed at 20ºC and 37ºC for mMC9 persisted, 
with the gels formed at 20ºC continuing to stiffen for an extended period. Not only was G’ 
significantly lower for mMC9 when gelation occurred at physiologic temperature, but it was also 
found not to be significantly different from the two lower methacrylation percentages at the same 
temperature. This disproves the hypothesis that thermogelation and redox-initiated gelation would 
have an additive effect, resulting in stiffer gels. Moreover, it suggests that there is a point at which 
temperature directed network structure formation at 37ºC prevents efficient or complete chemical 
crosslinking reactions between methacrylate groups. While it is generally understood that chemical 
crosslinks are much stronger than physical crosslinks, steric influences of physical crosslinking 
can dictate how many chemical crosslinks are able to actually form. Phase separation and syneresis 
may prevent mixing and penetration of free radicals produced by the redox initiators (Sarkar 1979; 
Wu et al. 2021; Arvidson et al. 2013; Nasatto et al. 2015). While these effects appear to be 
negligible in mMC2 and mMC5, the strength of the hydrophobic aggregate formation in mMC9 
demonstrated by G’>G” (even at 4ºC), the lack of shear thinning behavior, and rupture during 
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strain sweeps at 37ºC appears to be causing syneresis-driven inefficiency in free-radical 
crosslinking at physiologic temperature. Morozova et al. (2019) have also shown that allyl-
modified MC hydrogels result in softer gels when chemically crosslinked at a higher temperature 
versus low temperature, based on the permanent chemical crosslinking of the MC network/fibrils 
formed by physical aggregation at higher temperatures. 
 As tunability is a highly desirable factor in biomaterial development, understanding the 
interaction of the thermosensitive nature of MC and the reaction efficiency of redox-initiated 
crosslinking will be important for predicting the behavior of these gels when injected and formed 
in vivo. It is well established that macromer concentration, degree of methoxy substitution, and 
solvent all influence the thermoresponsive behavior and rheo-mechanical properties of MC 
solutions (Nasatto et al. 2015; Sarkar 1979). In addition, it was previously shown that chemically 
crosslinked Ma-MC can produce highly tunable chemically crosslinked hydrogels for a variety of 
applications (Stalling, Akintoye, and Nicoll 2009; Gold et al. 2014; 2015; Varma et al. 2018). 
Here, it was demonstrated that increasing methacrylation percentage gave rise to increased inter-
chain hydrophobic interactions, further resulting in lowered thermogelation onset temperature 
(Figure 2.3) and stiffer physically crosslinked gels (Figure 2.6). Formulations with higher 
methacrylation percentages (i.e., mMC5 and mMC9) showed very strong interchain interactions, 
particularly in PBS, which was reflected by G’>G” at 4ºC (Figure 2.3B and Figure 2.5), as well 
as strain stiffening behavior. These solutions exhibited significant increases in viscosity at 37°C 
(relative to values at 4ºC) without the addition of redox-initiated crosslinking (Figure 2.6B).  This 
suggests that these specific formulations are less likely to rapidly migrate or diffuse from the 
injection site. Further tuning of the methacrylation percentage and a wider range of strain 
measurements would provide more in-depth information regarding control of the injectable 
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system. Initial complex viscosity of all groups tested was on the lower end of commercially 
available dermal fillers (i.e., Teosyal Meso, 0.942 Pa·s), while final viscosity for physically and 
dual-crosslinked gels was comparable to medium and high viscosity commercial fillers (Belotoro 
(32.9 Pa·s) and Restylane (532.4 Pa·s), respectively), all of which are injectable via 27-30 gauge 
needles (Falcone and Berg 2009).  
Previous studies in our lab have employed the use of “pre-gelling” redox-initiated crosslinked 
systems by warming the dual-barrel syringe containing mMC and redox initiators to 37ºC prior to 
injection (Varma et al. 2018). Anecdotal observation has shown that while the thermogelled system 
remains injectable (as corroborated here by strain sweep and strain recovery), a large amount of 
force is required to eject the pre-gelled solution, which can interfere with handling, particularly in 
situations where careful volume control is necessary such as dermal fillers. In addition, the present 
data indicate that at high methacrylation percentages, not only is injection of a pre-gelled solution 
more difficult (due to strain stiffening), but it may also interfere with complete redox-initiated 
crosslinking efficiency. Still, the increase in thermoresponsiveness of mMC at higher 
methacrylation percentage is indicative of rapid in situ gelation that would likely resist 
extravasation at physiologic temperatures and supports the use of pre-cooled solutions for 
injectable applications. 
Beyond injectable applications, dual-crosslinked injectable hydrogels show great potential for 
3D printing and bioinks (Loebel et al. 2017). Similar dual-crosslinked MC hydrogels have recently 
been formulated with tyramine-modified MC, which possess initial storage moduli (uncrosslinked) 
on the same order of magnitude as mMC but require higher MC concentrations (8%) (Shin et al. 
2020). These formulations resulted in softer thermogelled constructs (G’ ≈ 11 Pa) that maintained 
fidelity of the printed shape when extruded at 37ºC, and were then able to be photocrosslinked and 
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cured to form gels with moduli up to 250 Pa. As shown previously, mMC can successfully form 
stable, biocompatible hydrogels via photo-initiated crosslinking (Stalling, Akintoye, and Nicoll 
2009), resulting in much stiffer gels (3-8 kPa) at lower concentrations (2-4%), which holds promise 
for future studies that might use cell-laden mMC as a bioink for 3D printing of tissues. 
2.5   Conclusion 
In this study, increasing methacrylation of MC was shown to increase intermolecular 
attraction via hydrophobic interactions, which in turn decreases thermogelation onset temperature 
and enhances the strength of the thermal response.  Moreover, the methacrylate contribution to 
MC thermogelation accelerates the redox-initiated crosslinking reaction and contributes to matrix 
stiffening at physiologic temperatures. Nevertheless, there is a limit after which thermal 
aggregation of hydrophobic groups prevents efficient chemical crosslinking due to phase 
separation. This behavior is not only critical in assessing the injectability of potential 
thermoresponsive, dual-crosslinking biomaterials, but also in predicting the in situ behavior of the 
gels. Future studies will further characterize the molecular mechanisms and long-term mechanical 
behavior of these dual-crosslinked hydrogels. 
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3.1   Introduction 
Degeneration of the intervertebral disc (IVD) has been implicated as a primary cause of lower 
back and neck pain, which are responsible for 12-14% of all adult medical visits in the United 
States (not counting physical therapy and chiropractic visits) (Bone and Joint Initiative USA 2015). 
IVD degeneration is characterized as an aberrant, cell-mediated response to structural failure, 
wherein diminished nutrient transport,  cellular senescence, increased enzymatic activity, and 
changes in matrix composition and hydration progressively and rapidly contribute to the 
breakdown of the disc (Adams and Roughley 2006).  The etiology of the disease is thought to 
begin with the loss of hydration in the central nucleus pulposus (NP) region, which causes a 
decrease in IVD height and increased loading on the circumferential annulus fibrosus (AF).  This 
leads to AF bulging, fissures, and potentially herniation of the NP through the AF, in addition to 
vertebral changes such as endplate calcification and osteophyte development (Adams & Roughley, 
2006). Symptomatic degeneration is associated with discogenic pain, which is caused by the 
infiltration and subsequent stimulation of nociceptive nerve fibers in the AF, or by radiculopathy, 
which results from compression of spinal nerve roots, inducing pain, numbness and tingling 
throughout the lower back and legs (Peng 2013).  Medical treatment for degenerative disc disease 
is conservative and generally involves physical therapy, pharmaceutical pain management, or a 
combination of the two, although these methods are purely palliative and do not address the 
progressive degenerative state.  Eventually late-stage degeneration can be treated surgically via 
spinal fusion, however, this alters spinal loading further, and does not reduce the progression of 
degeneration in adjacent IVD segments (Zhao et al. 2019; Natarajan and Andersson 2017).  
Biomaterial replacement of the degenerate NP has been proposed in order to restore IVD 
height and mechanical properties and to promote the biological repair of the injured tissue by 
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directing cellular behavior within a biomaterial scaffold (Choi, Park, and Lee 2019; Stergar et al. 
2019; Tendulkar et al. 2019; Pelletier et al. 2016; Goins et al. 2005). Hydrogels, water-swollen 
polymeric matrices, are an ideal class of material for NP repair, as they resemble the highly 
hydrated network properties of the native tissue (Peppas et al. 2006; Guan et al. 2017; D’Este, 
Eglin, and Alini 2018; Bowles and Setton 2017). Several natural and synthetic hydrogels have 
been shown to support NP-like matrix deposition by encapsulated NP cells and mesenchymal stem 
cells (MSCs) (Tsaryk et al. 2014; Illien-Jünger et al. 2016; Thorpe et al. 2017; Wang et al. 2019; 
Kumar et al. 2016; Gupta, Cooper, and Nicoll 2011). Recent clinical trials exploring such 
hydrogels as acellular NP replacements or as cell delivery vehicles for NP regeneration have had 
some success targeting patients exhibiting discogenic pain without disc bulging or herniation, and 
with no more that 30% to 50% loss of disc height at the treatment level (Amirdelfan et al. 2021; 
Ceylan et al. 2019). 
Cellulose-derived scaffolds are a unique class of materials in that they are naturally-derived, 
plant polysaccharides with similar structure to glycosaminoglycans (GAGs) that are the most 
abundant dry constituent of the NP.  Moreover, since they are not animal derived, cellulosic 
materials are not susceptible to enzymatic degradation by the elevated levels of matrix 
metalloproteinases that may be present in the injured and degenerate IVD (Sivan, Wachtel, and 
Roughley 2014). Cellulose ethers such as methylcellulose (MC) and carboxymethylcellulose 
(CMC) are water-soluble cellulose derivatives that have been FDA-approved for a number of 
biomedical and food applications (Rohowsky et al. 2016). We have demonstrated previously that 
methacrylation of both CMC and MC allows for the formation of stable, covalently crosslinked 
hydrogels via free radical polymerization.  The resulting gels exhibit a very mild foreign body 
response and can be used for various clinical indications (Gold et al. 2015; 2014; Varma et al. 
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2014; Stalling, Akintoye, and Nicoll 2009; Reza and Nicoll 2010a).  In particular, photocrosslinked 
hydrogels fabricated from methacrylated CMC (Ma-CMC) were investigated for NP tissue 
engineering due to the negatively charged carboxyl groups on the CMC backbone, which 
contribute to its high swelling capacity and similarity to the polyanionic sulfated GAG-rich 
network of the native NP.  These Ma-CMC-based hydrogels were shown to promote NP-like 
matrix elaboration by encapsulated cells with exogenous delivery of transforming growth factor-
beta 3 (TGF-b3) in vitro (Gupta, Cooper, and Nicoll 2011; Gupta and Nicoll 2015). In follow-up 
studies employing redox polymerization to impart superior injectability and in situ gelation 
properties (in contrast to photopolymerization systems) (Varma, DiNicolas, and Nicoll 2018), Ma-
CMC was not retained within the high-pressure IVD space and extravasated before gelation 
completion (Varma et al. 2018). In order to be an effective minimally invasive therapy, the 
replacement material (with or without biologics or therapeutics) must remain localized at the 
injection site and be delivered via a small gauge needle so as not to compromise the mechanics 
and pressurization of the IVD (Elliott et al. 2008; Iatridis et al. 2013). MC has a unique 
thermogelation capacity, which allows it to increase in viscosity at increasing temperatures (Sarkar 
1979; Haque and Morris 1993). Here, we propose the use of a thermoresponsive, cellulosic 
formulation that undergoes redox-initiated crosslinking within the IVD void space may provide 
improved intradiscal retention in situ.   
The degenerate NP is marked by extremely limited nutrient availability due to the diminished 
concentration of sulfated GAGs, which drive the influx of nutrients and cytokines into the IVD ( 
Huang, Urban, and Luk 2014; Loibl et al. 2019; Ohnishi, Novais, and Risbud 2020; Walter et al. 
2016). Artificial sulfation by the addition of negatively charged sulfate (SO42-) or sulfonate (SO3-
) groups directly onto a candidate biomaterial may be used to mimic the mechanism by which 
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growth factors and other proteins are localized by sulfated GAGs in native tissues (Zhu and 
Marchant 2011; Censi et al. 2012; Belair, Le, and Murphy 2014; Wang and Von Recum 2011). 
For example, heparin-based growth factor delivery systems have been investigated due to the 
affinity of many growth factors such as bone morphogenetic proteins, basic fibroblast growth 
factor, and TGF-β to heparin, thus enabling sustained release of the incorporated growth factor 
(Liang and Kiick 2014; Jennifer Lei, Trevino, and Temenoff 2016; Park et al. 2012; Hettiaratchi 
et al. 2014; Jeon et al. 2011). Interaction of growth factors with matrix macromolecules has also 
been shown to enhance growth factor bioavailability, with some growth factors showing greater 
resistance to proteolysis and thermal denaturation when bound to heparin or heparan sulfate (Ji et 
al. 2009; Park et al. 2008). Previous work has demonstrated that exogenous transforming growth 
factor-b3 (TGF-b3) supplementation supports the differentiation of encapsulated NP and bone 
marrow-derived stromal cells in cellulosic hydrogels in vitro (Gupta, Cooper, and Nicoll 2011; 
Gupta and Nicoll 2014; 2015; Lin et al. 2016; Varma, DiNicolas, and Nicoll 2018). However, 
exogenous supplementation of growth factors in culture media is not translatable for an in situ 
curing system. A viable therapy utilizing an injectable scaffold would need to deliver the signaling 
factors by directly incorporating them into the biomaterial.  Recently, polysaccharides such as 
alginate (Freeman, Kedem, and Cohen 2008), hyaluronic acid (Feng et al., 2017; Purcell et al., 
2014), and cellulose (Portocarrero Huang et al. 2018; Arora, Mahajan, and Katti 2017; Waghmare 
et al. 2018) have been artificially sulfated for affinity-based growth factor delivery, with promising 
results,  and suggest a similar approach may be employed with MC. 
This study presents the characterization of an injectable, in situ-gelling NP replacement 
biomaterial capable of growth factor sequestration.  Specifically, hydrogels comprised of Ma-MC 
macromers at low effective concentrations (2%, 3%, and 4%) were sulfonated with the addition of 
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2-sulfoethyl methacrylate (2SEM), which can react with free methacrylate groups on Ma-MC 
during redox-initiated, free radical polymerization (Figure 3.1). This method of sulfonation takes 
advantage of the hydrogel polymerization reaction and negates the need for extra processing steps.  
The addition of charged methacrylate monomers in the formulation may support serum protein 
adsorption and enable growth factor sequestration but may also hinder the gelation process during 
injection and formation via competition for pendant methacrylate groups. Therefore, the objectives 
of this study were to assess the effects of sulfonate modification on the injectability, gelation, 
functional material properties (i.e., mechanics, swelling), and TGF-β3 sequestration capability of 
MC hydrogels as potential NP replacements. 
3.2    Materials and Methods: 
3.2.1   Methacrylation of Methylcellulose 
Methacrylated methylcellulose (Ma-MC) was synthesized through esterification of hydroxyl 
groups based on previously described protocols (Figure 3.1A) (Stalling, Akintoye, and Nicoll 
2009; Gold et al. 2014). A 1:1 ratio of 15 kDa and 41 kDa MC (degree of substitution of methoxy 
groups: ~1.5-1.9) (Sigma-Aldrich, St. Louis, MO) was dissolved at 1% (w/v) total macromer 
concentration in deionized H2O (diH2O) and reacted with methacrylic anhydride (Sigma-Aldrich, 
St. Louis, MO) in 20-fold excess (based on a theoretical 10% modification) for 48 hours at 4°C 
with periodic adjustments of pH with NaOH to maintain a pH of 8.0 (Varma et al., 2018). The 
combination of low and medium molecular weight MC was employed to balance the need for ease 
of handling (i.e., mixing and injectability) with producing hydrogels of sufficient structural 
integrity (Gold, 2017; Varma et al., 2018). The modified Ma-MC solution was purified of excess 
methacrylic anhydride via dialysis using Spectra/Por 1 dialysis tubing (MWCO 6-8 kDa, Spectrum 
Laboratories, Rancho Dominguez, CA) against deionized water for three days. During dialysis, 
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membranes were changed once daily and diH2O changed twice daily to drive purification. Purified 
Ma-MC was recovered via lyophilization, and stored at -20°C. 
Figure 3.1: Synthesis and characterization of sulfonated methylcellulose (sMC) hydrogels. 
A) Methacrylation of MC and B) 1H-NMR spectra confirming methacrylate proton peaks. C) 
Hydrogel fabrication via redox-initiated crosslinking. sMC hydrogels were fabricated with 1, 5, or 10 mM 
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3.2.2   Proton Nuclear Magnetic Resonance Spectroscopy (1H-NMR) 
Purified Ma-MC was acid hydrolyzed and 1H-NMR (Varian 500 MHz, Agilent Technologies, 
Santa Clara, CA) was conducted to verify and quantify the degree of methacrylation. The relative 
integrations of methacrylate proton peaks (methylene, d=6.2 and 5.8 ppm; methyl peak, d=2.0 
ppm) to protons on the methylcellulose backbone were used to determine the molar percentage of 
methacrylation. 
3.2.3   Hydrogel Fabrication 
Hydrogel constructs were fabricated by mixing polymer precursor solutions in dual-barrel 
syringes. Ma-MC was dissolved in Dulbecco’s phosphate-buffered saline (DPBS) (Gibco) at final 
macromer concentrations of 2%, 3%, and 4% (w/v). Redox initiators ammonium persulfate (APS) 
(Sigma) and tetramethylethylenediamine (TEMED) (Sigma) were added at 10 mM final 
concentration each in opposing barrels of the syringe for free radical polymerization. 
Sulfonation was achieved during polymerization through the addition of 2-sulfoethyl 
methacrylate (2SEM) (Polysciences) at 0 mM, 1 mM, 5 mM, and 10 mM final concentrations 
(Figure 3.1C). Mixing tips (1:1) were used to mix polymer precursors during ejection to create 
hydrogels in custom casting devices; polymer was allowed to cure for 15 min at room temperature 
to form cylindrical gels (5-mm diameter, 2-mm height). 
3.2.4   Sulfonation Quantification 
Hydrogel sulfonation was evaluated via 1,9-dimethylmethylene blue (DMMB) staining and 
quantification (n=5). Gels were swollen overnight in DPBS at 37°C and then stained with DMMB 
dye overnight. Unbound DMMB stain was removed by rinsing stained gels 2x in PBS. Gross 
images of stained gels were captured using a stereomicroscope (Stemi 2000-C) with Zeiss 
AxioVision software. Gels were then de-stained using a 4M Guanidine Hydrochloride (GuHCl) 
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solution overnight at 37°C with gentle agitation. Desorbed stain was quantified via absorbance at 
656 for relative sulfonation (Barbosa et al. 2003). 
3.2.5   Mechanical Testing 
Compressive mechanics were measured by unconfined compression testing of the hydrogels 
on a custom apparatus as previously described (n=5) (Soltz and Ateshian 2000; Gold et al. 2014). 
Hydrogels were formed in molds as described in 2.3 and stored at -20°C until testing. Gels were 
thawed and equilibrated at room temperature in PBS for 2 hours prior to testing. The testing 
protocol consisted of an initial creep test (tare load = 1 g) at a ramp speed of 10 µm/s held at 2700 
s until equilibrium was reached (equilibrium criterion: <10 µm displacement in 10 min), which 
was followed by a multi-ramp stress relaxation test, consisting of three 5% strain ramps with a 
2000 s relaxation period between ramps (equilibrium criterion: <0.5 g change in 10 min. 
Equilibrium Young’s modulus (EY) was determined as the slope of the equilibrium stress 
(calculated at each ramp) versus applied strain curve. Peak stress (spk) and equilibrium stress (seq) 
were calculated at the third ramp corresponding to 15% strain, and percent relaxation was 
calculated by the formula 
 𝑃𝑒𝑟𝑐𝑒𝑛𝑡	𝑅𝑒𝑙𝑎𝑥𝑎𝑡𝑖𝑜𝑛 = @1 − -"(
-)*
B (3.1) 
3.2.6   Swelling Properties and Hydrogel Network Characterization 
 Equilibrium weight swelling ratio (Qw) was measured for all hydrogel formulations (2%, 3%, 
4% w/v Ma-MC; 0, 1, 5, 10 mM 2SEM) (n=4). Freshly made hydrogels were swollen in PBS 
overnight at 37°C. Gels were removed from PBS and blotted to remove excess liquid and then 
placed in pre-weighed 1.5 mL microcentrifuge tubes. Wet weight, (Ws) was taken prior to freezing 
at -80°C. Frozen gels were lyophilized and dry weight measured (Wd). Equilibrium weight swelling 






and volumetric swelling (Qv) was determined from the weight swelling ratio by 
 𝑄0 = 1 + E
1)
1+
(𝑄. − 1)H (3.3) 
where rp is the density of the dry polymer (0.276 g/cm3) (Leach et al. 2003; Marsano, Gagliardi, 
et al. 2000), and rs is the density of the solvent (PBS = 1.01 g/cm3). The average molecular weight 
between crosslinks (𝑀J2) was calculated using a modified Flory-Rehner equation (Flory and Rehner 
1943b; Mason et al. 2001; Gold et al. 2015; Leach et al. 2003): 
 𝑄0





− 𝜒N (3.4) 
where ?̅? is the specific volume of the dry polymer, V1 is the molar volume of the solvent (PBS @ 
water 18.0 mol/cm3), and c is the Flory polymer-solvent interaction parameter (0.473) based on 
the assumption that c for MC is comparable to that of other polysaccharides such as hyaluronic 
acid and dextran due to similar chemical structures (Gold et al. 2014; 2015; Leach et al. 2003). 
The Flory-Rehner model was then used to calculate effective crosslinking density, ne, and 
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where R?̅?;9 is the root-mean-square distance between crosslinks (Canal and Peppas 1989; Leach 
et al. 2003; Lin et al. 2016). The root-mean-square end-to-end distance previously reported for 




≅ 2.1nm (3.7) 
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was used as an approximation for MC, as the polymer backbones are nearly identical (Gold et al. 
2014; 2015). Here n represents the degree of polymerization: 
 𝑛 = ,/
,2
 (3.8) 
where Mn is the number average molecular weight of the polymer and Mo is the molecular weight 
of the monomer unit (186.67 g/mol). In this study, a 1:1 ratio of 15 kDa and 41 kDa MC was used 
in order to facilitate handling, so we have taken the average, 28 kDa, as the Mn for mesh 
calculations, giving an average n of 150. The values calculated for ne, and x are considered 
approximations due to the assumptions made in the Flory-Rehner calculations. 
3.2.7   Gelation Properties 
Rheometric analysis was conducted on 2%, 3% and 4% w/v Ma-MC using an AR2000ex 
Rheometer (TA Instruments) equipped with a cone and plate geometry (2°, 20mm). Optimal test 
parameters (1% strain, 1 Hz frequency) were selected via strain and frequency sweep 
measurements on the base polymer solution (3% (w/v)) in DPBS.(Gold et al. 2015; D. M. Varma 
et al. 2018; Gold et al. 2014) Storage modulus (G’), loss modulus (G”), complex viscosity (|h*|), 
and dynamic shear modulus (|G*|) were measured for each test. Results were analyzed using TA 
Data Analysis software (Advantage v5.4.0).  
3.2.8   Thermogelation Onset Temperature 
A temperature ramp from 4°C to 40°C (ramp rate: 1°C/min) was conducted to determine the 
temperature of thermogelation onset of the polymer solution (n=3). Polymer solutions were 
prepared without redox initiators in order to isolate the effect of temperature-sensitive physical 
crosslinking of MC polymer. Thermogelation onset was defined as the temperature at which the 
storage modulus (G’) increased greater than 2% for 4 or more consecutive points.  
3.2.9   Redox-Initiated Gelation 
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To assess gelation kinetics of the injectable, redox-polymerized system, a time sweep was 
conducted on polymer samples with redox initiators APS and TEMED (10 mM each) mixed into 
separate sides of 1:1 dual-barrel syringes (Pearson Dental Supply Co) (n=3). To simulate in vivo 
injection, syringes were maintained at ~4°C and the polymer mixture was dispensed directly onto 
the pre-heated Peltier plate at 37°C. Time zero was considered as the point at which the initiators 
were mixed. Gelation onset, determined by oscillation measurement, was defined as the point at 
which the elastic modulus (G’) and viscous modulus (G”) were equal, or G’/G” = 1 (Winter and 
Chambon 1986). Gelation completion was defined as the first point at which four consecutive 
values of G’ increased by less than 2% (Gold et al. 2014; Temenoff et al. 2003). 
3.2.10  In Situ Gelation 
Ma-MC and sMC (10 mM 2SEM) hydrogels were evaluated for their ability to gel and be 
retained in situ in an ex vivo bovine motion segment model (n=3). Bovine coccygeal bone-disc-
bone motion segments (cc1-2 and cc3-4) were harvested from healthy, skeletally mature bovine 
tails acquired from a local abattoir (Lin et al. 2019; Varma et al. 2018; Likhitpanichkul et al. 2014). 
Extraneous musculature and ligaments were removed with a scalpel, vertebrae were cut proximal 
and distal to vertebral endplates, and facet and transverse processes were removed with a bone 
band saw, after which motion segments were wrapped in PBS hydrated tissue to preserve hydration 
and frozen at -20°C until future use. Segments were thawed at 37°C in PBS prior to use. Cruciate 
incision was created posterolaterally with a #15 blade through the AF and nucleotomy was 
performed by removing 0.15-0.20 g (~ 60%) of the NP tissue with a pituitary ronguer via the 
incision.(Malhotra et al. 2012) Ma-MC (2%, 3%, and 4% w/v), redox initiators (APS and TEMED, 
10mM each), and 2SEM (0 or 10mM) were prepared in dual-barrel syringes as previously 
described. Trypan blue stain was added to aid in hydrogel visualization. Polymer solution and 
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motion segments were warmed to 37°C and polymer solution was injected with a 20G needle into 
the NP void space via the injury site. Initial gross gelation was assessed after incubation at 37°C 
for 30 minutes (Varma et al., 2014). 
3.2.11  In Vitro Stability 
In vitro stability of sMC hydrogel constructs was determined by measuring the dry weight of 
hydrogels over an 8-week period (n=3-4). 3% (w/v) MC hydrogels (0, 1, 5, and 10 mM 2SEM) 
were fabricated in molds as described in 2.3. Samples were incubated in PBS at 37°C on an orbital 
shaker for the duration of the experiment in order to mimic the temperature and fluid flow of the 
native IVD environment. PBS buffer was changed 3 times weekly, and at 4 and 8 weeks, gels were 
collected and lyophilized, and measured for dry weight (Varma et al. 2014; Lin et al. 2019; Gold 
et al. 2015). In addition, stereomicrographs of the gels were captured at each timepoint for visual 
assessment. 
3.2.12  Cytocompatibility 
Human dermal fibroblasts (hDFs) were encapsulated within MC and sMC hydrogels to assess 
construct cytocompatibility. Hydrogels were prepared as described in section 2.3 with the addition 
of hDFs in the prepolymer mixture. Lyophilized Ma-MC polymer was sterilized under germicidal 
UV light for 30 min and dissolved in sterile PBS (3% (w/v)) (Lin et al. 2016). Redox initiators 
APS and TEMED (10 mM each) and sulfonate monomer 2SEM (0, 1, 5, and 10 mM) were 
prepared as previously described with the additional step of sterilization via syringe filtration (0.22 
µm filter size) (Lin et al. 2019). Sterile polymer precursors were prepared in dual-barrel syringes 
with the addition of hDFs at a final cell concentration of 4 x 106 cells/mL. Gels were formed as 
detailed earlier and cultured for 5 days at 37°C and 5% CO2 in high glucose DMEM with 1% 
Penicillin/Streptomycin and 10% fetal bovine serum (FBS). Fibroblasts were used as a general 
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screen for cytocompatibility of sMC as the material can also be used for other applications (such 
as soft tissue fillers) (Varma et al. 2018; Shin, Olsen, and Khademhosseini 2012).  
Total DNA content was measured to assess cell proliferation on days 1 and 5. Gels were 
frozen and lyophilized, homogenized and digested in pepsin based on previous protocols (Gupta, 
Cooper, and Nicoll 2011). Briefly, lyophilized gels were digested in a pepsin (Sigma) solution in 
0.05N acetic acid for 48 hrs. at 4°C, after which the solution was neutralized with 10x tris-buffered 
saline. Samples were analyzed using the PicoGreen assay (Invitrogen, ThermoFisher Scientific, 
USA) according to manufacturer’s protocol using calf thymus DNA (Sigma) as a standard, at an 
excitation/emission of 480/520 nm on a BioTek Instruments plate reader (Synergy 4, Winooski, 
VT, USA) (n=5). Cell viability was also assessed visually at 1 and 5 days of culture using the 
Live/Dead assay kit (Invitrogen, ThermoFisher Scientific, USA), staining with calcein AM and 
ethidium homodimer-1 (0.75 µM each) for live and dead cells, respectively (n=2). 
3.2.13  Protein Adsorption 
Freshly made hydrogel constructs (3% MC; 0, 1, 5, 10 mM 2SEM) were swollen in PBS for 
1 hour and then incubated in sterile FBS at 37°C for 2 hours on an orbital shaker. Gels were rinsed 
3x in PBS to remove non-adherent proteins. Gels were then placed in extraction buffer (1% SDS, 
1 mM EDTA, and 10 mM Tris, pH 8.0) on an orbital shaker at 37°C for 1 hour. Release buffer 
was analyzed using the Bicinchoninic Acid (BCA) protein assay (Pierce, Thermo Fisher Scientific) 
according to the manufacturer’s protocol using bovine serum albumin (BSA) as a protein standard 
for total protein content (n=4). 
3.2.14  Growth Factor Release  
Sequestration of TGF-b3 within sMC hydrogels was assessed by encapsulating growth factor 
within hydrogels and measuring cumulative release over 14 days. Hydrogel precursors were 
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prepared as described in section 2.3, with the addition of rhTGF-b3 (R&D Systems, Minneapolis, 
MN). UV-sterilized Ma-MC polymer (3% w/v) was dissolved in sterile PBS and mixed with sterile 
redox initiators (10 mM) and 2SEM (0, 1, 5, and 10 mM) in dual-barrel syringes. TGF-b3 was 
added to the TEMED side of the dual-barrel syringe only for a final concentration of 2000 ng/mL 
(~80 ng/gel), corresponding to the total amount of TGF-b3 that would be supplemented via cell 
culture media for 2 weeks based on previous studies (M. S. Gupta and Nicoll 2015). Preliminary 
studies showed that direct exposure to oxidizing agent APS denatures the TGF-b3 and reduces its 
bioactivity rendering it undetectable via enzyme-linked immunosorbent assay (ELISA). Growth 
factor-laden hydrogels were maintained in release buffer (sterile PBS with 1% BSA) for 2 weeks 
at 37°C on an orbital shaker for the duration of the experiment. Release buffer was collected and 
replaced at various time points and frozen at -20°C for future quantification. The DuoSet TGF-b3 
ELISA (R&D systems) was used according to manufacturer’s instructions to quantify total growth 
factor released (n=4). 
Release behavior was characterized via the Korsmeyer-Peppas power-law model: 
 ,#
,3
= 𝑘𝑡@ (3.9) 
where Mt/M∞ is the fractional release of the solute at time t, k is a constant representing structural 
and geometric characteristics of the system, and n is the diffusional exponent indicative of the 
release mechanism. Cylindrical gels used in this study had an aspect ratio of 2.5 (diameter/height), 
and therefore, n was taken to be 0.43 based on modeling the system as a tablet exhibiting release 
via Fickian diffusion (Ritger and Peppas 1987a). Swelling effects were assumed to be negligible 
(swelling < 25% of the original volume) (Ritger and Peppas 1987b). 
3.2.15  Statistics 
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A two-way ANOVA was used to determine the effects of macromer concentration and 2SEM 
concentration on hydrogel properties. One-way ANOVA was used to determine effects of 
sulfonate concentration on protein adsorption. Two-way repeated measures ANOVA was used to 
determine effects of sulfonate concentration and time on cumulative release of TGF-b3. Tukey’s 
post-hoc tests were used in all cases to assess significance (p<0.05).  Data represent mean ± SD. 
3.3   Results 
3.3.1   Spectroscopy and Methacrylation Quantification 
The percentage of methacrylate substitutions via esterification of hydroxyl groups on the MC 
backbone was found to be 5.25%, as determined by relative integrations of methacrylate proton 
peaks to protons on the MC backbone (Figure 3.1B). 
3.3.2   Sulfonation Quantification 
Hydrogels were formed by crosslinking using redox initiators APS and TEMED (10 mM 
each) and with the addition of 2SEM in the prepolymer mixture. Sulfonation of sMC formulations 
was assessed qualitatively and quantitatively via DMMB stain. Hydrogels showed increasing 
intensity of blue stain with increasing 2SEM concentration, with 0 mM 2SEM gels staining faintly 
blue, 1 mM 2SEM gels staining a moderate blue, and 5 and 10 mM 2SEM gels staining deep indigo 
for all macromer concentrations (Figure 3.2A).  For all macromer percentages (2%, 3%, and 4%), 
hydrogel sulfonation by inclusion of 2SEM during polymer crosslinking resulted in a dose-
dependent increase in DMMB staining intensity, as quantified by GuHCl destaining and 
spectroscopic analysis (Figure 3.2B). DMMB staining was significantly higher in 5 and 10 mM 
2SEM gels than 0 and 1mM gels at 3% and 4% macromer concentration, and significantly higher 
in all 2SEM containing groups (1 mM, 5 mM, and 10 mM) at 2% macromer concentration. All 
2SEM concentrations showed significantly higher sulfonation relative to gel weight in the 2% 
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macromer concentration compared to the equivalent 2SEM concentrations in the other two 
macromer concentrations. 
 
Figure 3.2: Quantification of sulfonation. 
A) Relative quantification of DMMB staining exhibiting an increase in staining intensity with 
increasing 2SEM (i.e., sulfonate) concentration. B) Stereomicrographs of DMMB stained hydrogels. 
Scale bar represents ~5 mm. Significance set at p < 0.05 * — significantly different w.r.t. 0 mM 2SEM 
within macromer concentration. # — significantly different w.r.t. same 2SEM concentration of different 
macromer concentration. 
 
3.3.3   Compressive Properties 
Equilibrium mechanical properties were determined via unconfined compression. Constructs 
with the highest macromer concentration (4% w/v) showed the highest EY (24.97 ± 6.79 to 31.60 
± 3.80 kPa) (Figure 3.3A) as well as peak stress (speak) (Figure 3.3B) which were all significantly 
higher than those of 2% and 3% w/v hydrogels. Percent relaxation was not significantly different 
across all groups, averaging 46.00 ± 11.77%. Sulfonate concentration had no significant effect on 
all measured mechanical properties. 
3.3.4   Equilibrium Swelling and Hydrogel Mesh Characterization 
Equilibrium weight swelling (Qw) was measured for all gels, and crosslinking density (ne) and 
mesh size (x ) calculated from the acquired data using the Flory-Rehner model (Table 3.1). Qw 
was significantly different across all macromer concentrations. The range of Qw was from 16.05 ± 











































1.53 to 26.40 ± 0.61 with increasing macromer concentration resulting in decreasing swelling ratio.  
Similarly, ne increased with macromer concentration, ranging from 4.75 x 10-5 ± 1.65 x 10-6 to 1.00 
x 10-4 ± 1.36 x 10-5 mol/cm3, and x was inversely associated with macromer concentration, ranging 
from 19.79 ± 1.89 to 33.07 ± 0.81 nm. Sulfonate concentration had no significant effect on the 
swelling behavior or corresponding crosslinking density and mesh size. 
Figure 3.3 Equilibrium mechanical properties of MC and sMC hydrogels. 
A) Equilibrium Young’s modulus, and B) peak stress, spk. Significance set at p<0.05 * — 
significantly different from all other macromer concentrations of corresponding 2SEM concentration, # — 
significantly different from corresponding 2SEM concentration w.r.t. 2% MC, a — significantly different 
from each other. 
 











0 22.82 ± 1.52 5.94x10-5 ± 5.76x10-6 28.37 ± 1.98 
1 26.40 ± 0.61 4.75x10-5 ± 1.65x10-6 33.07 ± 0.81 
5 24.96 ± 1.34 5.18x10-5 ± 4.31x10-6 31.17 ± 1.75 
10 24.88 ± 0.92 5.20x10-5 ± 2.87x10-6 31.06 ± 1.22 
3% 
0 20.21 ± 1.50 7.12x10-5 ± 7.58x10-6 # 25.02 ± 1.93# 
1 20.43 ± 2.68* 7.13x10-5 ± 1.41x10-5 * 25.31 ± 3.42* 
5 19.08 ± 1.29a# 7.74x10-5 ± 7.18x10-6# 23.58 ± 1.64#a 
10 22.95 ± 0.76a 5.87x10-5 ± 2.93x10-6 28.54 ± 0.99a 
4% 
0 16.69 ± 2.97* 9.74x10-5 ± 2.61x10-5* 20.61 ± 3.68* 
1 16.05 ± 1.53* 10.00x10-5 ± 1.36x10-5* 19.79 ± 1.89* 
5 16.41 ± 1.13# 9.63x10-5 ± 9.18x10-6# 20.25 ± 1.40# 
10 17.96 ± 2.41* 8.60x10-5 ± 1.68x10-5* 22.19 ± 3.03* 
Qw = equilibrium weight swelling ratio; ne = effective crosslinking density; x = hydrogel mesh size; 
Significance set at p<0.05 a – significantly different from other sulfonate concentration within macromer 
concentration * – significantly different from corresponding sulfonate concentration w.r.t. 2% MC 
concentration # – significantly different from corresponding sulfonate concentration w.r.t. all other MC 
concentration 
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3.3.5   Gelation Properties 
3.3.5.1   Thermogelation Onset Temperature 
The effect of macromer and sulfonate concentration on thermal behavior of the prepolymer 
mixture was measured via temperature ramp. Thermogelation onset temperature was defined as 
the temperature at which G’ of the polymer solution (without chemical crosslinking agents) 
increased by 2% or more for 4 or more consecutive points (Figure 3.4A, arrow indicates 
thermogelation onset). This point more accurately identifies the sharp increase in G’ at the onset 
of thermally induced physical crosslinking than when G’=G”, which occurs at much lower 
temperatures where the rate of increase in G’ is still quite low (not shown). Thermogelation onset 
occurred within the physiologic range (<37°C) for all concentrations tested, ranging from 24.6 ± 
0.52°C to 34.23 ± 2.40°C (Figure 3.4B). All 2% MC formulations began to gel at a significantly 
higher temperature than 3% and 4% gels. There was no significant effect on thermogelation due 
to the addition of sulfonate groups to the polymer solution. G’ and |η*| were closely mirrored 
throughout the temperature ramp as shown in the representative graph (Figure 3.4A). 
3.3.5.2   Redox-Initiated Gelation  
Redox polymerization of the prepolymer mixtures with the addition of redox initiators APS 
and TEMED (10 mM each) was measured via time sweep. Time zero was defined as the moment 
the MC/TEMED mixture was combined with the MC/APS mixture in the mixing tip of the dual-
barrel syringe. Gelation onset, when G’ and G” were equal, occurred under 30 seconds for all 
polymer solutions at 37°C (Figure 3.4C), followed by a sharp increase in G’. Gelation completion, 
defined as the point at which increase in G’ was less than 2% for 4 or more points was achieved 
between 4.22 ± 0.45 and 6.61 ± 1.46 minutes for all formulations (Table 3.2). As with the 
thermogelation without initiators, |η*| was closely associated with G’ throughout the measured 
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gelation time. Initial |η*| and |η*| at gelation completion were dependent on macromer 
concentration; at both time points viscosity was significantly different based on the concentration 
of MC. Similarly, upon gelation completion, |G*| increased with increasing macromer 
concentration. The concentration of sulfonate monomer did not have a significant effect on the 
|η*| or |G*| at either timepoint measured.  









|η*| at Gelation 
Completion (Pa.s) 






0 0.58 ± 0.39* 148.62 ± 104.4 * 993.93 ± 656.54* 5.07 ± 0.17 
1 0.53 ± 0.39* 151.33 ± 61.83* 950.63 ± 388.42* 6.61 ± 1.46 
5 0.53 ± 0.23# 156.27 ± 5.40# 981.80 ± 33.82# 5.51 ± 0.46 
10 0.81 ± 0.34# 145.47 ± 14.45* 913.80 ± 90.66* 5.58 ± 0.41 
3% 
0 3.10 ± 0.52 564.70 ± 10.05* 3,548.00 ± 63.17* 5.39 ± 0.52 
1 3.28 ±0.70* 480.63± 20.32* 3,019.67 ± 127.60* 5.80 ± 0.84 
5 2.47 ± 0.70# 387.77 ± 138.85# 2,436.33 ± 871.85# 6.37 ± 1.51 
10 1.27 ± 0.44# 603.23 ± 118.87 3,790.00 ± 747.35* 5.20 ± 0.29 
4% 
0 4.89 ± 1.97* 970.17 ± 81.76* 6,095.00 ± 513.36* 5.11 ± 0.58 
1 6.60 ± 0.90* 1,172.33 ± 133.28*a 7,289.67 ± 755.74* a 4.86 ± 0.36 
5 5.42 ± 2.12* 952.87 ±138.85* 5,987.00 ± 2206.9* 5.59 ± 1.86 
10 6.24 ± 1.70* 865.13 ± 40.78 a 5,435.67 ± 256.14* a 4.22 ± 0.45 
|η*| = complex viscosity; |G*| = dynamic complex modulus; Significance set at p<0.05  * – significantly 
different w.r.t. corresponding sulfonate concentration in all other macromer concentrations #  –  
Significantly different w.r.t. corresponding sulfonate concentration at 4% MC a – significantly different 
from other sulfonate concentration within macromer concentration. 
 
3.3.6   In Situ Gelation 
MC formulations (2%, 3% and 4% w/v) with and without sulfonate (0 or 10 mM 2SEM) and 
redox initiators were screened for their ability to form stable hydrogels in situ within the void space 
of bovine IVD motion segments post-nucleotomy. Transverse dissection of the motion segments 
after gelation was allowed to take place for 30 minutes at 37°C showed that 2% MC formulations 
were not retained in situ (not shown), while 3% (Figure 3.4D) and 4% (not shown) formulations 
with and without added sulfonates were both retained within the disc space. 
Based on the material characterization data, 2% and 3% MC hydrogels exhibited a modulus 
and swelling behavior that were closest to the native human NP (Cloyd et al. 2007; Reza and Nicoll 
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2010b). The 3% and 4% MC formulations gelled in situ but 4% gels were stiffer than the target 
tissue, so 3% MC was selected for further characterization. 
 
Figure 3.4: Gelation kinetics and in situ gelation. 
A) Representative rheometric graph of uncrosslinked MC solution showing G’ and |η*| over a 
temperature ramp from 4°C to 40°C. Arrow indicates point of thermogelation onset. B) Thermogelation 
onset temperature of MC polymer solutions with 2SEM of varying concentrations. Red dashed line 
indicates physiologic temperature, 37°C. C) Representative rheometric graph of redox-initiated gelation 
behavior of Ma-MC with 10 mM redox initiators APS and TEMED and varying concentrations of 2SEM, 
showing G’, G”, and |η*| over time. Red arrow indicates redox-initiated gelation onset, which occurs 
nearly instantaneously before the first data point is collected. Dashed black line indicates redox-initiated 
gelation completion. A,C) Representative graphs both show 3% MC, 10 mM 2SEM as examples. D) 
Gross images of 3% MC hydrogels with 0 mM 2SEM (left) and 10 mM 2SEM (right) injected into the 
void space of nucleotomized bovine caudal IVDs. Hydrogels are stained blue with trypan blue for 
visualization. Significance set at p<0.05 * — significantly different from other macromer concentrations. 
 
3.3.7   In Vitro Stability 
Mass loss studies of 3% hydrogels with varying sulfonate content demonstrated that all 
material formulations maintained their structure (Figure 3.5A) and dry weights (Figure 3.5B) over 




































Figure 3.5: In vitro stability of 3% MC hydrogels of varying 2SEM concentration (0, 1, 5, 10 mM) 
over 8 weeks. 
A) Stereomicrographs of representative gels at 0, 4, and 8 weeks after initial casting. B) Dry weight 
of gels showing no significant change in mass over 8 weeks. Significance set at p<0.05 
 
3.3.8   Cytocompatibility 
Human dermal fibroblasts were encapsulated within 3% w/v sMC hydrogels for 5 days as 
model cells for characterizing scaffold cytocompatibility. PicoGreen analysis of encapsulated 
hDFs showed a significant increase in cell DNA content between day 1 and day 5 (Figure 3.6A). 
The inclusion of sulfonate monomers had no significant effect on fibroblast viability. Live/dead 
staining (Figure 3.6B) confirmed cell survival with minimal cell death. 
3.3.9   Protein Adsorption 
3% MC gels were incubated for 2 hours in FBS, and adsorbed proteins were extracted and 
quantified via BCA assay. Protein quantification showed significantly higher protein adsorption 
on 5 mM and 10 mM 2SEM gels in comparison to 0 and 1 mM 2SEM gels (Figure 3.7A), with 























Figure 3.6:  Cytocompatibility of 3% MC hydrogels with varying concentrations of 2SEM (0, 1, 5, 
10 mM) with encapsulated human dermal fibroblasts (hDFs). 
A) DNA content of hDFs cultured within hydrogels on day 1 and day 5, and B) representative 
images of live/dead staining of encapsulated hDFs in MC only gels (top) and sMC gels prepared with 10 
mM 2SEM (bottom). Significance set at p<0.05 * — significantly different from corresponding 2SEM 
concentration w.r.t. day 1. 
 
3.3.10  Growth Factor Release 
TGF-b3 was incorporated within hydrogels during gel formation, and cumulative release 
measured over 14 days. Release data showed a burst release of growth factor within the first 24 
hours from all groups, likely due to initial swelling of the hydrogel. By 24 hours, the growth factor 
released from all sulfonated groups was significantly less than the unsulfonated MC hydrogels 
(Figure 3.7B). At the end of 2 weeks, the 0 mM 2SEM hydrogels released 52.6 ± 6.9% of the total 
loaded growth factor (Figure 3.7C) while the 10 mM 2SEM gels released only 10.6 ± 3.9% of the 
total growth factor loaded within the gels. There was no significant difference between the release 
from 5 mM and 10 mM 2SEM gels for all time points beyond 24 hours. Because the total loaded 
growth factor was not released from any of the constructs, fractional release was calculated as total 
mass of TGF-b3 released normalized to the total average released from unsulfonated MC gels (0 
mM 2SEM). Under the assumptions for the Korsmeyer-Peppas model, equation (3.9) is applicable 
3% MC, 10 mM 2SEM, day 5
3% MC, 0 mM 2SEM, day 5































for the first 60% of solute release. When plotted against tn where n = 0.43 for the given geometry 
and aspect ratio of the system, the data for each system show a linear fit with strong R2 values, 
indicative of Fickian diffusion (Figure 3.7D). The slopes of the lines, representing k and directly 
proportional to the diffusion coefficient, were all significantly different, with the steepness of the 
lines (i.e., absolute value of the slopes) inversely proportional to sulfonate concentration. 
 
Figure 3.7: Protein adsorption and TGF-b3 release from 3% MC hydrogels of varying sulfonate 
concentration (0, 1, 5, and 10 mM 2SEM). 
A) Serum protein adsorption on hydrogels after 2-hour incubation in sterile FBS as quantified by 
BCA assay. B) Cumulative release profile of encapsulated rhTGF-b3 from hydrogels over the course of 2 
weeks, as quantified by ELISA. C) Percent of total loaded growth factor released at the end of 2 weeks. 
D) Korsmeyer-Peppas model of Fickian release from sMC gels. Significance set at p<0.05 * — 


































































































3.4   Discussion 
Affinity-based sequestration of signaling molecules via sulfonation of biomaterials has the 
potential to deliver soluble growth factors in the local vicinity of host and seeded cells to promote 
sustained matrix elaboration.  However, modification of NP replacement biomaterials for growth 
factor sequestration has not been investigated. MC has previously been utilized in its 
methacrylated, chemically-crosslinked form for soft tissue reconstruction applications due to its 
tunable mechanics and resistance to enzymatic degradation in vivo (Stalling, Akintoye, and Nicoll 
2009; Gold et al. 2014; 2015). Similarly crosslinked polyanionic Ma-CMC hydrogels have shown 
promise as tissue engineering scaffolds for NP regeneration (Reza and Nicoll 2010b; 2010a; 
Varma, DiNicolas, and Nicoll 2018), yet despite redox initiators rendering them injectable, the 
lack of thermoresponsiveness resulted in incomplete retention in situ and extravasation from the 
IVD void space. Therefore, a dual-polymer network (DPN) combining MC along with CMC was 
investigated as a biomaterial for NP repair, combining the high swelling capacity of CMC with the 
thermogelation feature of MC (Varma et al. 2018). The incorporation of MC was found to be 
critical, as the thermogelation property allowed for a rapid increase in viscosity and improved 
polymer retention upon injection into the intradiscal void space post nucleotomy (Lin et al. 2019; 
Hom et al. 2019). The CMC-MC DPN system, while serving as a promising acellular repair 
strategy, is not as favorable for cellular delivery due to its high effective macromer concentration 
(6% (w/v)). Numerous studies have shown that increasing macromer concentration is deleterious 
to cell proliferation and chondrogenic differentiation of encapsulated MSCs (Erickson et al. 2009; 
Gupta and Nicoll 2014; Burdick et al. 2005; Panebianco et al. 2020). Thus, the present study aimed 
to explore the effectiveness of sulfonated MC-based gels alone as injectable NP replacements, as 
well as potential scaffolds for future cell-laden, tissue-engineered constructs. Sulfonates were 
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added to increase hydration of the MC network and more closely mimic the sulfated GAG-rich 
matrix of the native NP.  
The facile method of sulfonation described here using 2SEM takes advantage of the 
methacrylate modification present on the MC macromers to covalently bind sulfonates to the 
polymer chains. Alternate techniques for sulfation and sulfonation of cellulosics and other 
polysaccharides have been investigated, such as reaction of available hydroxyls with 
chlorosulfonic acid, but require further processing, purification, and characterization (Portocarrero 
Huang et al., 2017; Wang et al., 2007; Zeng, Groth, & Zhang, 2019). In addition, direct chemical 
modification of the MC backbone with charged groups can potentially alter or disrupt the 
mechanism of thermoresponsiveness, which relies on the aggregation of hydrophobic methoxy 
groups at increasing temperatures (Sarkar 1979; Wu et al. 2021). Usage of sulfonated monomers 
as detailed in this study allowed for reliable and controlled tuning of sulfonate content. The 
coupling of the sulfonates occurs during the redox-initiated polymerization process to form the 
hydrogels, utilizing some of the pendant methacrylates functionalized onto the MC backbone to 
attach 2SEM. DMMB staining showed that sulfonates were successfully incorporated into the MC 
gels and that staining intensity increased in a dose-dependent manner.  
Mechanical and material properties of the sMC constructs were tested to investigate their 
potential as NP replacement materials.  Since the NP plays a critical role in spine mechanics, it is 
necessary to recapitulate the physical behavior of the healthy native NP. Unconfined compression 
testing was used to investigate the influence of added sulfonates and macromer concentration to 
the elasticity of the Ma-MC hydrogels. The utilization of methacrylate monomers to couple 
sulfonates via available methacrylate groups on the modified MC backbone potentially consumes 
methacrylates that might be used for crosslinking, thereby altering hydrogel mechanics. 
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Unconfined compression demonstrated that, as previously reported, EY may be tuned by varying 
macromer concentration (Gold et al. 2014; 2015). Data also showed that the addition of 2SEM at 
the concentrations tested did not have a statistically significant effect on the hydrogel elasticity. 
Similarly, spk increased with increasing macromer concentration but was unaffected by the 
incorporation of sulfonate monomers. EY of 2% gels measured between 3.99 ± 2.49 and 6.18 ± 
1.64 kPa, within the range of the native human NP (~5 kPa), and all formulations studied exhibited 
elasticity in the range of other injectable hydrogels under investigation for NP replacement (Cloyd 
et al. 2007; Smith et al. 2014; Francisco et al. 2013; Kumar et al. 2014). EY values higher than that 
of healthy native NP may be necessary to resist matrix breakdown within the degenerative 
environment in vivo (Roughley 2004). In addition, our recent study using a similar redox-
polymerized cellulosic hydrogel system revealed that injection into the IVD void space results in 
a lower EY in comparison to gelation in a casting device in vitro (16.62 ± 3.59 kPa in situ gelation 
versus 34.27 ± 4.53 kPa in vitro) (Varma et al. 2018). This is likely due to the casting device being 
rigid and constricted, in contrast to the soft tissue of the IVD void space, potentially resulting in 
less efficient mixing and crosslinking, with free radicals lost due to reaction with ambient oxygen 
in the air.  With this in mind, the proposed material at the concentrations studied is well within the 
range of the mechanical properties of the native human NP.  
In addition to altering the compressive mechanical properties, the presence of sulfonates in 
the MC gels has the potential to alter the swelling behavior of the materials. It was hypothesized 
that negatively charged sulfonates would increase the attraction and influx of water molecules into 
the hydrogel in a manner similar to sGAGs, which would potentially alter the swelling and 
hydrostatic pressure within the gel network. NP hydration is regulated by the abundance of sGAGs 
within the tissue, and the addition of sulfonates to MC was intended to replicate the chemistry and 
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function of native sGAGs. Previous studies artificially sulfating polysaccharides have shown 
increased water retention and swelling ratio in response to the added negative charge (Rother et 
al. 2017; Liang et al. 2016; Purcell et al. 2014). However, equilibrium weight swelling 
measurements on sulfonated MC constructs demonstrated that the addition of sulfonate groups had 
no effect on the swelling behavior of the gels. This may be due to the dominating effect of 
interchain covalent crosslinks between methacrylate groups, which stabilize the gel network and 
prevent any further swelling caused by the anionic sulfonates attracting water.  Interestingly, based 
on the calculations of crosslinking density using a modified Flory-Rehner model, the addition of 
the 2SEM monomers did not significantly affect the number of crosslinks formed, and thus, the 
overall mesh size. This seems to indicate that at the concentrations of 2SEM and redox initiators 
used in this study, the available methacrylate groups on the MC backbone are not fully saturated. 
This may be a result of temperature-dependent formation of physical crosslinks via aggregation of 
hydrophobic moieties within MC, which create rigid structural assemblies that only permit 
interchain coupling reactions between methacrylate groups that are accessible and in close 
proximity. Indeed, this phenomenon was also observed in the lack of significant differences in 
swelling behavior and related network properties (i.e., crosslinking density and mesh size) between 
redox-polymerized Ma-MC hydrogels of varying methacrylation percentage (Gold et al. 2014).  
Conversely, increased methacrylation percentage did significantly affect swelling ratio and mesh 
size in Ma-CMC hydrogels, suggesting that the process of redox-polymerized network formation 
is influenced by the formation of hydrophobic aggregates within the MC polymer, a characteristic 
which is not shared with CMC (Gold et al. 2014; Lin et al. 2016). This might indicate that within 
redox-polymerized Ma-MC hydrogels, a number of unsaturated pendant methacrylate groups 
remain available to react with methacrylate monomers such as 2SEM. The evidence that sulfonate 
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monomer concentration had no effect on swelling ratio, crosslinking density or mesh size is 
consistent with the lack of 2SEM monomer concentration influence on MC hydrogel mechanical 
properties.  This is supported by the theory of rubber elasticity, which predicts a proportional 
relationship between crosslinking density and hydrogel stiffness (Canal and Peppas 1989; Anseth, 
Bowman, and Brannon-Peppas 1996). 
One of the primary advantages of MC as a biomaterial is its thermoresponsive character. 
Aqueous solutions of MC form thermoreversible hydrogels upon heating, due to the aggregation 
of the hydrophobic methoxy groups at higher temperatures (Desbrières, Hirrien, and Ross-Murphy 
2000; Haque and Morris 1993). As such, the influence of sulfonates on the temperature-sensitive 
behavior of MC was characterized given that this is the first known study to functionalize MC with 
charged moieties in this manner. The addition of other solutes, in particular ionic groups such as 
sulfates, has previously been shown to alter the thermogelation point of MC (Xu, Li, et al. 2004; 
Xu, Wang, et al. 2004). Xu and colleagues have shown that the sol-gel transition of MC can be 
shifted to lower or higher temperatures based on the Hofmeister series, an order of ions ranked 
based on how strongly they affect the hydrophobicity of a solute in water (Hofmeister 1888). In 
this series, SO42- is one of the lowest of the kosmotropes, ions that enhance the hydrophobicity of 
a solute or cause a “salt-out” response. This accelerates the sol-gel transition as temperature 
increases, effectively lowering the onset temperature of thermogelation. They also showed that 
this salt-assisted effect is concentration dependent. Therefore, 2SEM was added to Ma-MC, and 
the thermoresponsiveness of the polymer solution was characterized via temperature ramp to 
determine whether the presence of negatively charged sulfonated monomers in solution would 
have a similar effect on the thermogelation properties of the MC hydrogel. Rheological properties 
were measured from 4°C to 40°C, as this was the relevant temperature range to capture for a 
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material stored in a standard 4°C refrigerator and injected into physiologic temperature. 
Thermogelation onset temperature was defined as the temperature at which G’ increased for 2% 
or more for at least 4 consecutive points. This measure was chosen as a true indicator of the 
increase in viscosity caused by the aggregation of hydrophobic moieties on MC. The crossover 
point of G’ and G”, where the elastic portion of the shear modulus G’ becomes dominant over the 
viscous portion G”, is the classical definition of gelation onset in rheometry of viscoelastic 
materials (Winter and Chambon 1986; Ferry 1980). However, in cases such as this where the 
magnitude of the change is very low (under 10 Pa), the cross-over point is of limited physical 
relevance, as the solution does not behave like a gel. In addition, the point of sharp increase in G’ 
has been shown to more closely correlate with the onset of the endothermic peak when thermal 
capacity of MC solutions are measured using differential scanning calorimetry, indicating the 
rapid, temperature-dependent aggregation of hydrophobic regions (Li 2002; Xu, Li, et al. 2004; 
Zheng et al. 2004). The addition of sulfonated monomers had no significant effect on the 
thermogelation of the Ma-MC base polymer, maintaining thermogelation onset temperature above 
room temperature but below physiologic temperature (24.6°C ± 0.0°C to 34.23± 2.4°C), an ideal 
characteristic for maintaining injectability. It should be noted that the polymer solutions used for 
thermogelation experiments were dissolved in 1X PBS (as were all polymer solutions in this 
study). The concentration of salts in PBS are an order of magnitude higher than the highest 
concentration of 2SEM studied here (137 mM NaCl being the highest salt concentration), and may 
likely dominate the thermogelation behavior of the solutions (Zheng et al. 2004). 
Sulfonated MC hydrogel solutions were then assessed for injectability and gelation kinetics 
in the context of a minimally invasive NP repair strategy. When redox initiators were added to the 
polymer solution, gelation onset (G’/G” =1) at 37°C was nearly instantaneous, occurring under 
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30 seconds from initial injection. Prepolymer solutions were maintained on ice prior to injection 
onto the pre-warmed platform to simulate the instantaneous temperature change of injection into 
the body. The thermogelation component of MC without the influence of initiators allows for rapid 
aggregation of hydrophobic methoxy groups on the MC backbone; this in turn promotes more 
rapid and efficient mixing and reaction between methacrylate groups when in the presence of redox 
initiators. In contrast, pilot studies showed that the gelation time (initiation and completion) was 
delayed by nearly 6 minutes when the same samples were measured at 20°C. Gelation completion, 
defined as the point at which G’ increased less than 2% for 4 consecutive points (<0.3% 
change/second), occurred between 4.22 ± 0.45 and 6.61 ± 1.46 minutes for all groups, within ISO 
Standard 5833:2002 for injectable acrylic materials (4-15 min). The initial |η*| of all formulations 
was on the order of 0.53 ± 0.23 to 6.60 ± 0.90 Pa·s, predicting ease of delivery through a fine gauge 
needle (usually 18-20G). In comparison, |η*| of commonly used polysaccharide-based dermal 
fillers range from 0.942 to 1,199.0 Pa·s, using even finer needles of 27-30 gauge (Falcone and 
Berg 2009). By gelation completion, |η*| increased by two orders of magnitude over the initial 
|η*|, indicating likelihood that the injectable material would resist extravasation. The dynamic 
shear modulus |G*| also increased with increasing macromer concentration, with 4% Ma-MC gels 
approaching the reported range of |G*| for non-degenerate human NP (~7.4 kPa), and all 
concentrations were comparable to other injectable constructs under development (Iatridis et al. 
1996; 1997; Chen et al. 2013; Frith et al. 2013). 
The measured rheological parameters indicate that the sulfonated MC gel can be rapidly 
injected and solidify within the time frame of a spinal microdiscectomy procedure and can 
therefore be implemented within a clinical workflow. Still, rheometric analysis alone cannot 
determine whether the injectable material will form and be retained within the void space. Previous 
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work in our laboratory showed that CMC (2% w/v) with 10 mM redox initiators APS and TEMED 
initiated gelation in under 90s (the first point of recorded data) and reached gelation completion at 
~12 min with a corresponding complex shear modulus, G*, of ~758 Pa (Varma, DiNicolas, and 
Nicoll 2018). When injected into bovine motion segments, even with higher macromer content 
and initiator concentration (3% w/v, 20 mM initiators), CMC was not retained in situ and required 
the addition of MC to provide the necessary thermogelation capacity and allow the hydrogel to 
remain localized within the IVD at physiologic temperature (Varma et al. 2018). Therefore, in situ 
injections were performed with Ma-MC and sMC (10 mM 2SEM) at all three macromer 
concentrations (2%, 3% and 4%) in order to verify that rheometric results were translatable into a 
clinically relevant ex vivo model. Pilot studies showed formulations at 2% were not retained in 
situ, likely due to the low |η*| upon gelation completion (145.47 ± 14.45 to 156.27 ± 5.40), 
however, 3% and 4% were both retained within the IVD space. To strike a balance between 
mechanical properties, clinical translatability, and potential future use as cell delivery scaffold, 3% 
Ma-MC constructs of varying sulfonate concentration were investigated in subsequent studies 
(Panebianco et al. 2020). 
Long-term structural integrity of NP replacement materials is important for maintaining IVD 
mechanical function. Cellulose-based hydrogels are not susceptible to enzymatic degradation in 
the human body, as humans do not produce the enzyme cellulase. This provides an advantage over 
other constructs generated from animal-derived ECM components, particularly when considering 
the degenerate IVD setting which exhibits higher levels of matrix-degrading enzymes (Rodrigues-
Pinto, Richardson, and Hoyland 2014). Previous studies have shown that Ma-MC hydrogels are 
generally stable and resist degradation in aqueous environments, whereas Ma-CMC hydrogels lose 
significant amounts of their dry weight over time under the same conditions (Gold et al. 2015; 
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Varma et al. 2014). Here, Ma-MC-based hydrogels were found to retain their weight and structural 
stability and were not significantly impacted by the incorporation of charged sulfonates over 8 
weeks in an aqueous environment. This corroborates the swelling results, which showed 
sulfonation did not increase hydration or swelling capacity of the construct, and thereby does not 
increase susceptibility to hydrolytic degradation. Further study in a clinically relevant ex vivo 
motion segment model or in vivo testing, which would incorporate mechanical and biochemical 
cues, would be necessary to confirm long-term stability of the constructs (Lin et al. 2019). 
Another concern for clinical translation is cytocompatibility. Ma-MC hydrogels have 
exhibited robust cytocompatibility in vitro and elicit a minimal immune response in vivo in 
subcutaneous rodent models (Stalling, Akintoye, and Nicoll 2009; Gold et al. 2014; 2015; Gold 
2017). However, the incorporation of methacrylate monomers in the pre-gel solution adds a 
potential source for cytotoxicity (Ansteinsson et al. 2013). As such, the survival of cells 
encapsulated within sMC hydrogels was investigated. Human dermal fibroblasts were mixed 
directly into the pre-polymer mixture, and thus, were exposed to unreacted 2SEM for a short 
amount of time before gels were injected into molds and redox polymerization consumed the 
methacrylate monomers. Dermal fibroblasts were used as a general screen for connective tissue 
cytocompatibility as the sMC material holds potential for other clinical applications (i.e., soft 
tissue reconstruction, dermal fillers, drug delivery vehicle), and as a comparison to our previous 
studies with similar cellulosic gels (Varma et al. 2018; Gold et al. 2014; 2015). Studies were 
conducted over 5 days in accordance with ISO standard 10993-5:2009 for biological evaluation of 
medical devices, which stipulate that cytotoxicity assessments should be performed for 24-72 
hours. Live/dead staining showed that there were negligible cells dead at either day 1 or day 5.  
Moreover, PicoGreen DNA analysis revealed that there was no significant effect of sulfonate 
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content on cell proliferation over the 5-day culture period. Further, proliferation of encapsulated 
hDFs demonstrates the potential use of sMC hydrogels for cell encapsulation-based regenerative 
therapies.  
Aside from influencing the hydration of polymeric constructs, artificial sulfation has been 
used as a method of protein attraction and sequestration. Electrostatic interactions between 
positively-charged growth factors and negatively-charged sulfates and sulfonates have been 
widely utilized as affinity binding methods for growth factor delivery for a variety of tissue 
engineering applications, including cartilage repair, but to the best of our knowledge this is the 
first study to utilize this method in IVD repair (Jeon et al. 2011; Freeman, Kedem, and Cohen 
2008; Waghmare et al. 2018; Re’em et al. 2012; Purcell et al. 2014). Charged polymer scaffolds 
can influence adsorption of proteins from the surrounding media, which can alter surface 
chemistry, cell-material interactions, and immune responses in vivo (Lin et al. 2014; Freeman, 
Kedem, and Cohen 2008; Hartvig et al. 2011; Hoven et al. 2007). Gels were incubated in FBS to 
simulate early serum protein adsorption on an in vivo implant. Protein adsorption correlated with 
sulfonate concentration (R2 = 0.9621), as MC gels modified with 5 and 10 mM 2SEM exhibited 
significantly more adsorbed serum protein than samples polymerized with 0 and 1 mM 2SEM. In 
the degenerate IVD, decreased nutrient transport mediated by changes in the cartilaginous 
endplates and vertebral vasculature contribute to altered metabolism, which may be exacerbated 
by the loss of hydration and osmotic pressure caused by matrix breakdown, and regenerative repair 
strategies may require increased nutritional demand (Huang, Urban, and Luk 2014). The ability of 
a charged scaffold such as sMC to attract and bind local proteins has the potential to increase 
nutrient and cytokine bioavailability to drive endogenous repair. 
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Sulfonation of MC hydrogels enabled the sequestration of growth factor encapsulated within 
the hydrogels in a manner similar to its adsorption of serum proteins. TGF-b3 was incorporated 
within the hydrogels during formation, and release was measured over the course of two weeks. 
Previous studies have shown similar methods of growth factor sequestration of heparin-binding 
proteins like TGF-b3, however, many do so by taking advantage of the ability of the pre-formed 
charged material to absorb proteins into the hydrogel bulk (Waghmare et al. 2018; Portocarrero 
Huang et al. 2017). For hydrogels that form in situ, such post-polymerization growth factor loading 
is not possible. The pre-polymerized material must contain the growth factor, sequester it within 
the forming hydrogel, and protect it from denaturation during polymerization and thereafter. This 
may necessitate protection of the growth factor from polymerizing agents (McCall, Lin, and 
Anseth 2011). In pilot studies of this project, exposure of TGF-b3 to APS, a powerful oxidizing 
agent, denatures the growth factor and renders it unable to be detected by ELISA. Thus, TGF-b3 
was mixed only into the TEMED containing barrel of the dual-barrel syringe system, to avoid 
overexposure to APS. 
TGF-b3 release over two weeks showed decreasing release rate with increasing concentration 
of sulfonates. Varying the mesh size is a well-established method of controlling diffusivity of 
proteins from within a hydrogel network, which scales relative to diffusivity in a pure solvent by 
(1-Rh/x), where Rh is the Stokes radius of the protein and x network mesh size (Mason et al. 2001; 
McCall, Lin, and Anseth 2011). Although the hydrodynamic diameter of TGF-b3 has not been 
published, it can be approximated based on the molecular weight of its dimeric form (25.5 kDa) 
in comparison to other proteins of similar weight, such as PDGF-BB (24.3 kDa, 7 nm), to have a 
diameter of ~ 3.0 - 7.0 nm (Rehmann et al. 2017; McCall, Lin, and Anseth 2011). Given that there 
was no statistically significant difference in mesh size calculated from swelling data for gels of the 
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same macromer concentration regardless of sulfonate concentration (23.58 ± 1.64 to 28.54 ± 0.99 
nm for 3% w/v MC gels), and that the calculated mesh size was much larger than the encapsulated 
growth factor, it can be inferred that any changes in the release profile of TGF-b3 were due to 
chemical differences in the hydrogel composition and not to structural differences in the hydrogel 
mesh network (Amsden 1998). This suggests that sulfonated MC hydrogels interact with the 
encapsulated growth factor via electrostatic affinity, retarding the overall diffusive release and 
sequestering growth factor within the construct, similar to the mechanism by which growth factors 
are sequestered within sGAG rich tissues. Affinity-controlled release from hydrogels is driven by 
the reversible association (kon) and dissociation (koff)  rates between affinity binding groups 
(Hettiaratchi and Shoichet 2019). In this study, the affinity-binding moiety 2SEM was the same 
between groups, thus it can be surmised that the association/dissociation constants did not change. 
Instead, the increasing concentration of 2SEM increased the number of binding sites, promoting 
the rapid re-association of TGF-b3 with the hydrogel network, thus limiting the diffusion of 
dissociated TGF-b3 outside of the hydrogel (Vo and Meere 2013). Indeed, modulation of sulfation 
concentration in heparin-based microparticles has been shown to tune protein release from 5% to 
60% (Tellier et al. 2015). 
The ability to sequester cationic proteins such as TGF-b3 suggests sulfonated MC hydrogels 
may be well suited as scaffolds for cell-based therapies to improve growth factor bioavailability 
to encapsulated cells. The amount of TGF-b3 loaded into the hydrogels was calculated based on 
the total growth factor that is delivered exogenously to encapsulated cells via cell culture media 
(at a concentration of 10 ng/mL) over the course of 2 weeks. Previous studies have shown that 
spatiotemporal control of TGF-b3 stimulation is critical for both chondrogenic and NP-like 
differentiation of cells in vivo (Martin et al. 2017; Gupta and Nicoll 2015; Huang et al. 2009). The 
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precise dosing of sequestered TGF-b3 for direct or extended stimulation of MSCs varies in the 
literature and will require titration studies; however, the present investigation shows that growth 
factor concentration within the hydrogel system and release rate can be easily tuned by adjusting 
sulfonate concentration. 
3.5   Conclusions 
The results presented here demonstrate the successful fabrication of injectable, sulfonated MC 
hydrogels, which form and are retained in situ in a bovine nucleotomy model. The addition of 
sulfonates had no significant impact on gelation or mechanical properties, resulting in a sulfonated 
biopolymer scaffold with tunable properties relevant to NP replacement. The materials were not 
cytotoxic and supported cell proliferation.  Moreover, the sulfonated MC hydrogels displayed 
affinity for adsorbed serum proteins and encapsulated growth factor, which was proportional to 
the concentration of sulfonate incorporated into the constructs. Taken together, these results show 
that sMC hydrogels are a promising scaffold material for nucleus pulposus repair. Future studies 
will investigate the utility of the sulfonated scaffolds for cell-based, NP tissue engineering 
strategies. 
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4.1   Introduction 
Low back and neck pain continue to be among the leading causes of disability, with up to 
80% of the world’s adult population affected by it in their lifetime (Tamrakar et al. 2021). This 
has enormous social and economic repercussions, with low back and neck pain ranking as the most 
expensive health conditions in the United States, resulting in $134.5 billion in healthcare spending 
in 2016 alone (Dieleman et al. 2020). The prevalence of low back pain has increased by over 50% 
between 1990 and 2015, and with continually aging populations, both the number of sufferers and 
economic cost is only set to grow (Hartvigsen et al. 2018). A large majority of this disability is 
caused by degeneration and injury to the intervertebral disc (IVD), the complex fibrocartilaginous 
tissue situated between the vertebral bones of the spine (Peng 2013). Degeneration of the IVD 
results in loss of disc height, limited mobility, and often discogenic pain associated with ingrowth 
of nerves into the IVD, or impingement of spinal nerve roots, causing radiculopathy (Peng 2013).  
IVD degeneration is understood to begin in the central nucleus pulposus (NP) region of the 
disc. Aberrant cellular responses to loading lead to matrix breakdown, decreased transport of 
nutrients and metabolites, and cellular senescence (Zhao et al. 2007). In particular, increased 
catabolism and breakdown of the negatively charged proteoglycans that maintain the high water 
content of the NP causes a reduction in hydrostatic pressure and the ability of the NP to resist 
compressive loads (Sivan, Wachtel, and Roughley 2014). This shifts stress to the outer lamellar 
portion of the IVD, the annulus fibrosus (AF) (Adams, McNally, and Dolan 1996), leading to 
further IVD degeneration and injury such as bulging, fissures, and potential herniation of the NP 
through the AF (Galbusera et al. 2014). Because the IVD is generally avascular, with low 
cellularity, it has very little ability for self-repair. Nutrient supply in the healthy adult IVD is 
limited mainly to diffusion via the cartilaginous endplates (CEP) that sandwich the disc, which 
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receive blood supply from adjacent vertebral bones. This becomes further limited by the 
compounding effects of aging and degeneration, which include endplate calcification as well as 
regression and occlusion of the vessels originating in the vertebral bones (Huang, Urban, & Luk, 
2014). Although prevalence of symptomatic IVD degeneration continues to rise, therapeutic 
options have largely not improved. Current treatments largely involve palliative care and pain 
management, ranging from over-the-counter pain relief to steroidal injections and physical 
therapy; however, these treatments address pain and not the underlying issue, allowing the 
degenerative cascade to progress (Zhao et al., 2019). 
Tissue engineering strategies incorporating cells, materials and biological signaling molecules 
have been explored to restore mechanical function of the IVD and to reverse the existing tissue 
damage (Bowles and Setton 2017; Hudson et al. 2013; Tendulkar et al. 2019). In particular, NP 
replacements have been investigated as interventions for early-stage degeneration to prevent 
further disease progression and the development of more serious injuries (i.e., herniation). 
Hydrogels are a class of polymeric scaffold that are ideal for NP tissue engineering, as they mimic 
the highly hydrated network of the native NP (Gupta, Cooper, and Nicoll 2011; Halloran et al. 
2008; Showalter et al. 2015; Tsaryk et al. 2015; Alinejad et al. 2019; Iatridis et al. 2013; Lewis 
2012). Many studies have investigated stem cell-laden hydrogels for NP regeneration, however, 
the vast majority of tissue engineering studies are validated first in vitro wherein the constructs 
receive nutrients and differentiation cues from cell culture media, which is not readily translatable 
to the clinical setting (Risbud et al. 2004; Steck et al. 2005; Kregar Velikonja et al. 2014; Sakai 
and Andersson 2015). For example, previous reports have shown promising results with cellulosic 
hydrogels as scaffolds for mesenchymal stromal cells (MSCs) that differentiate towards NP-like 
phenotypes and elaborate NP-like matrix components (Varma, DiNicolas, and Nicoll 2018; Lin et 
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al. 2016; Gupta and Nicoll 2015; 2014). These studies required exogenous delivery of the growth 
factor, transforming growth factor-b3 (TGF-b3), a cytokine which is critical for differentiation of 
chondrogenic tissues such as cartilage and NP (Chen et al. 2019; Mackay et al. 1998; Madry et al. 
2014). Hydrogels, while excellent carriers for cell encapsulation, frequently exhibit burst release 
of such soluble factors loaded within them, due to the influx of water into the polymer network 
(Lin and Metters 2006; Brazel and Peppas 2000; Ritger and Peppas 1987a; 1987b). To drive 
clinical translation, growth factors must be retained within the construct long enough to stimulate 
cell differentiation. Studies have shown that transient TGF-b stimulation is sufficient to initiate 
chondrogenic differentiation from MSCs, thus a system that maintains growth factor concentration 
within the vicinity of encapsulated cells long enough to initiate differentiation is desirable (Huang 
et al. 2009; Gupta and Nicoll 2015; Kim et al. 2012). 
Recently, we developed and characterized an injectable, in situ forming sulfonated 
methylcellulose (sMC) hydrogel that sequesters encapsulated TGF-b3 (Chapter 3). 
Methylcellulose (MC) is a thermoresponsive, water-soluble derivative of cellulose, the most 
abundant polysaccharide on earth. The addition of sulfonates to the polysaccharide backbone of 
MC mimics the structure of the sulfated glycosaminoglycans (sGAGs) that comprise the matrix of 
the healthy NP. In addition to facilitating tissue hydration, part of the essential function of sGAGs 
is acting as depots for growth factors, extending their bioavailability and functionality via 
electrostatic interactions between cationic growth factors and anionic sulfates (Soares Da Costa, 
Reis, and Pashkuleva 2017). Similarly, the sMC hydrogels electrostatically sequester loaded 
growth factor over the course of 2 weeks of in vitro culture. The release rate of loaded TGF-b3 
can be tuned by controlling the concentration of sulfonates added to the MC scaffold. Moreover, 
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the resultant scaffold delivers growth factor directly incorporated into the pre-gelled polymer 
solution, which can be injected via fine-gauge needle and form stable hydrogels in situ. 
The present study aimed to investigate the ability of this growth factor-sequestering hydrogel 
system to support MSC growth and differentiation towards the NP-cell phenotype. Bone marrow-
derived MSCs were thus encapsulated within the sMC hydrogels and evaluated for functional NP-
like differentiation by quantifying characteristic matrix elaboration (type II collagen and sGAGs) 
and the development of functional construct material and mechanical properties over time. The 
potential for the sMC scaffold to drive differentiation in the absence of growth factor was also 
investigated in order to evaluate the influence of charged sulfonates on MSC differentiation, as 
matrix sulfation has been shown to be critical for the development of healthy skeletal tissues 
(Cortes, Baria, and Schwartz 2009; Mertz et al. 2012; Paganini et al. 2020). We hypothesized that 
the combination of matrix sulfonation and stimulation by sequestered TGF-b3 would support 
functional NP-like differentiation and matrix elaboration by encapsulated MSCs resulting in a 
clinically translatable, injectable tissue-engineered construct for NP replacement.  
4.2   Materials and Methods 
4.2.1   Macromer Preparation  
Methacrylated methylcellulose (Ma-MC) was fabricated by esterification of hydroxyl groups 
with methacrylic anhydride (Sigma-Aldrich) according to previously described protocols (Gold et 
al. 2014; Stalling, Akintoye, and Nicoll 2009; Varma et al. 2018). Briefly, 15 kDa (low viscosity) 
and 41 kDa (medium viscosity) methylcellulose powder (Sigma-Aldrich, degree of substitution of 
methoxy groups ~1.5-1.9) was mixed 1:1 (for ease of handling and control for injectable 
applications) (Varma et al. 2018; Lin et al. 2019) and then added to deionized H2O (diH2O) at 1% 
(w/v) at 80°C until it was evenly disbursed, after which the temperature was lowered to 4°C and 
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allowed to continue to dissolve fully for ~24 hours. The solution was then reacted with methacrylic 
anhydride with a molar excess of 20 (based on theoretical 10% modification) at 4°C and pH 8 for 
48 hours. The reaction product was purified by dialysis (Spectra/Por, MWCO 6-8 kDa) over 3 
days to remove unreacted methacrylic anhydride. Purified solution was lyophilized and stored at -
20°C. Polymer samples were acid hydrolyzed as previously described by 1H-NMR spectroscopy 
(500 MHz, Varian Mercury 500) (Stalling, Akintoye, and Nicoll 2009; Reza and Nicoll 
2010a). The relative integrations of methacrylate protons (d = 6.1 and 5.7 ppm; methyl, d = 1.9 
ppm) to carbohydrate protons were used to determine the molar percentage of methacrylation 
(Stalling, Akintoye, and Nicoll 2009). 
4.2.2   Human Mesenchymal Stromal Cell (hMSC) Culture 
Cryopreserved bone marrow-derived hMSCs were acquired from RoosterBio (Frederick, 
MD) and expanded according to the manufacturer’s protocol using proprietary high-performance 
expansion media (RoosterBasal™ -MSC medium with RoosterBooster™-MSC supplement). Cell 
lots from three healthy biological donors (MSC00115, MSC00175, and MSC00179) were used to 
reduce donor variability (Table 4.1). Each lot of hMSCs was expanded separately, to an average 
population doubling level (PDL) of 16.24 ± 0.27. Cell lots were passaged according to the 
manufacturer’s protocol and then pooled at equal cell number for encapsulation as mixed donor 
samples. All cell culture was performed at 37°C and 5% CO2, under normoxic (18.6% O2) 
conditions. 
Table 4.1: RoosterBio™ hMSC donor lot characterization and differentiation potential profiles 
 Donor information Differentiation Potential 
MSC Lot # Age Sex Adipogenic Osteogenic Chondrogenic 
00115 20 y.o. Female Yes Yes Yes 
00175 25 y.o. Male Yes Yes Yes 




4.2.3   Hydrogel Preparation and Culture 
Lyophilized Ma-MC was sterilized under germicidal UV light for 30 minutes and dissolved 
in sterile DPBS for a final concentration of 3% (w/v). Additional polymer precursors, redox 
initiators ammonium persulfate (APS) and N,N,N′,N′-tetramethylethylenediamine (TEMED), and 
2-sulfoethyl methacrylate (2SEM) were prepared at 200 mM and 500 mM working concentration, 
respectively, and sterilized via syringe filtration (0.22 µm filter size). APS and TEMED (Sigma-
Aldrich) were added to separate barrels of dual-barrel syringes (Pac-Dent) for a final working 
concentration of 10 mM each. Sulfonated gels were formed by including 2SEM (Polysciences) in 
the prepolymer mixture for a final concentration of 5 mM. Gels containing directly incorporated 
TGF-b3 were formed by adding rhTGF-b3 (R&D Systems, Minneapolis, MN) to the TEMED side 
of the dual-barrel syringe only, for a final concentration of 2 µg/mL (~80 ng/gel) corresponding to 
the total amount of TGF-b3 to be supplemented via cell culture media for 2 weeks (when 
maintained at a concentration of 10 ng/mL) (Gupta and Nicoll 2015). Pooled-lot hMSCs were 
mixed directly into the prepolymer solution for encapsulation in redox-polymerized MC hydrogels 
at 20 x 106 cells/mL. Hydrogels were formed by injecting the polymer solution through a 1:1 
mixing tip into custom casting devices and allowed to cure for 15 minutes at room temperature to 
form cylindrical gels (5-mm diameter, 2-mm height). 
Cell-laden hydrogels were cultured in vitro in chemically defined medium (CDM), consisting 
of high-glucose DMEM (Gibco), 1% insulin-transferrin-selenium-A (with sodium pyruvate) 
(Gibco), 100 U/mL penicillin + 100 µg/mL streptomycin (Gibco), 40 µg/mL l-proline (Fisher 
Scientific), 50 µg/mL ascorbic acid 2-phosphate (Sigma-Aldrich), and 100 nM dexamethasone 
(ACROS Organics). Negative controls for growth factor supplementation were maintained without 
TGF-b3. Positive control gels received media supplemented with 10 ng/mL TGF-b3 (CDM+).  
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Culture conditions are outlined in Figure 4.1. Media were changed three times weekly. Hydrogels 
were isolated at 1, 7, 21, and 42 days for various forms of analysis. Used media were collected and 
stored at -20°C for analysis (n=4). 
Figure 4.1: Schematic of hydrogel formulations, culture conditions and outcome measures 
All hydrogels were cultured in chemically defined medium (CDM). Media supplemented with 
exogenous TGF-b3 referred to as CDM+. Constructs were cultured for 42 days total and collected at 1, 7, 
21 and 42 days for analysis. CDM was collected after each media exchange for analysis of growth factor 
release. 
 
4.2.4   TGF-b3 Release 
Cumulative release of active TGF-b3 from hydrogels fabricated with incorporated growth 
factor (MCb and sMCb) was quantified over the first 3 weeks of culture. CDM was collected after 
each media exchange and stored at -20°C until quantification. Solid phase sandwich DuoSet 
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active growth factor released (n=4). Any potential latent growth factor produced by the cells was 
not quantified by skipping the activation step (rhTGF-b3 loaded within gels at fabrication was 
already in its active form). Unused CDM was used as a negative control. 
4.2.5   Cell Viability 
Cell-laden hydrogels were examined for viability and proliferation over the 42-day culture 
period. Hydrogels isolated for quantitative analysis were lyophilized, homogenized and digested 
with 4560 units/mL pepsin (from porcine gastric mucosa, Sigma-Aldrich) in 0.05N acetic acid (pH 
2.8) (Sigma-Aldrich) for 48 hours at 4°C with constant agitation, after which pepsin activity was 
neutralized by adding 10x Tris-buffered saline (pH 8.0) (Gupta, Cooper, and Nicoll 2011; Reza 
and Nicoll 2010b). Total DNA content was quantified via Quant-iT™ PicoGreen™ Assay 
(Invitrogen Molecular Probes, Eugene, OR) against calf thymus DNA (Sigma-Aldrich) standard 
curve and analyzed with a BioTek Instruments microplate reader (Synergy 4, Winooski, VT) at 
excitation and emission of 480 nm and 520 nm, respectively (n=6). Cell viability was assessed 
visually by Live/Dead staining (Invitrogen) using calcein AM (green, indicative of live cells) and 
ethidium homodimer-1 (red, indicative of dead cells) (n=2) and imaged on a Zeiss Axio Imager 
Z1 (Carl Zeiss, Inc., Thornwood, NY) optical microscope and ZenBlue software (Carl Zeiss, Inc.). 
4.2.6   Biochemical Analysis 
Hydrogels were isolated on days 7, 21, and 42 to quantitatively measure matrix elaboration. 
Gels were homogenized and digested in pepsin as described in the previous section. Sulfated GAG 
content was quantified using the 1,9-dimethylmethylene blue (DMMB) assay (Sigma-Aldrich). 
DMMB assay reagent was prepared as previously described, with pH 1.5 to minimize the 
confounding effects of scaffold and DNA interference (Zheng and Levenston 2015). Absorbance 
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was measured at 525 nm and 595 nm against a chondroitin-6 sulfate standard (Sigma-Aldrich) and 
the difference in optical density (OD) used to quantify total sGAG present (OD525-OD595). 
Collagen production was quantified via indirect enzyme-linked immunosorbent assay 
(ELISA), using monoclonal antibodies to type II collagen (Col II, II-II6B3, Developmental Studies 
Hybridoma Bank, University of Iowa, Iowa City, IA) as previously described (Gupta et al., 2011; 
Lin et al., 2016). Protein values were determined using human type II collagen standards 
(Chondrex, Inc., Redmond, WA). Absorbance was measured at 450 nm. Total GAG and collagen 
content were normalized to wet weight of the gels (n=6).  
4.2.7   Histological/Immunohistochemical Evaluation 
Hydrogels were rinsed in DPBS and fixed in a buffered zinc-formalin solution (Z-fix, 
Anatech, Battle Creek, MI) overnight at room temperature, and then stored in ethylene glycol 
monoethyl ether (EGME, Fisher Scientific). Samples were then dehydrated in a graded series of 
ethanol and then embedded in paraffin. Embedded constructs were sectioned to a thickness of 8 
µm using a Thermo Scientific Rotary Microtome (MC HC325, Walldorf, Germany) and then 
sections were mounted on charged slides and dried at 37°C overnight. Slides were deparaffinized 
with Citrisolv™ Hybrid Solvent and rehydrated in graded ethanol. Cellular morphology and 
distribution were visualized with Hematoxylin & Eosin Y (alcoholic) (Sigma-Aldrich) staining. 
Distribution of sulfated GAGs was determined by staining with 1% Alcian Blue (pH = 1.0) 
(Pastewka 1974).  
Immunohistochemistry was used to visualize specific matrix macromolecules. Clearer 
visualization of Col II and Col VI was achieved by first exposing collagen epitopes by 30-minute 
treatment of samples in hyaluronidase (type IV-S, Sigma-Aldrich) at 37°C to remove interfering 
GAGs. Sections were further swollen in 0.5 N acetic acid (Sigma-Aldrich) for 2 hours at 4°C to 
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increase access to epitopes. Slides were blocked in 10% horse serum for 20 minutes at room 
temperature, followed by incubation in primary antibodies (1 µg/mL in 10% horse serum) 
overnight at 4°C (Col II II-II6B3 monoclonal mouse IgG, Developmental Studies Hybridoma 
Bank (DSHB)). Non-specific mouse IgG was used as a control. Alexa Fluor™ 488 (Invitrogen) 
Goat anti-Mouse IgG (H+L) secondary antibody was applied at 1:200 dilution and 4′,6-diamidino-
2-phenylindole (DAPI, Sigma-Aldrich) was used to counterstain cell nuclei. All stained sections 
were imaged and captured using the Zeiss Axio Imager optical microscope and AxioVision 
software (Carl Zeiss) (n=2-3). 
4.2.8   Swelling Behavior 
Equilibrium weight swelling ratio (QW) of cell-laden hydrogels was measured at day 1, 7, 21 
and 42 (n=3-6). Constructs were isolated and blotted to remove excess liquid, and then weighed 
to determine the wet weight (Ws), after which gels were frozen at -80°C, lyophilized and weighed 





4.2.9   Mechanical Testing 
Cell-laden hydrogels were characterized for their mechanical properties under unconfined 
compression using a custom-built apparatus as previously described (n=5) (Soltz and Ateshian 
2000; Gold et al. 2014). Gels were isolated at days 1, 7, 21 and 42 and stored at -80°C until testing. 
Gels were thawed and allowed to equilibrate completely in PBS overnight at 4°C prior to 
mechanical testing. The testing protocol consisted of a creep test (tare load = 1 g) at a ramp speed 
of 10 µm/s held at 2700 s until equilibrium was reached (equilibrium criterion: <10 µm 
displacement in 10 min), followed by a multi-ramp stress relaxation test, consisting of three 5% 
strain ramps with a 2000 s relaxation period between ramps (equilibrium criterion: <0.5 g change 
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in 10 min).  Equilibrium Young’s modulus (EY) was determined as the slope of the equilibrium 
stress (calculated at each ramp) versus applied strain curve. Peak stress (spk) and equilibrium stress 
(seq) were calculated at the third ramp corresponding to 15% strain, and percent relaxation was 
calculated by the formula 
 𝑃𝑒𝑟𝑐𝑒𝑛𝑡	𝑅𝑒𝑙𝑎𝑥𝑎𝑡𝑖𝑜𝑛 = @1 − -"(
-)*
B (4.2) 
4.2.10  Statistical Analysis 
 Data are represented as the mean ± standard deviation. A two-way ANOVA with a Tukey’s 
post-hoc test was used to determine the effects of sulfonation and growth factor supplementation 
at each time point, and subsequent one-way ANOVA of time across each group on hMSC-laden 
hydrogel constructs. Two-way repeated measures ANOVA was used to determine the effect of 
sulfonation and time on TGF-b3 release. All statistical analyses were carried out using GraphPad 
Prism v.9 (GraphPad Software, San Diego, CA) with significance set at p < 0.05. 
4.3   Results 
Methylcellulose was methacrylated to enable redox-initiated crosslinking at 5.84% 
modification as confirmed by 1H-NMR (not shown). 
4.3.1   Growth Factor Release from Sequestering Hydrogels 
TGF-b3 that was incorporated into hydrogels during formation was measured during media 
exchange to track sequestration in sulfonated vs sulfonate-free gels (sMCb vs. MCb, respectively). 
Each media change was collected and assayed for TGF-b3 present in the media, and daily and 
cumulative release was calculated for the duration of the culture. Both conditions experienced a 
burst release in the first day (42.62 ± 11.59 ng, MCb and 21.71 ± 5.77 ng, sMCb), with the 
unsulfonated gels releasing significantly more TGF-b3 per day over the first 5 days (Figure 4.2A). 
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Cumulative release from sMCb reached a plateau by day 3, while MCb gels continued to release 
growth factor until reaching a plateau by day 16, Figure 4.2B shows sulfonate-free gels released 
the total amount of calculated TGF-b3 loaded (indicated by dotted grey line). The wide standard 
deviation (shown by the shaded region) is indicative of the variability in loading efficiency during 
hydrogel fabrication (78.73 ± 18.66 ng/gel). Sulfonated gels released 37.35 ± 6.87% of the 
calculated total amount of TGF-b3 loaded within the gels over the time measured (29.33 ± 5.39 
ng/gel).  
4.3.2   Cell Viability, Distribution, and Morphology 
hMSC-laden MC hydrogels were fabricated at a seeding density of 20 x 106 cells/mL 
(~800,000 cells/gel) and exhibited DNA values ranging from 51.33 ± 23.54 ng/mg to 77.01 ± 19.67 
ng/mg (DNA/wet weight). There was a statistically significant decrease in cellularity over time, as 
indicated by decreasing DNA content (Figure 4.3A), for all groups except sMCb and sMC+. 
Significant differences in cellularity between groups were seen at day 21, with nonsulfonated 
constructs displaying DNA levels significantly lower than sulfonated constructs (24.45 ± 9.30 
ng/mg to 29.08 ± 7.52 ng/mg versus 41.77 ± 11.11 ng/mg to 48.04 ± 9.51 ng/mg, respectively). 
By the end of the 6-week culture, there were no significant differences in cell density across all 
groups (ranging from 48.65 ± 18.16 ng/mg to 30.04 ± 9.86 ng/mg). These findings were 




Figure 4.2: Daily A) and cumulative B) release of encapsulated TGF-b3 from hMSC-laden 
hydrogels. 
Shaded regions indicate SD. * - Significant difference in amount of TGF-b3 released between 
groups. Significance set at p < 0.05. 
 
Hematoxylin and eosin staining (Figure 4.4) also confirmed the decrease in cellularity, 
showing much more sparsely populated constructs on day 42 versus day 7 across all groups. 
Although fewer in number and distribution, cells in sulfonated gels at day 42 still displayed a large, 
rounded cell morphology, characteristic of an NP-like phenotype. Conversely, the majority of cells 
seen in MC only gels at day 42 appeared small or showed evidence of membrane disruption and 
cellular lysis. 
4.3.3   NP Matrix Elaboration and Distribution 
 The sGAG content in the hydrogels increased over time only in groups with both sulfonates 
and growth factor supplementation (sMCb and sMC+) (Figure 4.5A). By day 42, sMCb produced 
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significantly more sGAGs (836.24 ± 181.89 ng/mg) than sulfonate-free constructs with and 
without exogenous growth factor delivery, and sMC+ constructs produced more sGAG than all 
other groups (1,242.35 ± 286.11 ng/mg). Alcian blue staining of day 42 samples was strongest in 
sMCb and sMC+ sections, consistent with the DMMB results, and concentrated pericellularly, 
rather than spreading diffusely throughout the bulk of the construct (Figure 4.6A). Not all cells in 
those constructs were producing sGAG, however, as smaller, unstained cells can be seen adjacent 
to larger cells that did stain positively for sGAGs. Alcian blue staining of the charged sulfonated 
constructs unrelated to sGAG production was observed, as seen in the staining of sMC- gels, where 
cells were clear of any blue dye. Faint blue staining was seen diffusely around the cells in MC only 
constructs, which were smaller and less rounded. 
Type II collagen production increased in all groups over time except in MC+ (averaging 25.83 
± 6.58 ng/mg over all time points) (Figure 4.5B). Col II production peaked at 21 days of culture 
in sulfonated gels (82.68 ±16.91 ng/mg, 70.93 ±4.38 ng/mg, and 57.26 ± 10.68 ng/mg in sMCb, 
sMC- and sMC+, respectively), with a decrease in Col II accumulation in sMC- constructs (43.42 
± 6.31 ng/mg) and no significant change between day 21 and 42 for sMCb and sMC+ constructs 
(67.26 ± 30.92 ng/mg and 62.14 ± 13.60 ng/mg, respectively). At 21 days, each sulfonated group 
showed significantly greater Col II accumulation compared to all non-sulfonated constructs. By 
day 42, MCb and MC- had increased Col II elaboration and values were not statistically different 
from the sulfonated gels (48.34 ± 16.34 ng/mg and 49.17 ± 9.93 ng/mg, respectively).  
Immunohistochemical staining of day 42 constructs for Col II showed positive staining in all 
constructs, although not all cells in each construct elaborated matrix (Figure 4.6B). Faint 
pericellular staining was evident in MCb gels, and few cells demonstrated staining in MC- 
conditions. Staining was more abundant in MC+ and sMC- constructs, but still faint. Consistent 
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with results of the Col II ELISA, staining in sMCb and sMC+ gels was more abundant 
pericellularly, with some staining in the interterritorial space.  
 
Figure 4.3: Viability and survival of hMSCs encapsulated within MC and sMC hydrogels. 
A) DNA content over 42 days as quantified by PicoGreen assay. Significant difference between 
time points within the same group: *– p < 0.05, **– p < 0.01, ***– p < 0.0005, ****– p < 0.0001, $– 
significantly different from all other constructs of different scaffold sulfonation within the same time 
point. a– significantly different from each other. Significance set at p < 0.05. B) Representative Live/Dead 




 Figure 4.4: Hematoxylin & Eosin staining of hMSC-laden hydrogels at day 7 and day 42. 
Scale bar = 50 µm. 
 
Figure 4.5: Biochemical content of hMSC-laden MC hydrogels over time. 
A) Sulfated GAG and B) Col II. Significant difference between time points within the same group: 
*– p < 0.05, **– p < 0.01, ***– p < 0.0005, ****– p < 0.0001, $– significantly different from all other 
constructs of different scaffold sulfonation within the same time point. a,b,c,d,e,f,g,h– significantly different 





Figure 4.6 ECM localization within hMSC-laden MC hydrogels at 42 days. 
A) Alcian blue staining of sGAGs, and immunofluorescence of B) Col II and C) Col VI localization 
(green), with nuclei stained with DAPI (blue). Scale bar = 50 µm.. 
 
4.3.4   Material Properties of Constructs 
Construct mechanics were stable and showed very little change over time. There was no 
significant change in EY between day 1 and day 42 for all groups studied (Figure 4.7A). Final EY 
for all groups ranged from 7.57 ± 2.02 kPa (MCb) to 12.34 ± 1.55 kPa (sMC-). At day 21, sMC+ 
and sMC- (but not sMCb) were significantly stiffer than all unsulfonated constructs, regardless of 
growth factor delivery. By day 42, sulfonated gels without growth factor supplementation (sMC-) 
exhibited a significantly greater equilibrium Young’s modulus than unsulfonated gels with 
encapsulated growth factor (MCb) and without growth factor supplementation (MC-, 8.42 ± 1.67 
kPa). Similarly, at intermittent time points sulfonated gels achieved greater speak than unsulfonated 
samples, irrespective of growth factor supplementation. However, by day 42 there were no 
significant differences in the speak achieved by any groups, ranging from 1.83 ± 0.45 kPa (MCb) 

























significant effect on % relaxation. Despite % relaxation decreasing within MC- and MC+ groups 
over time, relaxation behavior was also relatively stable, with an average % relaxation of 35.23 ± 
4.49% across all groups (Figure 4.7C). 
Figure 4.7: Material properties of hMSC-laden MC hydrogels over time. 
A) Equilibrium Young’s modulus (EY), B) peak stress (speak), C) % relaxation, and D) equilibrium 
weight swelling ratio (Qw). Significant difference between time points within the same group: *– p < 0.05, 
**– p < 0.01, $– significantly different from all other constructs of different scaffold sulfonation within the 
same time point. a,b,c,d,e,f,g– significantly different from other group within the same time point. 
Significance set at p < 0.05. 
 
Swelling ratio (Qw) did not change significantly over time for most groups, with 
MCb showing the only significant change in swelling ratio by 42 days (Figure 4.7D). Growth 
factor delivery method and scaffold sulfonation had no effect on swelling ratio over the first 3 
weeks of culture; by 6 weeks, however, MCb and MC- displayed higher equilibrium swelling ratio 
(20.77 ± 2.82 and 19.95 ± 0.51, respectively) than the sulfonated constructs (14.9 ± 1.82 to 16.66 
± 2.23). 
4.4   Discussion 
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 Tissue engineering repair of the NP is a promising strategy for treatment of IVD 
degeneration that aims to prevent further downstream breakdown of the disc by restoring the 
mechanical and biological function of the healthy NP. A clinically-viable tissue-engineered 
replacement for the NP requires that the traditional triad of tissue engineering components – 
scaffold, cells, and signals – are delivered together in a minimally invasive manner, such that 
differentiation and development of the replacement tissue can proceed in situ. To this end, we 
recently developed a GAG-mimetic cellulosic biomaterial system that is injectable, forms robust 
hydrogels in situ, and sequesters TGF-b3 directly within the scaffold for ease of delivery (Chapter 
3). By incorporating negatively charged sulfonates onto the backbone of the physically and 
chemically crosslinked MC scaffold, we have been able to sequester TGF-b3 via electrostatic 
interactions to serve as a depot for growth factors in a mechanism similar to sGAGs found in the 
native NP. TGF-b is critical in the development of the IVD and other cartilaginous tissues (Chen 
et al. 2019; Reza and Nicoll 2010b; Haberstroh et al. 2009; Gupta, Cooper, and Nicoll 2011; Barry 
et al. 2001; Mackay et al. 1998). Thus, the present study aimed to investigate the ability of this 
scaffold to support differentiation and NP-like matrix elaboration of encapsulated MSCs. The 
effect of TGF-b3 sequestration and enhanced bioavailability was examined with and without the 
influence of sequestering sulfonates, while TGF-b3 delivered exogenously through supplemented 
media was included as a positive control. Studies have shown that artificially sulfated scaffolds 
can promote early chondrogenic differentiation in the absence of soluble differentiating factors, 
therefore, constructs with and without sulfonates were also cultured without TGF-b3 in order to 
isolate the effect of matrix sulfonation on MSC growth and differentiation (Kwon et al. 2010; 
Kwon 2012). 
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Artificially sulfated scaffolds and sGAG-mimetics have become increasingly popular 
methods of sustained growth factor delivery for tissue engineering applications, but to the best of 
our knowledge, this is the first study to utilize the method specifically for IVD tissue engineering 
(Zeng, Groth, and Zhang 2019; Arslan, Guler, and Tekinay 2016; Yaylaci et al. 2016; Freeman, 
Kedem, and Cohen 2008; Portocarrero Huang et al. 2017; Waghmare et al. 2018; Feng et al. 2017). 
Sulfonated MC gels successfully sequestered incorporated TGF-b3 for the duration of the culture, 
with characteristic burst release on the first day of culture, followed by sustained release for all 
gels. The concentration was loaded at 2 µg/mL, the equivalent of 2 weeks of supplementation at 
10 ng/mL in chondrogenic medium (Madry et al. 2014). Previous studies have shown transient 
exposure to TGF-b for 2 weeks is sufficient to stimulate chondrogenic differentiation in MSCs 
(Kim et al. 2012; Huang et al. 2009; Gupta and Nicoll 2015). The wide disparity in release from 
non-sulfonated gels may be due to variations in mixing while loading or to variability in individual 
gel network formation; if it is not the former, it is conceivable that some gels maintained trace 
amounts of TGF-b3 within them. Release from these gels reached a plateau corresponding to the 
total theoretical loaded growth factor within 2 weeks, crossing below the threshold for therapeutic 
concentration at approximately 1 week. Sulfonated gels also experienced a burst release that was 
significantly lower than the non-sulfonated gels. Interestingly, the release quickly plateaued and 
did not appreciably increase beyond the 27.5 ng/mL released, indicating true sequestration rather 
than delayed or sustained release. Preliminary data (not included) have shown that 2SEM does not 
denature or reduce the detectability of TGF-b3 by the ELISA, and as all the theoretical load was 
released from the unsulfonated gels, we are able to discern that the loaded growth factor was not 
denatured. Because affinity-based sequestration techniques rely on association-dissociation 
reactions between the therapeutic and binding ligand, release behavior is dependent on the strength 
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of the affinity between the ligand and therapeutic, with diffusion-based release kinetics driven by 
the amount of unbound therapeutic at a given time (Vulic et al. 2015). The data here suggest very 
strong binding interactions between the sulfonates and TGF-b3. 
Based on the release data alone, it is not immediately obvious whether sequestration translates 
into increased presentation to encapsulated cells or to reduced bioavailability due to over-
sequestration. Strong sequestration of growth factors has been observed in chondroitin sulfate- and 
heparin-containing biomaterials, in which selective de-sulfation increased the release of 
encapsulated growth factors (Lei, Trevino, and Temenoff 2016; Lim and Temenoff 2013).  In prior 
studies, we showed that sequestration of TGF-b3 is tunable by titrating the sulfonate concentration. 
Fluorescence recovery after photobleaching (FRAP) is a technique that has been previously 
employed to determine the ratio of mobile to immobile TGF-b by visualizing the rate of influx of 
fluorescently-labeled growth factor into an area of interest that had been photobleached (Jha, 
Mathur, et al. 2015). Further investigation of the movement and distribution of TGF-b3 within the 
sulfonated scaffolds using FRAP may provide greater insight into the bioavailability of the 
sequestered growth factor. It is important to note that tethered TGF-b3 has successfully been used 
to induce chondrogenesis in encapsulated MSCs (McCall, Luoma, and Anseth 2012), 
demonstrating that even immobilized growth factor can promote differentiation, provided the 
spacer arm of the tethering polymer is long enough to prevent steric hinderance from impeding 
cellular access and ligand binding. 
The combined effects of sulfonation and TGF-b3 appear necessary for maintaining cell 
survival within this crosslinked MC hydrogel system.  This is evidenced by the finding that DNA 
content decreased over time in all groups except for those with both sulfonate and TGF-b3 
supplementation (sMCb and sMC+). Neither scaffold sulfonation nor TGF-b3 supplementation 
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alone (sMC-, or MCb and MC+, respectively) were sufficient in preventing significant decrease 
in cellularity. The reduction in cellularity was clearly visualized both in live/dead staining and 
H&E histological sections. H&E staining showed those cells that remained in the sulfonated 
constructs displayed a large, rounded morphology, typical of the chondrocytic cell phenotype, but 
that the vast majority of cells in the non-sulfonated gels were shriveled and seemed unhealthy, 
appearing to have disrupted membranes or have lysed.   Similar results were observed in heparin-
modified hyaluronic acid hydrogels, where heparin-bound TGF-b1, but not unbound incorporated 
or exogenous delivery of TGF-b1, enhanced survival and proliferation of encapsulated cardiac 
progenitor cells by retaining the active form of the growth factor in close proximity to the cells for 
an extended amount of time (Jha, Tharp, et al. 2015).  In our development of the sMC hydrogel 
(Chapter 3), there was no indication of cell death, and in fact, there was evidence of proliferation 
over the course of the study.  Nevertheless, the focus of that cell study was on cytocompatibility, 
in accordance with ISO standard 109935:2009, and lasted 5 days to assess the cytotoxic potential 
of the hydrogel components during and immediately following gel formation, and not on long-
term survival. The fact that a significant decrease in cell number was observed in MCb gels as 
early as 7 days of culture despite direct encapsulation of TGF-b3 was surprising, as TGF-b has 
been shown to inhibit disc cell apoptosis (Ni et al. 2014; Xie et al. 2020). The burst release of 
TGF-b3 from the unsulfonated hydrogel seen in the release study may be responsible for the lack 
of response. MC+, which received continuous exogenous TGF-b3 delivery, did not display 
significant cell loss until 21 days. Still, sulfonated MC gels without TGF-b3 supplementation 
(sMC-) showed a significant drop in cellularity only by day 42, suggesting that the sulfonation of 
the scaffold alone may have assisted in maintaining cell survival.  Qualitative inspection of 
live/dead staining showed an obvious decrease in the density of live cells across all groups, 
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although there was no statistically significant change in cell number. From morphological analysis 
alone it is not possible to discern whether cell death was caused by apoptosis or necrosis. In the 
absence of phagocytic cells to engulf apoptotic bodies, apoptotic cells go through secondary 
necrosis (Silva 2010). Staining of cleaved caspase-3, an apoptotic marker, was not performed, but 
could be used in the future to elucidate whether apoptosis or necrosis was the cause of cell death 
in these scaffolds. 
The decrease in cell viability and proliferation observed in most of the MC hydrogel 
formulations may be due to subtle alterations in gel material properties (i.e., stiffness, hydration, 
nutrient transport) attributed to the hydrophobic character and thermoresponsive nature of the 
biomaterials. Earlier studies directly encapsulating bovine NP cells into similar hydrogels of 
photocrosslinked methacrylated MC (3% w/v) reported only 20-30% survival by 21 days of culture 
(culture medium contained serum and no TGF-b3 supplementation), which is comparable to the 
survival at day 21 in sulfonate-free gels (MC-) in the present investigation (Reza, Stalling, and 
Nicoll 2006). We hypothesized that this may have been caused by the limited hydration of MC 
that results from the presence of hydrophobic methoxy substitutions on its backbone. When MC 
is in solution, the methoxy groups (as well as the methacrylates on modified MC) aggregate at 
increasing temperatures to form thermoreversible physical crosslinks. Few studies have 
investigated dual-crosslinked MC systems similar to the one presented here, wherein the reversible 
thermally induced physical crosslinking of MC is combined with permanent redox-initiated 
chemical crosslinks to form more stable and mechanically robust hydrogels (Pakulska et al. 2015; 
Morozova et al. 2019; Shin et al. 2020). Morozova et al. (2019) have recently shown that allyl-
modified, photocrosslinked MC formed at lower temperatures (~20°C) form amorphous 
crosslinked hydrogels that retain some of their thermoresponsive nature, with increasing storage 
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modulus and decreasing volumetric swelling with increasing temperatures, but it was not clear if 
this increase was significant within the range of 20°C to 37°C. Shin et al. (2020) have also recently 
formulated tyramine-modified photocrosslinkable MC for use as a bioink and found that dual-
crosslinked MC (chemically and thermally at 37°C) result in stiffer gels than those chemically 
crosslinked at room temperature, regardless of the order of stimuli. While the chemical and 
material specifics of these studies are different, they exhibit the strength of the hydrophobic 
interactions in MC, even when chemical crosslinking dominates the material behavior. In the 
present study, hydrogels were chemically crosslinked for 15 minutes at room temperature, as 
maintaining the developing system at 37°C was not feasible while ensuring sterile conditions. It is 
possible that once the hydrogels were moved to 37°C, the gels contracted or stiffened, which has 
implications both on the mechanical stimuli experienced by the cells, as well as on the transport 
of fluid and nutrients within the constructs. We have generally operated under the assumption that 
the methacrylate-derived crosslinks dominate the properties of the gels, as these permanent 
chemical bonds result in storage moduli 1-2 orders of magnitude higher than gels stabilized solely 
by physical thermal crosslinks (see Chapter 2).  Nevertheless, the thermally driven contributions 
to the network structure may still influence the viability of cells encapsulated within the cellulosic 
scaffolds.  
 Despite evidence that cells were not apparently proliferating within the constructs and cell 
death was observed across many of the groups, metabolic activity via production of matrix 
components in all constructs suggests the observed cell death was apoptotic rather than necrotic, 
as necrotic cells would not be actively producing matrix components (Strehl et al. 2002). As might 
be expected, the groups that produced the most NP specific matrix components (sGAG and Col II) 
were also the groups with the best cell survival. Both sMCb and sMC+ exhibited increasing sGAG 
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accumulation over the course of culture, with the greatest amount of sGAG accumulation exhibited 
in constructs with exogenous growth factor delivery. The finding that all sulfonate-free groups, 
even with TGF-b3 stimulation, did not display a significant increase in sGAG accumulation over 
time indicates that the inclusion of the negatively charged moieties was necessary for matrix 
stimulation. This is likely attributed to the sequestration and presentation of TGF-b3 in the vicinity 
of the cells, as growth factor-free, sulfonated constructs (sMC-) showed no significant increase in 
sGAG production, nor any improvement over any of the non-sulfonated constructs. Interestingly, 
sMC- gels presented with intense non-specific Alcian blue staining not localized to cells.  As 
Alcian blue dye is cationic and attracted to negative charges, the stronger blue staining throughout 
the sMC- gels may be interpreted as uniform staining of the construct with evenly distributed fixed 
charge distribution. In contrast, the sMC+ and sMCb gels that produced more sGAGs (as 
confirmed by the DMMB assay) presumably had a higher concentration of negatively charged 
sulfates and associated fixed charge density in the vicinity of the pericellular neomatrix. This 
would result in the observed sequestration of Alcian blue dye in the pericellular space and less 
non-specific staining of the sulfonated scaffold.  Moreover, this was confirmed via Alcian blue 
staining of all day 7 sulfonated gels, which also exhibited stronger non-specific background 
staining, as did acellular sulfonated gel sections (not shown). 
 With respect to Col II production, there was a significant increase in all groups except MC+ 
over the course of the 6-week culture. All sulfonated groups exhibited marked, significant 
increases in Col II production between days 7 and 21, regardless of growth factor stimulation. 
However, sMC- demonstrated an equally significant drop in Col II content by 42 days. The 
decrease in accumulated Col II may be relative to the loss of cellularity; when normalized to DNA, 
Col II in sMC- gels was not significantly different at day 42 than 21.  Even though Col II 
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production was more rapid in the sulfonated gels, the non-sulfonated gels did catch up, and by 42 
days there was no significant difference between Col II production in non-sulfated and sulfated 
gels, except for those where TGF-b3 was delivered exogenously. Data normalized to DNA suggest 
again that the combination of scaffold sulfonation and continuous exogenous TGF-b3 stimulation 
resulted in the most robust anabolic activity, as well as the most consistent increase in Col II over 
time.  
The distribution of dead cells and elaborated matrix did not exhibit any spatial pattern that 
would indicate nutrition or diffusional constraints, as has been exhibited in previous studies (Gupta 
and Nicoll 2015; Varma, DiNicolas, and Nicoll 2018). As mentioned earlier, labeling of TGF-b3 
to image distribution, motility, and consumption may be useful in determining whether 
sequestration played a role in limiting the growth and differentiation of the encapsulated cells. 
Additionally, this study used a pooled batch of 3 distinct hMSC donors. Pooled-donor usage has 
been shown to have no negative effects on viability, proliferation, or differentiation when 
compared to single donor studies, and is intended to eliminate the need for biological replicates 
(Hejretová et al. 2020; Widholz et al. 2019). However, lack of an evident pattern in the distribution 
of dead cells and metabolically active cells (as exhibited by GAG and Col II staining around some, 
but not all cells) raises the question of whether one or more donor cell source was exhibiting a 
more robust response than others. Pooling donors eliminates the ability to discern minute 
biological differences that could influence cellular response, and future studies may need to take 
that into account. Yet, this issue has not been raised in other NP tissue engineering studies that 
used pooled donors (Thorpe et al. 2010; Frith et al. 2014; Potier and Ito 2014). 
In this study, matrix production was analyzed to provide evidence of NP-like differentiation, 
as the goal of tissue engineering is to develop de novo healthy tissue.  Hence, the production of the 
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major matrix components responsible for healthy NP functionality were the primary outcome 
measures to assess cell-driven repair. Type II collagen and proteoglycans, specifically aggrecan, 
are the most abundant matrix components of the NP as well as hyaline cartilage. Indeed, 
differentiation of NP cells is often somewhat loosely referred to as chondrogenesis despite the two 
tissues being distinct. The mechanical role and behavior of the two tissues are quite different, 
which is reflected in the ratio of these matrix components. The high hydration and soft viscoelastic 
behavior of NP tissue is afforded by the abundance of sGAGs, which appear at a ratio of 27:1 to 
hydroxyproline, as opposed to ~2:1 in healthy adult cartilage (reaching a maximum of 5:1 in 
degenerate cartilage) (Risbud et al. 2015; Mwale et al. 2004). As the mass ratio of hydroxyproline 
to collagen has been reported as 1:7.5, the effective sGAG:Collagen ratio was calculated as 3.6:1 
in healthy adult NP and 1:1.5 to 1:3.75 in cartilage. Type II collagen accounts for nearly 100% of 
the collagen content in the NP (other collagens like type VI, IV, and XI are present but their relative 
quantities are so much lower as to be negligible for the current approximation) (Antoniou et al. 
1996). Due to the slower apparent collagen production in sulfonate-free MC constructs, the 
sGAG:Col II ratio was significantly higher in MC-only constructs versus sMC constructs (~34-
40:1 versus 16-19:1, respectively) at day 21 but by day 42 the differences in ratio were no longer 
significant between groups, averaging ~22:1. While relative matrix production is a useful tool in 
phenotypic distinction, absolute quantity allows for better assessment of the regenerative potential 
of the system. By 42 days of culture, sGAG production was nearly 50-fold lower than the native 
NP (525 µg/mg dry weight) at 2.33% across all conditions, and collagen production was lower 
still, at 0.36% (250 µg/mg dry weight) (Antoniou et al. 1996).  
The production of sGAG and Col II were evaluated as the primary endpoints for successful 
differentiation and tissue regeneration in the present study. NP-specific gene markers have been 
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identified such as N-cadherin (CDH2), keratin 19 (K19) (Lv et al. 2014) , PAX1, FOXF1, HBB, 
and CA12 (Minogue et al. 2010), and can be useful in determining early differentiation. However, 
in the absence of downstream protein translation, gene expression profiles provide limited 
functional information. Given the limited matrix deposition and cell survival exhibited in this 
study, further genetic characterization was not pursued. As future studies optimize the system for 
cell survival, gene expression will become a more relevant tool for identifying differentiated NP 
cells. 
Histological images showed that matrix accumulation was generally limited to the pericellular 
area for both Col II and sGAGs. Only sMCb constructs showed some faint interterritorial staining 
for Col II. The limited diffusion of matrix components into the hydrogel is likely due to the 
combined effects of the low swelling capacity of MC and lack of matrix degradation. Numerous 
studies investing the effects of hydrogel material properties have shown that matrix deposition by 
cells is a function of the available volumetric space and diffusivity (Bian, Hou, et al. 2013; 
Erickson et al. 2009; Lin et al. 2016; Gupta and Nicoll 2014). The effective mesh size of these MC 
based hydrogels has been previously calculated from equilibrium swelling ratio to be on the order 
of ~20 nm (Chapter 3). Bryant and Anseth (2002) first reported that diffusion and distribution of 
elaborated sGAGs in hydrogels requires a mesh size of a minimum 9 nm. While these hydrogels 
satisfy that requirement, this assumes uniform distribution of the mesh and no steric or 
electrochemical interference that would limit Fickian diffusion of sGAG molecules. The largest 
mesh size of the poly(ethylene glycol diacrylate) hydrogels investigated in that study was 14 nm; 
despite being fairly close to the size of the matrix molecules, the construct showed good diffusion 
and distribution of sGAGs throughout the hydrogel. Given that the MC hydrogels have a mesh 
size that is permissive for sGAG diffusion, it is not clear why elaborated sGAGs would remain 
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within the pericellular region. Degrading hydrogels have shown promise as scaffolds for cartilage 
and NP tissue engineering as controlled breakdown of the scaffold is conducive to the elaboration 
of matrix, particularly larger matrix molecules like collagen (~300 nm fibril diameter) (Bryant and 
Anseth 2003; Chung et al. 2009; Reza and Nicoll 2010a). Ma-MC-based hydrogels exhibit 
excellent long-term stability and are typically not susceptible to hydrolytic degradation, both in 
vitro and in vivo (Stalling, Akintoye, and Nicoll 2009; Gold et al. 2015; Lin et al. 2019). Ester 
bonds formed between the methacrylate groups are susceptible to hydrolytic cleavage, however, 
actual hydrolysis is dependent on the hydration of the network and steric factors, with higher water 
content (and frequently larger mesh size) corresponding to increased exposure of the ester linkage 
to water (Reza and Nicoll 2010a; Varma et al. 2014; Jeon et al. 2009). The low swelling capacity 
of MC hydrogels due to the hydrophobic methoxy groups supports the long-term stability of the 
gel, but also prevents the hydrolysis-mediated creation of void space necessary for accumulation 
of neomatrix (Chung et al. 2009; Bryant and Anseth 2003). 
There was virtually no net change in compressive properties or swelling in any of the 
constructs over time. Given the limited matrix deposition shown via histology, it can be assumed 
that the stability of the mechanical properties is derived from the lack of scaffold breakdown. Some 
significant differences were observed in percent relaxation of MC-, MC+ and sMC- gels over time, 
however, this cannot readily be explained by the limited matrix accumulation. It may be an artifact 
of variability between gel casting, which could be reduced in further studies by increasing the 
sample size. All constructs were within the range of the mechanical and material properties 
reported for NP, which has been reported as having an EY of 5.39 ± 2.56 and percent relaxation of 
34.23% ± 11.30% (as calculated in Eq. 4.2) for human tissue in unconfined compression, and an 
equilibrium weight swelling ratio of 19.94 ± 3.09 for bovine  tissue (Cloyd et al. 2007; Reza and 
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Nicoll 2010b). From the perspective of mechanical replacement and restoration in the IVD, the 
stability of the constructs is promising, as it is not ideal to have an NP replacement that is too soft 
to withstand the compressive forces of the disc. Having a compressive modulus slightly higher 
than the native NP in unconfined compression has shown promising results for the restoration of 
motion segment mechanics in ex vivo models (Varma et al. 2018). Nevertheless, it has been well 
established that increasing scaffold stiffness by modulating macromer concentration and 
crosslinking density has negative effects on differentiation and matrix elaboration of cartilaginous 
tissues (Erickson et al. 2009; Gupta and Nicoll 2014; Lin et al. 2016). In the previous study 
(Chapter 3), it was determined that although the components of the sMC hydrogel system are 
tunable and allow for a wide range of mechanical properties, a minimum of 3% w/v macromer 
concentration was necessary to form stable hydrogels that gelled in situ and were retained when 
injected into the void space of a bovine disc explant model. Thus, this was the formulation 
employed for the current cellular investigation.  
The goal of a clinically translatable formulation for an NP replacement material is that it must 
be injectable and minimally invasive in order to preserve AF integrity, as well as immediately able 
to restore mechanical deficiencies of the degenerate disc. The challenge for in situ-based, tissue 
engineering strategies is that soft substrates that mimic the developmental milieu and promote NP 
cell differentiation (Navaro et al. 2015; Francisco et al. 2014; Francisco et al. 2013) provide little 
to no immediate biomechanical support or restoration of disc height, range of motion, and most 
importantly, reduction in pain for patients suffering from degenerative disc disease. Panebianco et 
al. (2020) have recently presented a systematic review of cell-based injectable biomaterials for 
IVD repair highlighting the ongoing competitive balance that exists between biomechanical and 
biological performance and asserted that materials that are able to combine high modulus with 
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controlled degradation and ability for cellular remodeling are likely to be the best candidates for 
successful translational tissue engineering of the IVD. 
Future work in developing this platform should consider incorporating hydrolytically or 
enzymatically cleavable crosslinks, in order to make the scaffold more permissive for matrix 
elaboration. As mentioned earlier, gels were formed at room temperature in rigid molds, neither 
of which truly recapitulate in situ gelation. Prior work has shown that redox-initiated gelation of 
methacrylated cellulosic hydrogels in situ resulted in gels with EY half that of gels made within 
custom molds (Varma et al. 2018). The softer gels are likely due to inefficient crosslinking with 
exposure to oxygen. While our previous investigation showed that this formulation is able to form 
stable hydrogels within the void space of the IVD post-nucleotomy, softer gels may also be better 
able to support MSC differentiation, matrix elaboration, and nutrient transport. Additionally, the 
current work was performed under static culture conditions. As the native disc is constantly 
mechanically loaded, dynamic culture will be necessary to ascertain the construct’s performance 
in supporting differentiation and survival of MSCs under more physiologically relevant conditions. 
Mechanical loading can stimulate differentiation of embedded cells and drive convective transport 
of TGF-b3 and elaborated matrix, all of which can potentially increase the success of this tissue 
engineering platform (Safshekan et al. 2012; Shah and Chahine 2018; Tsai et al. 2014; Huang et 
al. 2010; Li et al. 2010; Thorpe et al. 2010; Mauck et al. 2003). 
4.5   Conclusion 
This study examined the ability of artificially sulfonated MC scaffolds to support hMSC 
differentiation toward an NP-like phenotype as a potential injectable NP repair strategy. TGF-b3 
was successfully sequestered within sulfonated hydrogels and the combined effects of enhanced 
growth factor bioavailability and stimulation due to presumed sulfonate interactions were able to 
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maintain cell viability and promote the elaboration of NP-specific matrix components, namely 
sulfated GAGs and type II collagen. All the MC-based scaffolds maintained stable mechanical and 
swelling behavior over time that were within the range of compressive and swelling properties of 
the native NP. Matrix elaboration was limited to pericellular regions and did not distribute evenly 
throughout the construct, nor did gross levels of ECM components approach the quantities found 
in the NP, which was likely due to the limited ability to diffuse through the construct. The stability 
of the sMC hydrogels demonstrates its strong potential as a candidate for acellular NP replacement 
therapies; however, the limited matrix elaboration and low cell survival suggest further 
optimization is necessary to make the platform amenable to cell differentiation and biological 
repair. Future studies will investigate the efficacy of this platform for MSC-driven NP repair when 
combined with degradable linkages. 
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Chapter 5:   Conclusions, Limitations, and Future Directions 
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5.1   Overview 
The global objective of this thesis was to develop an injectable, MC-based hydrogel system 
as a functional NP replacement for both cell-based and acellular therapies for early IVDD. 
Previous studies have shown successful NP-like differentiation of encapsulated hMSCs within 
CMC hydrogels but were unsuccessful in forming gels directly in the disc, and it was found that 
the thermogelling capacity of MC combined with redox-initiated covalent crosslinking was 
necessary for retaining the injectable NP replacement within the disc. Thus, the focus of this work 
was to optimize a tissue engineering platform for the NP, centered on MC and taking cues from 
the successes of the previous CMC-based tissue engineering studies while preserving the 
thermogelation of MC that was necessary for clinical translation. 
 Although there is anecdotal evidence that the thermogelling behavior is preserved in 
methacrylated MC, the effect of methacrylate modification and percent modification on the 
thermoresponsive behavior of MC had not been investigated. As methacrylate groups are 
hydrophobic, it was hypothesized that methacrylates would enhance the thermogelation of MC. 
Thus, rheometric analysis of the influence of temperature and time was explored for various 
methacrylation percentages (Chapter 2). The addition of methacrylate groups was shown to lower 
the thermogelation onset temperature and increase the thermoresponsiveness of MC hydrogels.  It 
was also seen that there was a threshold of methacrylate concentration above which redox-initiated 
crosslinking efficiency was limited at physiologic temperatures, thus informing the most desirable 
degree of methacrylation for future studies. 
MC hydrogels have a much lower swelling capacity than CMC hydrogels. The swelling 
capacity of CMC is afforded by the negatively charged carboxyl groups on the polysaccharide 
background that increase hydration and subsequently make CMC more susceptible to hydrolytic 
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degradation of ester bonds within methacrylate crosslinks. Sulfonates were incorporated onto MC 
during redox polymerization in order to fabricate a “GAG-mimetic” sulfonated MC (sMC) 
hydrogel (Chapter 3). Using factorial design, sulfonated MC hydrogels were investigated for 
material properties and injectability. Sulfonate incorporation did not have any effect on the 
swelling ratio of MC hydrogels, which was tunable by modifying macromer concentration. Ex vivo 
bovine motion segment models for injection and retention showed that a minimum of 3% MC 
crosslinked with 10 mM APS and TEMED each was necessary to form hydrogels in situ. As 
another challenge to translation of tissue-engineered NP replacements has been delivery of TGF-
b3 within the hydrogel system, the ability of the GAG-mimetic sMC to sequester encapsulated 
TGF-b3 was investigated as well. Sulfonate concentration allowed for sequestration of TGF-b3 in 
a tunable fashion proportional to the concentration of sulfonates.  
Using the results of the factorial study in Chapter 3, 5 mM sulfonate concentration with 3% 
MC macromer concentration was selected for encapsulation of hMSCs. Sulfonation and TGF-b3 
delivery for hMSC-laden MC scaffolds was investigated over 6 weeks. The constructs showed 
moderate matrix deposition, with clear superiority in the groups that were both sulfonated and 
received TGF-b3 stimulation, regardless of delivery route, although cell viability decreased over 
time in all groups except those with both sulfonates and TGF-b3, indicating a potentially 
synergistic effect on survival and differentiation. The hydrogels exhibited no change in mechanical 
or swelling properties over time, indicating that MC remained resistant to hydrolytic degradation. 
The results suggested that scaffold sulfonation and encapsulated TGF-b3 delivery hold promise 
for cellulose-based hydrogels for NP tissue engineering, and elucidated areas for further 
optimization. The major findings and limitations of these studies, as well as recommendations for 
future work, are presented in this chapter. 
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5.2   Rheological Analysis of the Effect of Methacrylation on the Thermoresponsive 
Gelation of Methylcellulose in Aqueous Solutions (Chapter 2) 
Methylcellulose is a unique cellulose derivative that is water soluble and exhibits reverse 
thermogelation behavior, forming a physically crosslinked hydrogel at increasing temperatures. 
The modification of hydroxyls on cellulose with methoxy groups interrupt the strong interchain 
hydrogen bonds that render cellulose insoluble in water. Somewhat paradoxically, this solubility 
is afforded by methoxy groups which are hydrophobic themselves. Thus, the thermoresponsive 
behavior is mediated by the aggregation of hydrophobic groups at increasing temperatures. 
Previous studies in our lab have explored the effect of macromer concentration, molecular weight, 
and methacrylation percentage on hydrogel mechanics in unconfined compression, as well as 
swelling behavior. Additionally, the gelation kinetics of redox-polymerized gels were only 
investigated at room temperature, and so the effect of the thermoresponsive nature of MC on redox-
initiated gelation was not explored. Methacrylate groups are hydrophobic; thus, it was 
hypothesized that methacrylation of MC would enhance the thermal response and lower the 
gelation temperature of MC. 
Rheology was chosen as the primary means for measuring the thermal response of MC as it 
was directly relatable to the physical behavior of the gel and has implications for its handling and 
injectability. A preliminary challenge lay in the fact that the definition of thermogelation 
temperature varies widely in the literature, and so it is difficult to compare studies without first 
comparing the definition used in each study. As such, MC with varying methacrylation percentages 
was tested over a temperature ramp of 4°C to 80°C, and the onset of thermogelation was 
determined using three different methods based off of the literature. While the trend of decreasing 
thermogelation onset temperature with increasing methacrylation percent was mostly preserved 
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across all methods, the meaningfulness of the physical behavior depended how the definition is 
applied. For example, when the traditional Winter-Chambon definition of a gel, G’>G” is taken 
as indication of thermogelation, it can be seen that methacrylated MC frequently gels at 
temperatures well under physiologic temperature, but that this crossover point does not correspond 
to the sharp increase in G’ associated with the ordering of MC chains in response to increased 
temperatures.  Rather, it likely has to do with the passive aggregation of hydrophobic moieties at 
a higher concentration. Similarly, taking the derivative of the log of G’ as the point of sharpest 
increase in G’ to be the point of thermogelation onset (when it is more accurately the midpoint of 
the thermogelation process) selects for a higher temperature above 37°C for all groups, and may 
cause researchers to artificially and inaccurately conclude that a particular material does not 
achieve thermoresponsiveness at physiologic temperatures.  
The influence of methacrylation on thermogelation was then investigated under the formation 
of purely physically crosslinked gels at 37°C. As the temperature ramp data indicated, increasing 
methacrylation percentage resulted in stiffer gels at 37°C, and that the contributions of salts in PBS 
nearly doubled the stiffness at higher methacrylation percentages, while it had little effect with the 
low and unmethacrylated groups. Interestingly, strain stiffening behavior was observed at 37° in 
MC of higher methacrylation precents. This was attributed to the gradual ordering of MC chains 
at 37°C, along with a steady rate of increasing strain that strengthened the interchain bonds rather 
than slowly breaking them. This had direct implications on the injectability of the gels, so cyclic 
strain tests were employed to see how quickly the gels responded to rapid changes in strain. Even 
at high methacrylation percentages the gels were immediately able to respond to high strain, and 
that the recovery at low strain was gradual, a classic behavior of thixotropic materials.  
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The combined effects of methacrylation percentage and redox-initiated polymerization on the 
gelation kinetics at room temperature versus physiologic temperature were then examined. 
Gelation was observed to begin much more rapidly at 37°C than at 20°C, although it is likely that 
this can at least partially be attributed to the effect of temperature on the reaction chemistry; the 
observed “toe” region in the gelation profile at 20°C did not decrease significantly with increasing 
methacrylation, indicating that the process of free-radical formation and crosslinking was 
independently influenced by temperature and not the interaction of MC chains. The predefined 
completion of the redox-initiated reaction was reached at approximately the same time for all 
methacrylation percentages, which was predictably faster at 37°C than at 20°C. At this completion 
point, gels formed at 37°C were significantly stiffer than those formed at 20°C, but gels continued 
to stiffen slightly, and it was observed that if the reaction was allowed to continue, the maximum 
stiffness was reached by 20 minutes and was no longer significantly different between 
temperatures. The rapidity of the reaction at physiologic temperature is important for injectability 
and retention. In addition to decreasing the amount of time unconsumed free radicals would persist 
in situ, faster gelation could potentially prevent extravasation from the injection site.  
Interestingly, there was not an additive effect of the dual crosslinking mechanism on final 
stiffness, but rather the dual crosslinking played more of a role in kinetics of network formation. 
What was surprising to observe was the difference in stiffness measured between high 
methacrylation MC at differing temperatures. Specifically, the highest methacrylated MC (9.54%) 
formed significantly stiffer gels at 20°C than at 37°C, the opposite effect of what was observed at 
lower methacrylation percentages (5.84%, 2.44%). Furthermore, rather than reaching equivalence 
at the end of the reaction time, the G’ of mMC9 continued to diverge, with the stiffness at 20°C 
more than double that at 37°C. This seems to indicate that unused free radicals persist and that at 
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37°C the network formation of mMC9 may have been strong enough to resist chain movement and 
mixing to allow for completion of chemical crosslinking. Such network formation may also have 
contributed to microphase separations, which pushed free radical-containing water from the 
vicinity of hydrophobic methacrylate groups, diminishing the reaction efficiency. These 
observations have implications for the usage of methacrylated MC at room temperature versus 
physiologic temperature. If high methacrylation percentage MC macromers form stiffer gels at 
room temperature rather than physiologic temperature, it brings into question the comparison of 
data acquired with room temperature formed gels compared with their behavior in situ. Because 
this divergence was not observed in methacrylation percentages of ~6% and lower, only macromer 
methacrylated below that threshold was used for future studies so as not to introduce confounding 
factors. Overall, the results of this study show that methacrylation influences the 
thermoresponsiveness of MC, which is proportional to the modification percentage of the 
macromer and should inform future decisions in designing MC-based hydrogel systems.  
5.3   Injectable Sulfonated Methylcellulose Hydrogels with Tunable Growth Factor 
Sequestration as Potential Nucleus Pulposus Replacements (Chapter 3) 
Extensive investigation of methacrylated CMC has shown that it is a promising candidate 
material for NP tissue engineering applications. In particular, the negatively charged carboxyl 
groups on the polysaccharide backbone allow CMC to behave as a sort of GAG-mimetic material, 
with a high swelling capacity. Being a non-animal derived natural polysaccharide, it is not 
susceptible to hydrolytic degradation, which is a concern for implantation within the degenerate 
IVD space characterized by increased catabolic enzyme activity. The hydration of CMC also 
exposes the ester linkage within methacrylate crosslinks to hydrolytic degradation, which renders 
the scaffold permissive to matrix elaboration by encapsulated cells. As recent studies showed, 
167 
despite the adoption of a redox-initiated polymerization system which is amenable to injectable 
applications, CMC did not gel rapidly enough within the disc space to be retained in situ. Earlier 
preliminary studies with NP cells encapsulated in MC hydrogels showed less encouraging results 
than those generated with CMC gels. Thus, modification methods for MC hydrogel system were 
sought that would retain the thermogelling characteristic that allowed for in situ gelation and 
retention in the IVD, while incorporating similar features as CMC that would make it more 
supportive of cell differentiation. In addition, TGF-b3 was directly loaded into CMC hydrogels 
previously in order to examine the ability of negatively charged carboxyls to deliver cell-
instructive factors within the scaffold together with cells in a fully contained tissue engineering 
construct. Despite the negative charge of the carboxyl groups, CMC was not able to 
electrostatically sequester encapsulated TGF-b3. Incorporation of heparin into the CMC system 
also did not improve biological performance of cells encapsulated with growth factor, which was 
attributed to over-sequestration of TGF-b3, although this was not definitively proven. As such, 
development of a GAG-mimetic using MC as the base polymer was pursued, in order retained 
thermogelation behavior but increased swelling capacity and sequestered growth factors as a result 
of the incorporation of charged sulfonates at varying concentrations. coupled negatively charged 
sulfonates to the MC polymer was network using sulfonated methacrylate monomers during redox 
polymerization. Interestingly, no effect of the addition of sulfonates on any of the material 
properties of the scaffolds was observed. Thermogelation behavior was preserved, attributed to the 
fact that sulfonates were not covalently attached to the MC backbone until redox polymerization. 
It is likely that directly attaching negatively charged groups to the MC backbone would counteract 
the hydrophobic effects of the methoxy groups and reduced the thermogelation capacity of the 
polymer. As thermogelation was measured on uncrosslinked polymer, 2SEM was in solution, 
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rather than attached to the polymer, so hydrophobic aggregation continued as normal and was not 
affected. Interestingly, the incorporation of sulfonates had no effect on the swelling behavior of 
the hydrogels, further supporting the assumption that the sulfonates did not change the network 
formation of MC. Injection into ex vivo bovine motion segments showed that a minimum 
macromer concentration of 3% was necessary for gelation and retention when using 10 mM redox 
initiator concentration (higher initiator concentrations were not attempted, as were used in the prior 
in situ study using CMC-MC with 20 mM initiators (Varma et al. 2018). 3% MC hydrogels were 
further characterized for long-term stability, cytocompatibility, and growth factor sequestration. 
Similar to the swelling results, it was found that sulfonation had no effect on the stability of MC 
gels, which showed no evidence of hydrolytic breakdown over 8 weeks. Also, all sulfonate 
monomer concentrations were cytocompatible. Growth factor retention studies showed successful 
sequestration of TGF-b3 that correlated with the concentration of sulfonates. The combination of 
3% MC with 5 mM 2SEM for future hMSC encapsulation studies was chosen, as there was no 
significant difference between 5 mM and 10 mM 2SEM concentration. Although the hydrogels 
did not show evidence of increased swelling or hydrolysis despite the addition of negatively 
charged sulfonates, the ability to sequester growth factor, which was not achieved in the CMC 
system, was a promising step in the development of a clinically translatable, injectable NP tissue-
engineered system. 
5.4   TGF-b3 Sequestering, Sulfonated Methylcellulose Hydrogels Support Nucleus 
Pulposus-Like Matrix Elaboration by Encapsulated Human MSCs (Chapter 4) 
The sulfated GAGs of the NP play a critical role in NP mechanics and hydration, as well as 
cell homeostasis. Negatively charged sulfates attract and sequester growth factors within the ECM, 
extending their half-life and making them more locally available to cells. Disorders of sulfation 
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cause profound defunction in musculoskeletal development, resulting in debilitating and 
sometimes fatal chondrodysplasias. As such, a sGAG mimetic sMC hydrogels as potential cell-
instructive scaffolds was investigated. Having previously shown the injectability and ability to 
sequester growth factors in the prior chapters, the sMC material holds promise as a potentially 
translational tissue engineering platform. Here, hMSCs from a pooled batch of donors were 
encapsulated and investigated the effects of sulfonation and growth factor delivery over the course 
of 6 weeks in vitro. Similar to previous results, the hydrogels still exhibited a burst release of 
unbound growth factor, but the sulfonated hydrogels retained the majority of the loaded growth 
factor for the course of the study, while unsulfonated hydrogels released the entire payload in under 
2 weeks. Cell viability decreased in most groups, which was not unexpected based on earlier 
preliminary studies of NPCs in photocrosslinked MC. There was no statistical change in cellularity 
in gels that were both sulfonated and received growth factor, indicating that the two variables 
combined may have provided a synergistic protective effect on cells. Still, gross images showed 
that cells were more sparsely distributed even within those gels. Though it is not immediately clear 
what drove cell death, particularly as there was no spatial pattern indicative of limited nutrient 
distribution or diffusion, it is hypothesized that the resistance of the MC scaffold to degradation 
limited the cells ability to proliferate and elaborate matrix, which can also influence cell survival. 
Sulfonated gels with TGF-b3 stimulation exhibited greater production of matrix components Col 
II and sGAGs, although the absolute values of the ECM components were extremely small and 
did not begin to approach native levels. There was no net change in swelling and mechanical 
properties across any of the groups over the course of the study. While this is in keeping with 
previous data showing the long-term stability of MC hydrogels and their resistance to hydrolysis, 
it was interesting to note that the matrix produced was not enough to have an effect on the material 
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behavior of the scaffolds, likely due to the scaffolds’ resistance to degradation, which limited the 
permissiveness of the hydrogel to hMSC matrix deposition. Taken together, the results 
demonstrate that scaffold sulfonation and TGF-b3 sequestration show promise for future NP tissue 
engineering studies, but that the stability of MC may not be amenable to cell survival or matrix 
elaboration. It is possible that sMC + TGF-b3 can be used as a potential acellular NP replacement 
that delivers growth factor to local cells, or that this scaffold system can be made more permissive 
to cell differentiation by incorporating degradable crosslinking sites.  
5.5   Limitations and Future Directions 
This thesis has advanced the development of an injectable, MC-based hydrogel for cellular 
and acellular NP replacement and repair. However, there are several limitations to be noted and 
considerations to be made in determining future development of these biomaterials for clinical 
translation. 
The first study presented here focused on the rheological behavior of methacrylated MC as a 
thermoresponsive polymer. Rheological analysis was used to determine thermogelation rather than 
other methods, including differential scanning calorimetry (DSC) and turbidimetry, because 
rheology gives the most clinically relevant data in terms of material behavior. The conclusions 
with regards to the contribution of hydrophobic methacrylates to the hydrophobic aggregation of 
MC was based on knowledge of the thermogelation mechanism of MC from the literature and 
interpretation of the experimental results. Further analysis of the mechanism and structure of 
aggregating MC could be determined with cryogenic transmission electron microscopy (cryo-
TEM) and small-angle neutron scattering (Lott et al. 2013), however, it is not immediately clear 
whether this would provide any clinical relevance, and the investigation may be purely academic. 
Still, MC has been shown to exhibit unique behaviors related to the interaction of hydrophobic 
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groups even when chemically crosslinked.  As such, a deeper understanding of network formation 
at 37°C and its impact on parameters such as gelation kinetics and mesh size may have important 
implications on solute transport and hydration within the construct. Scanning electron microscopy 
(SEM) of chemically crosslinked gels would also potentially provide more insight into the gel 
structural network at a scale relevant to cell encapsulation. Even observation of MC 
thermogelation via optical microscopy can sometimes provide information about the clustering of 
MC at increasing temperatures, although the resolution would be low (Wu et al. 2021). 
Thermogelation of MC has been extensively characterized with respect to macromer concentration 
and molecular weight previously, so they were not further characterized here. The results observed 
here are expected to scale with different molecular weight distributions and macromer 
concentrations. With increasing macromer concentration, the differences between methods for 
determining thermogelation onset temperature disappear, as higher concentrations of macromer 
respond to temperature with greater magnitude, and so the distinctions in this study may not be 
relevant. However, for low macromer concentrations, which are more desirable for cell-based 
studies, the distinction is still important. Finally, the difference in G’ of high methacrylation % 
MC between 20°C and 37°C, which was not observed at lower methacrylation percentages, 
presents a number of questions. Firstly, methacrylation between 5.84% and 9.54% was not titrated 
in order to find the point at which this diversion in behavior begins, so an accurate threshold could 
not be identified beyond stating that 5.84% methacrylated MC did not exhibit such behavior. 
Elucidating the mechanism of this diversion is important as it does have implications on the 
biological performance and clinical translation of MC-based materials. All our previous studies 
investigating gelation kinetics and material properties of methacrylated MC were performed at 
room temperature; the assumption was that the chemical crosslinks would dominate the behavior 
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and that the hydrophobic interactions of MC would not factor in. This is clearly not the case in 
terms of the gelation behavior, and it raises the question of whether compressive mechanics and 
swelling behavior are significantly different between room temperature and physiologic 
temperature. If they are significantly different, this may impact the assumptions made from all 
tests of MC-based materials at room temperature, and future studies should all be performed under 
careful temperature control. 
The second study attempted to modify MC such that it would behave more like CMC 
hydrogels, which are well suited for NP matrix elaboration, while retaining the thermogeling 
capacity of MC. Sulfonates were incorporated during the redox gelation reaction; this made 
characterization of the sulfonates difficult, as the size of the hydrogels was not amenable to z-
potential analysis. Using the same gelation procedure, it may be possible to generate 
microparticles, or thin hydrogel films which may more easily undergo z-potential measurement to 
ascertain the charge of these gels. Preliminary ATR-FTIR analysis was not able to identify 
sulfonate peaks on the spectra of these gels, despite the fact that the intensity of DMMB staining 
correlated with the amount of 2SEM incorporated, indicating the presence of sulfonates in the 
hydrogel. Further optimization of the chemistry of the material will be necessary for validating the 
system. The finding that the inclusion of sulfonates had no effect on swelling behavior was 
surprising, but further points to the fact that the network formed by chemically crosslinked MC 
was unperturbed by the introduction of negatively charged groups. The negatively charged 
sulfonates did have an effect on protein adsorption and TGF-b3 sequestration, showing that they 
influence the electrochemical behavior of molecules in their vicinity. It is possible that the 
hydrophobic portions of MC resist the influx of water, which seems paradoxical for hydrogels in 
general, but also may be problematic for cell encapsulation. It is not immediately obvious whether 
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this can be overcome without risking losing the thermogelation capacity of MC. Direct sulfation 
of MC was not attempted, as has been performed previously with cellulose and other non-sulfated 
polysaccharides (Portocarrero Huang et al. 2018; Zeng, Groth, and Zhang 2019; Freeman, Kedem, 
and Cohen 2008; Purcell et al. 2014). It was hypothesized that the addition of a negatively charged 
group to the backbone of MC would inhibit its thermogelation. It may be worth attempting, 
however. Hydroxypropylmethylcellulose (HPMC) and hydroxyethylcellulose (HEMC) are 
derivatives of methylcellulose that contain both hydrophobic and hydrophilic moieties, and can 
form thermoresponsive hydrogels, albeit less strong than MC. The observed thermogelation 
behavior is proportional to the balance between hydrophobic methoxy groups and hydrophilic 
groups. This may give insight into the functionality a partially sulfated MC via direct modification, 
which may result in diminished, but not lost, thermogelation of MC. Still, it should be noted that 
the hydrophilicity of hydroxypropyl and hydroxyethyl are much less than that of sulfates and 
sulfonates, and so direct sulfation of MC still carries the risk of obliterating the thermogelling 
capacity of MC. 
Gross quantification of protein was performed when examining the adhesion of serum 
proteins on sMC gels. Further investigation could involve selectively exposing sMC to proteins of 
various charges to determine the mechanism of protein adsorption. Mass spectrometry of adsorbed 
serum proteins may also give insight into the types and features of serum proteins that adsorb onto 
the material, which would enable better understanding of potential cell adhesion and immune 
responses to sMC, particularly for applications outside of the IVD that are more vulnerable to 
immune reactions. Additionally, if sMC is to be used as an acellular growth factor depot in the 
intradiscal space, titrating the sequestration to promote some, but not total release of sequestered 
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TGF-b3 may be necessary to provide controlled release of the growth factor to local cells within 
the IVD. 
Bioactivity of TGF-b3 was not directly measured in this study. As the ELISA used only 
detects active TGF-b3, a cell-based bioactivity assay. Furthermore, the remaining TGF-b3 within 
the gels was not able to be extracted in order to quantify the total actual loaded within gels, and so 
calculations of percent release were based on the amount of theoretical load, assuming 100% 
loading efficiency. Placing TGF-b3 in the TEMED barrel of the dual-barrel syringe system 
protected it from the oxidizing effects of APS, but upon mixture during gel formation, it is possible 
some growth factor was denatured, and so break down of the gels and quantification of 
encapsulated TGF-b3 would give a more accurate understanding of both encapsulation and 
sequestration efficiency. While the results from chapter 4 appear to indicate that the encapsulated 
TGF-b3 is in fact bioactive (based on responsiveness of encapsulated hMSCs with encapsulated 
TGF-b3, as compared to exogenous delivery), a mink lung epithelial cell growth inhibition study 
to quantify the activity of released and encapsulated TGF-b3 could provide a more complete 
understanding of the effect of the encapsulation process on the growth factor. 
In the final study, hMSCs were encapsulated within the sMC hydrogel system optimized in 
Chapter 3. The first and most obvious limitation is the lack of degradation of the MC-based gels. 
Numerous studies have shown that matrix elaboration within hydrogels is limited when the 
hydrogels do not degrade, and so the main modification to the system should be the incorporation 
of degradable crosslinks. Given the hydrophobicity of MC, introducing hydrolytically cleavable 
crosslinks like those that contain lactic acid may not actually influence the degradation of the gels. 
Incorporation of MMP-sensitive crosslinks may allow the cells to break down the matrix as 
necessary, or MMPs could be incorporated into the cell culture media to simulate the catabolic 
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environment of the degenerate NP. This study was also conducted in neutral pH media. While 
previous studies have shown that acidic culture conditions that attempt to replicate the degenerate 
NP are not amenable to MSC differentiation (Wuertz, Godburn, and Iatridis 2009; Li et al. 2012), 
the fact is that the construct would be exposed to an acidic environment in the clinical scenario. 
Acidic medium may be better able to hydrolytically cleave the ester bonds within the methacrylate 
crosslinks. A short study investigating the effect of an acidic environment on hydrogel stability 
and encapsulated MSC survival would be able to give more insight into in vivo performance.  
Gene expression was not investigated in this study; instead, matrix elaboration was used as a 
more functional evaluation of hMSC differentiation, as mRNA expression does not always 
translate to actual protein production. Additionally, there is still no consensus on gene markers for 
the NP-phenotype, and so the chondrogenic markers COL II, ACAN and Sox9 would give an 
indication of chondrogenic differentiation but not necessarily distinguish between NP and AC 
phenotypes. 
Further analysis for apoptosis, such as the TUNEL assay or cleaved caspase-3 staining, was 
not performed. Production of matrix components was indicative of active metabolism; as such it 
was assumed that the cells were not necrotic, and that instead cell death was occurring via a 
controlled mechanism. Still, the presence of lysed and potentially hypertrophic cells on the H&E-
stained sections raises the question of mechanism of cell death, and so further analysis should be 
pursued. Cells that die via apoptosis and are not able to be consumed by macrophages (as is the 
case in in vitro cell culture, proceed on to secondary necrosis, and so visual inspection is not 
sufficient to ascertain the mode of cell death. Moreover, staining for the hypertrophic marker, type 
X collagen, would determine whether the remaining cells were undergoing hypertrophy. 
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The cell-laden sMC study was conducted under static culture, while it is known that the native 
tissue environment experiences cyclic loading. A dynamic culture system might contribute to 
convective transport of TGF-b3 and water throughout the hydrogel, which could promote cell 
survival and nutrient transport. As it stands, the mechanical testing system used in this study 
utilizes unconfined compression; while there are data on NP tissue in unconfined compression for 
comparison, it is not directly relevant to the in vivo condition, and confined compression would 
not only be more relevant to the in situ behavior of any NP replacement, but can give information 
about the constructs permeability, which is relevant to transport of nutrients and encapsulated 
growth factor into and out of the gel. In general, a more physiologically relevant loading regime 
must be incorporated into the analysis of any NP replacement. 
General limitations to this approach must also be addressed before clinical translation can be 
achieved. Reduced nutrient transfer within the degenerate IVD puts any cell-based therapeutic at 
a disadvantage; the introduction of a tissue-engineered construct with higher cell count than the 
adult disc might further stress the system by increasing nutritional demands on the already 
compromised tissue. Also, the constructs studied here are of a much smaller scale than the size of 
the human disc. Scaling up would not only require enormous amounts of cells and growth factor 
but would alter the transport of nutrients. Even within studies on successful NP-like differentiation 
in CMC, limited nutrient diffusion into some gels was observed as limiting the differentiation and 
matrix elaboration of cells within the center of the constructs. As mentioned above, dynamic 
culture might alleviate some of the diffusional issues presented with scale up, and so it is critical 
that the relevant in vitro models and testing be done to ensure that even preclinical in vivo studies 
are conducted with the best possible chance of success, having eliminated as many unknowns as 
possible before committing valuable resources. 
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The cells used in this study were acquired from a commercially available supplier and pooled 
from 3 donors. The usage of pooled donors is meant to eliminate the need for repeated studies in 
which donor cell quality is a variable added on top of variables that come naturally between 
studies. Pooled donor studies have shown that they can eliminate confounding donor variability 
without any negative impact on viability, proliferation, and differentiation, and have 
immunomodulatory effects equivalent to those of individual donors (Widholz et al. 2019; 
Hejretová et al. 2020). Pooled donor studies have frequently been used in NP tissue engineering 
(Frith et al. 2014; Potier and Ito 2014; Wang et al. 2016; Thorpe et al. 2010). Still, the donors used 
in this study were all young and healthy (in their 20s), and a study using donors from a more 
representative population may give better insight into the actual clinical performance of the 
construct.  
The mechanics and swelling behavior of the sMC gels both with and without encapsulated 
cells matched those of the native NP. Additionally, injectability of the material was validated by 
performing ex vivo injections into a bovine motion segment nucleotomy model. The motion 
segment was not subjected to further mechanical testing, however. Further motion segment testing 
should be performed to measure the restoration of disc height, compression and torsional 
mechanics, and resistance to extrusion/reherniation and failure before this material is tested in 
preclinical in vivo models. 
Finally, as mentioned earlier, direct sulfation of MC, or the use of HPMC or HEMC may 
alleviate some of the MC-specific issues of this culture platform while maintaining thermogelation 
and injectability but would require a full repeat of the studies performed here to determine the 
rheological behavior of the pre-gelled polymers, as well as a complete materials characterization 
of acellular HPMC or HEMC hydrogels before moving forward with any cell-based studies. 
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5.6   Final Conclusions 
Collectively, this thesis has contributed to the characterization and development of an MC-
based hydrogel system with potential as both an acellular and cell-laden NP replacement for IVD 
repair and regeneration.  MC is a fascinating biopolymer with unique behaviors that require further 
investigation in order to anticipate the behavior of an MC-based system within a clinical setting. 
The dual-crosslinking mechanism of thermogelation and methacrylate-mediated free-radical 
polymerization results in a robust hydrogel with many potential applications outside of the disc 
and should be explored. Sulfonation of the MC hydrogel generated an effective growth factor 
sequestration depot that retained its mechanical and structural integrity over time.  Although the 
sMC hydrogel supported NP-like matrix elaboration by encapsulated hMSCs, cell survival was 
not optimized, and matrix elaboration was limited by the lack of available void space for diffusion 
of freshly synthesized matrix components. Future work should focus on incorporation of 
degradable moieties within the sMC hydrogel to enhance cell survival and differentiation. 
Additionally, as sMC gels in situ and can achieve relevant NP-like mechanical properties, ex vivo 
motion segment testing should be the next step in validating the material’s acellular performance 
before moving forward. Despite the study limitations, we were able to produce a stable hydrogel 
material that is injectable and retained in situ, that exhibits mechanical and material properties 
relevant to the healthy human NP and sequesters encapsulated TGF-b3. This scaffold supported 
the deposition of relevant NP matrix components by encapsulated MSCs in vitro, and although 
gross matrix production was limited, it is an important first step in further developing an MC-
based platform for injectable NP tissue engineering therapeutics. In summary, this thesis has 
advanced the development of injectable NP biomaterials and has laid the groundwork for future 
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development of MC-based hydrogels for IVD repair and may be translated into beneficial uses in 














Appendix: Detailed Protocols 
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Methacrylated Methylcellulose Macromer Synthesis 
 
Materials 
Large Beaker (flat bottom) 
Stir bar 
Methacrylic anhydride (Aldrich, 27, 668-5, 760-93-0, MW = 154.17, density = 1.035g/mL) 
1N NaOH 
1N HCl 
Spectra/por membrane, MW cut-off 6-8kDa, flat width 110mm 
 
Day 1 
1. Dissolve 1.5g methyl cellulose (MC) in sterile H2O to a volume of 150mL. (adjust as 
necessary for desired volume) 
2. Heat ~100mL of sterile water to 80°C on a hot plate. 
3. Cool ~200mL of sterile water to 4°C in an ice-water bath. 
4. Measure 1.5g of methyl cellulose. (for low/med mix, measure out equal amounts of low 
viscosity and med viscosity MC and mix) 
5. Check the temperature of the heated and cooled sterile water before continuing. 
6. Pipet 50mL (1/3 of the total final volume) of 80°C sterile water into a new beaker 
containing a magnetic stir bar.  Place the beaker on the heated stir plate. 
7. Slowly add MC as the hot water is stirring.  As the clumps begin to dissolve, add more 
MC.  Continue this process until all of the MC is added. 
8. Place the MC solution on an UNHEATED stir plate. 
9. Add 50mL of 4°C sterile water to the MC solution and allow the solution to continue 
stirring.  The solution should become less cloudy with the addition of cold sterile water. 
10. Add an additional 50mL of 4°C sterile water to the MC solution making up a total 
volume of 150mL. 




1. Standardize the pH meter.  Make sure the hole at the top of the electrode is in the open 
position prior to standardizing in the 4.0, 7.0, & 10.0 buffers. 
2. Place ~100mL of 1% MC in a 250mL round bottom flask containing a football stir bar.  
The entire flask should be on ice for the entire reaction. 
3. Calculate the amount of methacrylic anhydride (MA) 
4. Grams x (1/335 g/mol) x (percent modification) x (amount excess) x (154.17 g/mol of 
MA) x (1/1.035 g/mL) 
5. Example: (1.0)(1/(335g/mol))(0.1)(20)(154.17g/mol)(1/(1.035g/mL)) 
6. In the hood, on ice, adjust pH to 8 with NaOH. 
7. Note the initial pH of the solution. 
8. Add 1/3 the calculated amount of MA all at once (note the lot # of MA used). 
9. Every 15 minutes readjust the pH to 8.5 for an hour (this is equivalent to 4 adjustments in 
1 hour). 
10. Note the pH after adding NaOH and at the end of each 15 minute interval. 
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11. After adjusting the pH to 8.5 for the 4th time, add the second 1/3 of the calculated 
amount of MA all at once. 
12. Every 15 minutes readjust the pH to 8.5 for an hour (this is equivalent to 4 adjustments in 
1 hour) 
13. Note the pH after adding NaOH and at the end of each 15 minute interval. 
14. After the 4th time, place the reaction in cold room overnight at 4°C (in ice, on stir-plate). 
 
Day 5 
1. In the morning note the reaction pH. 
2. Standardize the pH meter.  Make sure the hole at the top of the electrode is in the open 
position prior to standardizing in the 4.0, 7.0, & 10.0 buffers. 
3. Readjust the pH to 8.5. 
4. Add the last 1/3 of the calculated amount of MA all at once (make sure you are using the 
same batch of MA from Day 1). 
5. Every 15 minutes readjust the pH to 8.5 for 45 minutes (for a total of 3 adjustments). 
6. Note the pH after adding NaOH and at the end of each 15 minute interval. 
7. Begin setting up for dialysis: 
8. Cut a piece of dialysis membrane. 
9. Place the membrane in sterile water to soften. 
10. Fifteen minutes after the third adjustment, the pH should be close to 7.0.  If not, readjust 
the pH to between 7-7.5 until it is stable. 
11. Note the pH at which the reaction stabilizes. 
 
Day 6-8 
1. Dialyze the solution against sterile water for a total of 5-6 water changes (~8hrs between 
each water change) and 2 membrane changes (1 each day). 
 
Day 9 
2. Check to make sure all of the MA is dialyzed out by the 5th/6th water change.  If it is, 
continue to the next step.  If it is not, dialyze for longer. 
3. Filter dialyzed solution through a 40µm filter into a 200mL beaker.  Make sure the 
resulting solution does not smell of MA.  If it does, distribute the filtered sample into 
50mL conical of equal volumes and place on the centrifuge for ~5 minutes at ½ the 
centrifuge speed. 
4. Remove the supernatant avoiding the pelleted MA and pipet it into a NEW 200mL 
beaker. 
5. Distribute this solution into 50mL conical (~25mL per conical). 
6. Freeze all tubes at -80°C at an angle to prevent cracking of the plastic conical when the 
sample expands with freezing. 
 
Day 10-12 
1. Lyophilize sample for 2-3 days or until the sample looks completely dry. 
2. Store at -20ºC. 
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Methylcellulose Acid Hydrolysis 
 
Materials 
50mL Round bottom flask 





1. Warm oil bath to 80°C. Make sure electronic temperature probe and analogue 
thermometer are both in the oil and read the correct temperature. 
2. While oil bath is heating, place 20mg (0.02g) of polymer and 20mL of DI H2O in 50mL 
round bottom flask. 
3. Place round bottom flask with cork base on stir plate and stir at room temperature for ~5 
minutes, making sure all the polymer gets wetted. 
4. Polymer should be mostly dissolved.  Place on ice and stir 15-20 minutes to complete 
dissolving. 
5. Once dissolved, move polymer back to room temperature.  Allow solution to warm up to 
room temperature (17-20°C). 
6. Calibrate pH meter. 
7. Use pH probe to check temperature of solution.  Record initial pH and temperature.  If up 
to 17-20°C, begin to pH down to 2 using 1N HCl (~150µL total, add 100µL at once, then 
finish in 10-25µL increments to pH 2). 
8. Let sit at room temperature ~5 minutes to ensure pH is steady at 2.  Record final pH and 
temperature. 
9. Cover with rubber stopper top and use wire to tighten around rubber stopper.  Use ring 
stand to hold round bottom flask and lower into oil bath (at 80°C) for 2 hours and 20 
minutes (the 20 minutes are to allow solution temperature to heat up, can see MC drop 
out of solution and solution become cloudy).  Stir at 200rpm.  Make sure the liquid line in 
round bottom flask is below that of bath oil level (so that the total polymer solution is 
submerged). 
10. After 2 hr 20 minutes in oil bath, move straight to ice for ~10 minutes to dissolve 
polymer back into solution and come to room temperature. 
11. TURN OFF OIL BATH. 
12. Once solution goes from cloudy back to clear, move back to room temperature.  Wait for 
solution temperature to move up to 17-20°C, the pH to 7 using 1N NaOH.  (Use small 
increments of NaOH, as you get closer to pH 7, jumps in pH will happen more 
dramatically and you may overshoot. Use HCl to bring pH back down if needed). 
13. Once stable at pH 7, transfer solution to 50mL conical tube and place at -80°C to freeze 
overnight. 
14. About 4 days before scheduled NMR session, place frozen sample on lyophilizer for 2-3 
days and then immediately dissolve in 1 mL D2O once off the lyophilizer for NMR 
analysis.  Do not take sample off the lyophilizer if you can’t run NMR immediately – 
need to have ALL water removed from sample in order to minimize water peak in NMR 




Sample Preparation  
Day 1:  
1. The day before scheduled NMR session, remove modified, hydrolyzed, lyophilized 
sample off lyophilizer.  
2. Use a metal probe to quickly compress polymer into a ball at the bottom of the 50mL 
conical tube.  
3. Use a micropipette to transfer 1 mL of D2O into the conical tube; make sure that the 
entire polymer is wetted. Try to minimize exposure to air to reduce the water peak in 
NMR graph.  
4. Parafilm the conical tube. Place the tube in a beaker of ice then place into the 4oC fridge  
to dissolve the polymer overnight.  
Day 2:  
1. Using a 200μL-micropipette, transfer 700μL of dissolved, hydrolyzed sample solution 
into a NMR tube (200 + 200 + 200 + 100). If the solution gets stuck, put on the tube cap 
and carefully shake/flick the tube.  
 




Sample preparation & shimming: 
1. Start menu -> Lock On -> click “Eject” 
2. Remove placement tube and insert sample tube -> click “Insert” 
3. Lock On (lock magnetic field) 
4. Click “Find z0” to automate 
a. Z0 ~20 
b. Lock level ~40-50 
c. Power ~27 (should be <40) 
d. Gain ~38 (should be <40, usually = power + 10) 
e. Phase ~112 
5. Shim menu 
a. Can click “gradient shim” to automate shimming z1-z4 





a. Spectral width: -2 to 14 
b. # of scan (nt=): 92 or 128 
c. Relaxation (dl=): 5 sec 
d. Pulse angle: 45 degrees 
2. Check autogain box 
3. Type in command: bs = 8 





1. Type “wft” to show spectra 
2. Use mouse scroll to adjust height of the spectra 
3. Type “aph” for autophasing 
4. Type “lb=0.2” for line broadening to reduce noise 
5. Use right-hand side tool box to phase 
a. Click “phase mode” icon -> click left area of spectra, hold left click to drag and even out 
baseline 
b. Adjust spectra so that the baseline is even/horizontal 
6. After phase completion, click “redraw” icon 
7. Integrate peaks 
a. Process tab -> Integration tab 
b. Partial mode 
c. “Clear integral” 
d. Integration level -> scroll up/down over region so that the green line at the left side of 
the spectra is as flat as possible 
e. Command “dc” for digital correction 
f. “redraw” after operation 
g. Click “scissors” icon to cut peaks 
h. Click “red vertical line(s)” icon and place a single red vertical line on methyl peak 
(~2.0ppm) 
i. Integration -> “set integral area” -> single peak -> integral value = 1.00 -> click “set int 
value” 
j. Click “show integral values” 
k. Command “wp = 7p” and “sp = -0.2p” 
 
Save & Email/Print: 
1. Save file as .fid file 
2. Plot -> autplot preview -> okay: will produce a pdf file of the spectra with integral values 
and text descriptions 




• To load old settings: “file” -> “open” -> pick an old file to open -> now the settings for the 
old file should be loaded (check?) 
• “wp=7p” and “sp=-0.2p” after setting integral values, not sure what it means? 







Geometry: Cone & Plate 
  Cone angle 1:59:28 
  Cone diameter 20 mm 
  Truncation 53 µm 
 
***Protocol settings optimized for methacrylated methylcellulose by Gittel Gold. May need 
adjustments based on different materials*** 
 
SET UP MACHINE 
1. About an hour before working, make sure water tower (behind rheometer) is turned on and 
set to 3˚C so that peltier plate will cool properly. 
2. MAKE SURE AIR IS ON. Red knob should be parallel to open air valve. Machine will not 
work otherwise. Gauge should read ~30 psi 
3. Take black cap off spindle and white cover off of base 
4. Turn on power from surge protector, then power switch on back of rheometer 
5. Raise upper platform if necessary to attach Peltier plate (bottom plate) 
a. Magnet snaps Peltier plate into place 
b. Attach smart swap and flow & return tubes (push hard to snap in) 
6. Open software: AR Instrument Control 
7. Options à instrument à inertia à Calibrate 
a. After calibration, attach geometry from bottom. Tighten from top spindle. Stop at first 
bit of resistance 
8. Geometry à open à 20 mm 2˚ steel cone 
a. “Invalidate any zero point” à Yes 
b. “Map instrument  now” à Yes à Perform Mapping 
9. Instrument à oscillatory mapping 
a. Constant amplitude 
b. Frequency: 0.1000 to 100.00 
c. % strain: 1.00 
d. # points: 15 
e. Click perform new mapping 
10. Click zero gap 
a. Use arrows to bring platform down to ~5mm above base, taking care not to hit the 
base 
b. Continue 
c. When finished, back of distance à Yes (may need to change to 15000) 
 
SET UP EXPERIMENTAL PROCEDURE: 
11. Change file name/experiment name. Make sure destination of file is in the correct folder. 
12. Oscillation procedure: set up as necessary for your experiment 
a. Conditioning step (if necessary) 
i. Good if starting with specific temperature, may not be good if you’re under time 
constraint (i.e. with redox initiators) 
b. Example Frequency Sweep:  
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i. Frequency: 0.1 – 10 Hz 
ii. Mode: log 
iii. Points per decade: 20 
iv. Temp: whatever temp desired 
v. % strain: 1.000 
c. Example Temperature Ramp (good for measuring thermogelation, without 
redox initiators): 
i. Temperature: 4 to 40 ˚C 
ii. Ramp rate: 1˚C/min 
iii. Delay time: 15 sec 
iv. % strain: 1.000 
v. Frequency: 1 Hz 
d. Example Time Sweep (good for gelation with initiators): 
i. Delay 00:00:00 
ii. Duration: minimum 30 min 
iii. Temp: 37 ˚C 
iv. % strain: 1.000 
v. Frequency (single): 1 Hz 
e. Example Strain Sweep: 
i. Delay 00:00:00 
ii. Duration: 20 min 
iii. Temp: 4˚C or 37˚C 
iv. % strain range : 0.001 to max desired (100 to 500%) 
v. Frequency (single): 1 Hz 
f. Example Cyclic Strain Recovery: 
i. Time sweep 
1. Duration: 2 min 
2. Temp: 37˚C 
3. % strain range : 0.001% 
4. Frequency (single): 1 Hz 
ii. Time sweep 
1. Duration: 2 min 
2. Temp: 37˚C 
3. % strain range: 500% 
4. Frequency (single): 1 Hz 
iii. Repeat for as many cycles as desired 
iv. Plot against global time 
g. Post experiment step usually not necessary (can help to return temp to starting temp if 
doing a ramp) 
13. Double click everything on main page to zero (0àsetàgo) 
14. Fill top chamber of geometry with dH2O for moisture 
15. For analysis without initiators (not time sensitive): 
a. Place ~200 µl in center of bottom plate, using pipet top to spread it a little. Avoid 
bubbles 
b. START (machine will come down to proper height based on input geometry) 
c. During conditioning step, check for overflow. 
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d. Cover geometry with cover chamber, taking care to keep it centered and not bump the 
geometry. 
16. For analysis with initiators (time sensitive): 
a. Lower geometry to ~2000 (close to peltier but allowing enough space for injecting 
sample) 
b. Have a timer nearby to record lag-time 
c. Click START. Machine will ask if you want to bring geometry down. Don’t click yes 
until polymer has been dispensed. 
d. Using dual barrel syringe and mixing tip, inject a small amount of polymer onto a 
kimwipe to avoid bubbles, then inject 150-200 ul of polymer on to center of peltier. 
i. Immediately click yes to bring geometry down and start the procedure. Do not 
spread polymer out. 
ii. Start timer to record lag time. Stop when first data point is taken. 
e. Cover geometry with cover chamber, taking care to keep it centered and not bump the 
geometry. 
17. When sample is finished, remove cover, clean bottom Peltier plate and upper geometry, first 
with dry kim-wipe, then with ethanol and kim-wipe. If necessary, reset temperature before 
adding next sample. 
 
DATA COLLECTION 
18. Open software: TA Data Analysis 
19. File à Open à select file 
20. View à Table 
21. Copy table data into excel spreadsheet 
22. Switch between experimental steps using bar at the top. Make sure to copy table data from 
all experimental steps 
23. You can access the procedure and notes from the experiment in this program as well. (Not 
able to edit) 
24. Save excel spreadsheet(s) on desktop and send to yourself/copy to flashdrive. 
 
CLOSE EVERYTHING IN BACKWARDS ORDER THAT YOU SET UP: 
25. Close software 
26. Remove water from geometry well 
27. Raise platform and gently remove geometry 
28. Detach smart swap and flow & return tubes  
29. Push release button on machine to remove Peltier plate. Store in box in drawer 
30. Turn off power from back of rheometer. 
31. Turn off water tower. 
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Differential Scanning Calorimetry 
Instrument: TA Instruments DSC Q200 
 
*may want to do in conjunction with TGA to account for mass loss* 
1. Turn on nitrogen gas 
a. Delivery pressure should be 15 PSI 
2. May need to turn on using on/off switch on back of machine 
3. Open TA Instruments explorer 
4. Control à lid à open 
5. Prepare reference dish 
a. For samples in solution, use same solvent as reference 
b. Use cover for liquid sample and reference 
6. Weigh sample 
a. For liquid samples, use deep dish with lid 
b. Weigh dish and lid first, then add material 
c. 9-13 mg (do not exceed 13 mg) 
d. Close lid (poke hole in lid with needle if concerned about pressure build up) 
e. Don’t touch anything else after weighing (don’t want to add anything to weight of 
sample) 
7. Place sample on top of thermocouple. 
a. Make sure to remove any left over ash/debris 
b. Far thermocouple is for reference 
c. Close thermocouple is for sample 
8. Control à lid à close 
9. Summary (sample info) 
a. Mode: standard 
b. Test: custom 
c. Pan: Tzero Aluminum 
d. Sample size (- pan) 
10. Data file: Network à TA-PC à TA à Data à Your folder 
11. Procedure: editor 
a. *don’t use “initial temp” 
b. Remember to Apply changes 
12. Green button to start 
13. Don’t open lid until temperature comes back down to at least 40C (there’s no active 
cooling system) 
14. Sample purge flow ~ 30 Ml/MIN 
a. May change if using a coolant? 
15. Shutting Down 
a. Close Nitrogen gas – close main valve first 
b. When pressure on both gauges is 0, close second valve 
16. TA universal data analysis 
a. Right click – label point 
b. Integrate peak, select endpoints 
i. Right click: accept limits 
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Hydrogel Mechanical Testing 
Unconfined Compression using Multi-Ramp SRL 
 
Preparation 
1. Let frozen gel sample rehydrate in PBS for overnight at 4°C  before testing.  
2. Turn on SENSOTEC 250 gram load cell 1 hour before testing to warm up. 
 
I. Setup 
1. Change multimeter wiring so that voltmeter is reading load cell. 
a. Multimeter should be in –V setting. 
b. Clip alligator clips to read load cell (far left black/red wires on board). 
2. Calibrate load cell. 
a. Adjust by using screwdriver to turn “zero” until display on load cell zero setting 
read 000.0 (no + or – signs).  The display on the multimeter should read <0.002V. 
b. Press and hold “calibration” button, meanwhile use screwdriver to adjust “span” 
in order to obtain values taped on load meter.  Both the multimeter and the load 
cell should read appropriate values. (If too jumpy, pop off front face of Sensotec 
load cell read-out.  Unscrew face plate, adjust screw 2nd from bottom, between 
span and zero; this is the fine adjust for zero.  The screw above span is the fine 
adjust for span.  Be careful, these are very sensitive to small movements.) 
3. Switch alligator clips so that the multimeter reads from LVDT wires (on right on DAQ 
board). 
4. Clean platform and chamber with ethanol.  Tape on the chamber so that it is suspended 
around the load cell but not touching.  The load meter should read 19-20g. 
5. Clean the indenter with ethanol.  Screw on the indenter tight but be careful not the push 
up on load cell. 
6. Clean the glass base plate with ethanol.  Place the plate at the center of the platform.  
7. Lower the indenter so that it is approximately 5mm above the base plate.  Adjust the 
stage so that the multimeter reads -3 to -5V.  
a. Note that the multimeter voltage should be between -5 and 5V during the entire 
testing process to stay within the linear range. 
b. To raise or lower the top stage, use the 340-RC knob. Be sure that the inner rod 
does not touch QB condenser. 
c. Glass plates should be entirely parallel when touching, if not adjust front center 
hold with Allen wrench. 
8. Turn on stepper motor.  Connect stepper motor to the testing device via rainbow wires.  
9. Check Labview document folder to ensure that previous crp.dat and srl.dat files have 
been deleted. 
10. Open National Instrument software.  Open VI “creep_with_daq(cont 
pulse)_250g_Initial_AIC”.  Adjust load window axes so that load meter values are within 
display window.  Press “run”. Once the load jumps, stop the run, disconnect rainbow 
wires, and raise the indenter.   
11. Open crp.dat file [time/load/displacement/voltage].  Scatterplot load vs. time. Determine, 




II. Sample Placement 
12. Image gel sample in order to obtain area 
13. Wet glass base plate with a few drops of PBS. Load gel onto plate using a metal spatula; 
center gel.  Add more PBS to submerge gel.  Place plate with gel onto the platform 
14. Lower indenter until indenter barely touches the gel. Bring down and seal chamber 
15. Slowly add PBS along the wall of the chamber, make sure the gel does not slip out.  Add 
PBS until chamber is ¾ full. 
16. Slowly raise indenter such that it hovers right above the gel. 
 
III. Initial Creep – Sample Height 
17. Delete crp.dat file from previous base voltage step. 
18. Connect rainbow wire. 
19. Open initial creep VI “creep_with_daq(cont pulse)_250g_Initial_AIC”. 
20. Adjust load window axes accordingly.  Make sure ramp velocity is 10μm/s.  Run 
program. 
21. Watch load read out to determine when the indenter hits the gel sample; there should be a 
sharp increase in load.  Once the indenter has touched the sample, stop the program.  
Disconnect the rainbow wire and raise the indenter slightly. 
22. Open crp.dat file.  Scatterplot time (x) vs. load (y). Paste table.  Determine, find, and 
highlight contact point.  Copy/paste contact point information into table. Enter base 
voltage and LVDT constant.  Record initial thickness and initial tare load.  Save excel file  
time load disp voltage 
  
Contact point: 47.662 -18.509 412.763 0.419 
  
       
Base voltage (V): -3.768 
     
Desired Tare Load (g): 1 (set to 1)       
    
change in voltage: 4.187 (contact point voltage - base voltage) 
 
LVDT #1 (um/V): 558.21 (a constant value, calculated prior by calibrating 
LVDT) 
thickness (um): 2337.225 (change in voltage * LVDT) 
  
       
Initial Tare Load: -17.509 (contact point load + desired tare load) 
 
 
IV. Creep Test 
23. Delete crp.dat file from previous initial creep step. 
24. Open creep vi “creep_w_daq(cont pulse)_250g”. 
25. Change load limit to calculated initial tare load.  The input ramp velocity should be 
10μm/s.  Run the program.  Start timer when load reaches initial tare load then let the 
program run for 45min. 
26. After 45min, stop the program.  Open crp.dat file.  Scatterplot time (x) vs. load (y). Paste 
table.  Determine, find, and highlight final test point and the point 10min/600sec before 
that final point (choose points in the middle for representative points). Copy/paste 
information for those two points into table. (note that <10μm thickness change over 
10min is Alice’s equilibrium criteria.) Enter base voltage and LVDT constant.  Record 




 time load disp voltage   
Final Point: 2755.528 -17.395 392.662 0.112   
10min prior Point: 2156.614 -17.41 390.447 0.116   
       
Base voltage (V): -3.768  displacement(um)   
Desired Tare Load 
(g): 1  2.215  < 10um displacement 
change in voltage: 3.88      
LVDT #1 (um/V): 558.21      
thickness (um): 2165.855      
 
V. Stress-Relaxation Test 
27. Delete any old crp.dat or srl.dat files. 
28. Open stress-relaxation vi “Desktop SRL (multi_ramp)_250g”. 
29. Enter post-creep thickness.  Set ramp velocity to 10μm/sec. Set strain to 0.05. Set #ramps 
to 3.  Set relaxation time to 2000sec.  And set stop time to 6500sec.  Then run the 
program. 
30. When test is complete, open srl.date file.  Scatterplot time (x) vs. load (y). Then save the 
excel file.  Delete the srl.dat file.  Close National Instrument software. 
 
VI. Sample Removal and Clean-Up 
31. Raise indenter all the way. 
32. Remove PBS using a plastic transfer pipette. 
33. Carefully remove the plastic chamber.  Carefully unscrew the indenter.  Clean the 
platform, indenter, and glass base plate with ethanol.  Clean all remaining surfaces. 
34. Place tested gel in original Petri dish, parafilm, and store at -20°C freezer. 
35. Turn off step motor/power strip. 
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Bovine Tail Motion Segment Injury and Repair 
Materials: 
• Cleaned, thawed motion segment (soak in PBS and leave in 4°C the night before; leave in 
37°C room for 1 hr prior to experiment) 
• Dissolved polymer solution in double-barrel syringes 
• Initiator stock; trypan blue; 
• #4 scalpel and #20 or #22 blade for cleaning motion segment 
• #3 scalpel and #15 blade for creating injury  
• Rongeur, curette, and forceps 
 
Procedure: 
1. Work on blue pads 
2. Add initiators, trypan blue to polymer solution and mix with glass stir rod for 
visualization 
3. Leave polymer solution mixture in 37°C for 30 min 
4. Measure disc diameter and height 
5. Use #20/22 blade to clean segment 
6. Use #15 blade to make X annular tear (up to the length of sharpened part) 
7. Use curette to dislodge NP tissue 
8. Use rongeur to remove 0.15-0.2g of NP (Might need to repeat curette & rongeur action a 
few times) 
9. Once injury is complete, inject polymer solution 
10. Leave motion segment in 37°C for 30 min for gel to form (wrap motion segment in PBS 





Live/Dead Staining of Hydrogels 
Materials: 
 -1 mM Calcein AM (dissolved in DMSO) 
 -2 mM Ethidium homodimer (dissolved in DMSO) 
 -Sterile PBS 
 -24-well plate 
 
Protocol: 
1. Warm PBS in water bath. 
2. Remove calcein AM & ethidium homodimer from the -20ºC freezer and thaw to room 
temperature by placing in a drawer (both are light sensitive and must be protected from 
light while thawing).  Once thawed, vortex to ensure homogenous mixture.  
3. In the tissue culture hood with the lights turned off, measure out 3.2 mL of PBS and place 
in a 15 mL conical wrapped in foil. (this is for 2 gels) 
4. Add 2.4 μL of 1 mM calcein AM to the PBS 
5. Add 1.2 μL of 2 mM ethidium homodimer to complete the Live/Dead solution.  You can 
scale up the mixture accordingly for the # of samples you have, just keep everything in 
the same proportions. 
6. Return calcein AM and ethidium homodimer stock solutions to -20ºC. 
7. Vortex Live/Dead solution and return to tissue culture hood. 
8. Remove gels from incubator and transfer them into a new 24-well plate. 
9. Wash samples twice with 1.5mL PBS. 
10. Transfer samples into new wells.  Add 1.5 mL of Live/Dead solution to each well 
containing a gel. 
11. Wrap the 24-well plate in foil and place allow the gels to incubate for 45 minutes at room 
temperature, protected from light.   
12. Turn on fluorescence lamp for imaging at least 20 minutes prior to end of incubation 
period.   The fluorescence lamp requires at least 20 minutes of warm-up time prior to use 
and must be on for at least one hour total, so make note of the time you turn the lamp on. 
13. After 45 minute incubation, in the TC hood, rinse each gel twice with 1.5 mL PBS. 




1. Focus condensor at 10X.  Using Phase 1 filter, take a phase picture of gel.  Change light 
source from all to eyepiece to all to camera (this is especially important for fluorescence 
pictures). 
2. Using FITC filter, take live images (cells should be green). 




Digest to break down cell culture gels prior to PicoGreen Assay and ELISAs. Needs to be done 2 
days prior to these assays. 
 
Prior to digestion: 
1. Collect gels in preweighed 1.5 ml microcentrifuge tubes. Blot excess liquid prior to saving 
gels. 
2. Immediately record wet weight and then freeze at -80°C 
3. Lyophilize gels for ~3 days until completely dry. 
4. Remove gels from lyophilizer, record dry weight. Store at -80°C until digestion protocol. 
5. Calculate swelling ratio for each gel.  
 
Materials and Solutions to Prepare: 
Pestle (one for each gel, to prevent cross contamination) 
 
0.05N Acetic Acid: 
0.05N CH3COOH in sterile water, pH 2.8-3.0 with formic acid. 
Add 1.437mL of 17.4M acetic acid stock to 498.56mL of sterile water.  Adjust pH to 2.8 
with formic acid (starts ~3.0) 
 
Pepsin (4560 units/mL AA): 
13.22mg/mL solution in 0.05N Acetic Acid (for pepsin at activity of 345 units/mg solid).  
Alter mg/mL concentration (13.22) for different lot or activity of pepsin to keep units/mL 
consistent. 
 
10X TBS #2: 
1.0M Tris, 1.5M NaCl 
For 100mL: 12.114g Tris, 8.766g NaCl 
Dissolve in 70mL sterile water. pH down to 8.0 (starts ~10.5).  Fill to 100mL. Readjust pH to 
8.0 [Start with 12N HCl ~400µL increments.] 
 
Digest: 
1. Pulverize dry gel using 0.5mL pestle.  Add 425µL 0.05N Acetic Acid per tube.  Pulverize 
more. 
2. Add 100µL pepsin solution.  Vortex to mix.  
3. Rotate samples at 4°C for 48hours. 
4. Stop pepsin digestion reaction. 
a. Add 100µL of 10X TBS#2 (1:1 ratio with how much pepsin was added) and vortex 
sample.  Sample pH should be ~8.0 (pH must be >5 to neutralize pepsin). 
5. Aliquot 20 μL of each sample into new tubes and add 5 μL 5% Triton-X and store at -20°C 
for PicoGreen Assay. 






Collagen ELISA  
ELISA Protocol for both Type I and Type II Collagen in parallel 
 
2 days before ELISA, start Pepsin Digest: (See Pepsin Digest Protocol for reagents and 






ELISA plates:  Nunc Maxisorp 96-well plates (Fisher Item # 12-565-136) 
25X Wash Buffer:  R&D Systems Item # WA126 
TMB Substrate Kit:  Vector Labs Item # SK-4400 
Streptavidin HRP: R&D Systems Item # DY998 
Human Collagen (type I and type II) Standards: 
Collagen Type I: Chondrex CN: 1005 
Collagen Type II: Chondrex CN: 2015 
Primary antibody (Col I: Sigma; Col II: DSHB) 
Secondary antibodies (Vector Labs Item # BA-1400) 
 
Buffers & Solutions: 
Store all buffers and solutions at 4°C 
Complete ELISA with all standards/samples held at 4°C 




1.59g Na2CO3  Sodium Carbonate 
2.94g NaHCO3  Sodium Bicarbonate 
0.2g   NaN3  Sodium Azide 
Dissolve in 850mL DI water and adjust pH to 9.6 (starts ~ 9.7).  Fill to 1L and readjust. 
 
Washing Solution (PBS-T): 
5% (v/v) Tween 20 in PBS 
Make from 25X stock solution in 4°C fridge.  Dilute in DI H2O. 
 
Stopping Solution: 
1N sulfuric acid 
Add 13.3mL of sulfuric acid to 487mL of distilled water. 
 
10X TBS:  
1.0M Tris, 2M NaCL, 50mM CaCl2 
To 250mL of deionized water, add: 
 30.285g of Tris (MW: 121.14) 
 29.22g of NaCl (MW: 58.44) 
 1.8378g of CaCl2 (MW: 147.02) 
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Adjust pH to 8.0 (starts ~10.7) 
10X TBS #2: 




Dissolve in 70mL sterile water. pH down to 8.0 (starts ~10.5).  Fill to 100mL. Readjust pH to 
8.0 [Start with 12N HCl ~400µL increments.] 
 
Blocking Solution: (make fresh) 
2% BSA Fraction V and 0.1% NaN3 in non-sterile PBS 
Dissolve 2g of BSA in 100ml PBS.  Add 0.1g of NaN3 to the solution and stir.  
 
AA/Pepsin/TBS#2: 
To dilute Coll II Standards when using DSHB 1° Ab – from digestion solution ratios: 
 425µL 0.05N Acetic Acid 
 100µL Pepsin 
 100µL 10X TBS#2 
Scale up for total volume needed. 
 
DAY 1: 
1. Prepare plate layout and calculate amount needed for standards and solutions using Excel 
spreadsheet. Col I and Col II ELISAs run on separate plates – Primary antibodies are 
different, but all other steps are the same. 
2. Label all tubes  
14 standards + 3 stock tubes for each type Col 
1 for each sample and standard (50/50 dilution in coating buffer) 
3. Prepare all standards on ice.  Dissolve collagen I standard in 0.05N acetic acid and collagen 
II standard in AA/Pepsin/TBS#2 solution to make 0.1mg/mL stock solutions.  Make serial 
dilutions in 0.05N AA or AA/Pepsin/TBS#2 for standards. 
a. Collagen I (stock concentration = 0.5mg/mL) 
i. For 0.1mg/mL solution – 2:10 dilution of Col I standard (at 0.5mg/mL) in 
0.05N acetic acid 
ii. For 10µg/mL solution – 1:10 dilution of 0.1mg/mL solution in 0.05N acetic 
acid 
iii. For 1µg/mL solution – 1:10 dilution of 10µg/mL solution in 0.05N acetic acid 
b. Collagen II (stock concentration = 0.5mg/mL) 
i. Prepare same way as collagen I standards except that the diluent is 
AA/Pepsin/TBS#2 instead of acetic acid.  
4. Stop pepsin digestion reaction. 
a. Add 100µL of 10X TBS#2 (1:1 ratio with how much pepsin was added) and vortex 
sample.  Sample pH should be ~8.0 (pH must be >5 to neutralize pepsin). 
5. Vortex standards and samples, and then prepare 50/50 dilutions of each with coating buffer 
in 1.5mL microcentrifuge tubes (Take solutions from top of tube). 
6. Add 100µL per well of CB/standards and CB/samples to Nunc maxisorp plates. 
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7. Parafilm plates and incubate overnight at 4°C. 




1. Wash plate 4 times in PBS-T (one quick wash and three 5 minute washes). 
2. Add 100µL of blocking solution per well and incubate at room temperature for 1-2 hours. 
(1hr). 
3. Remove Blocking Solution but DO NOT WASH. 
4. Prepare 1° immediately before use. Add 100µL of primary antibody to each well (0.5µg/mL 
of antibody per well). 
a. 1:10,000 Collagen I (Sigma) primary antibody diluted in blocking solution 
b. 1:100 Collagen II (DSHB) primary antibody diluted in blocking solution 
5. Parafilm plates and incubate overnight at 4°C. 
 
DAY 3: 
1. Wash 4 times in PBS-T (one quick wash and three 5-minute washes). 
a. Make 2° Ab solution - 50 µL of 2° Ab in 10mL of blocking solution (Collagen 2°:  
biotinylated anti-mouse IgG/anti-rabbit IgG H+L) 
2. Add 100µL of secondary to each well and incubate for 30 minutes. 
3. Wash 4 times in PBS-T (one quick wash and three 5 minute washes). 
4. Add 100µL of Streptavidin HRP to each well and incubate for 30 minutes. 
a. 1:200 dilution in PBS  
5. Wash 4 times in PBS-T (one quick wash and three 5 minute washes). 
6. Make TMB Substrate Solution (immediately before use) 
a. Add 2 drops of Buffer Stock Solution to 5mL of dH2O and mix well  
b. Add 3 drops of TMB Substrate Solution and mix well 
c. Add 2 drops of Hydrogen Peroxide and mix well 
7. Add 100µL of TMB Substrate Solution and allow blue color to develop at room temperature 
for 10-30 minutes. (4 min. for Col I, Col II, and CSPG)  
8. Add 50µL of Stopping Solution and read plate at 450nm absorbance.  Wells should turn from 
blue to yellow with the addition of Stopping Solution. (TMB absorption may be read without 
use of Stopping Solution (650nm), but stopping the reaction increases the absorbance of the 
reaction product two- to four-fold.) 
 
REFERENCES: Chondrex, Inc. (www.chondrex.com)  Human Type I Collagen Detection Kit 




PicoGreen Assay  
Hydrogel constructs must go through pepsin digest before assaying (See pepsin digest protocol). 
Before performing PicoGreen assay, make sure that samples have gone through two freeze/thaw 
cycles. 
 
Associated spreadsheets:  








Pepsin digested samples (see Pepsin Digest Protocol 
5% Triton-X (from Triton-X 100 in Acetic Acid) 
Pepsin Solution Additive 
425 μL 0.05N Acetic Acid 
100 μLPepsin 
100 μL 10X TBS 
156.25 μL 5% Triton-X (for a 1% solution) 
DNA standard 
1X TE (Tris-EDTA Buffer) 
10X TBS 
1.0M Tris, 2M NaCL, 50mM CaCl2 
To 250mL of deionized water, add: 
30.285g of Tris (MW: 121.14) 
29.22g of NaCl (MW: 58.44) 
1.8378g of CaCl2 (MW: 147.02) 
Adjust pH to 8.0 (starts ~10.7) 
 
METHODS: 
1. Calculate volumes for 1X TE, DNA Standards, and PicoGreen solution. (solutions and 
plate set up excel sheet) 
 
DNA standards:  
1mL for absorbance + ~120μL for standards (x 3 to run in triplicates x number of plates) 
 
1X PicoGreen (diluted from 200X stock from Molecular Probes, diluted in 1X TE): 
Volume for standards (~100μL per standard x 5 standards x 3 to run in triplicate x number of 
plates) + 
Volume for samples (~100μL per sample x 3 to run in triplicate x total number of samples) 
 
1X TE (diluted from 20X TE in sterile H2O – dilute TE immediately before use): 
Volume for standards (~100μL per standard x 5 standards x 3 to run in triplicate x number of 
plates) + 
200 
Volume for samples (~100μL per sample x 3 to run in triplicate x total number of samples) + 
1mL for DNA absorbance + 
Volume to dilute DNA standard into 2μg/mL + 
Volume to dilute 200X PicoGreen stock to 1X 
 
2. Turn on plate reader; set up for DNA absorbance reading. Thaw PicoGreen samples and 
Solution Additive on ice. 
 
3. Prepare samples (usually done immediately after Pepsin digest): 20µL sample + 5µL 5% 
Triton-X for 1% solution, then go through 2 freeze/thaw cycles to lyse cells. 
 
4. Dilute 20X TE in sterile H2O to obtain an appropriate amount of 1X TE. 
 
5. Dilute DNA stock in 1X TE to obtain an appropriate amount of DNA with concentration 
approximately equal to 2μg/mL. 
 
𝑉𝑜𝑙𝑢𝑚𝑒AB&CDEF2G[µL] =






6. Read DNA absorbance at 260nm using cuvettes. 
• Protocol name: Biocell PicoGreen Std 
• Include blank: add 1mL 1X TE to Biocell cuvette #1 
• Include 2μg/mL DNA sample: add 1mL DNA standard to Biocell cuvette #2 
• Note: reading/opening of Biocell cuvette are on opposite sides.  Make sure that there 
are no air bubbles, especially on the reading side. 
• Read plate and save plate reading. 






• From Molecular Probes PicoGreen product sheet, absorbance260 of 0.04 corresponds 
to 2µg/mL double-stranded DNA solution, which is where 0.02 in the equation above 
comes from. 
 
7. Read blank black plate with clear bottom. 
• Protocol name: PicoGreen Assay (ex/em: 485/528) 
• Plate reader may ask you to wait 3 minutes for fluorescence to warm up before 
reading plate, in this case, place the plate on an orange plastic base (to protect clear 
bottom film) and leave in a drawer to incubate. 
• Read plate and save reading. 
 
8. Prepare standards in triplicates. 
• In general, add solutions directly into wells along the sides in order to avoid 
puncturing the bottom of the wells. Run each standard in triplicate. 
• Add appropriate amount of 1X TE according to the chart below. 
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• Add appropriate amount of DNA according to the chart below. 
• Add appropriate amount of Solution Additive according to the chart below. 
• Note: do not add PicoGreen until samples have been plated as well since PicoGreen 
solution is light-sensitive. 
 
Standard 













1 100 0 1 100 1 µg/mL 
2 10 89 1 100 100 ng/mL 
3 1 98 1 100 10 ng/mL 
4 0.1 98.9 1 100 1 ng/mL 
5 0 99 1 100 0 (Blank) 
 
9. Add samples; run each sample in triplicate. 
• Vortex and spin down (~1min) samples before adding to plate. 
• Using a multi-channel pipette, add 99μL of 1X TE to all the wells that will contain 
samples. 
• Add 1μL sample to each appropriate well; take sample from the top of the 
microcentrifuge tube). 
 
10. Add 1X PicoGreen to all wells.  
• Dilute 200X PicoGreen stock in 1X TE to obtain an appropriate amount of 1X 
PicoGreen solution. 
• Using a multi-channel pipette, add 100μL of 1X PicoGreen to all wells containing 
either standards or samples.  Mix by pipetting up and down but make sure to not 
introduce any air bubbles! Also make sure to switch to new tips when appropriate. 
• Incubate plate in a drawer for ~3min while setting up the plate reader. 
• Protocol: PicoGreen Assay. 
• Read plate (excitation/emission: 485/528) and save reading. 
 
11. Clean up and analyze 
• Note that PicoGreen has its own waste bottle! 
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DMMB Assay  
DMMB binds to sulfated GAGs 
 
Preparation: 
1. Have prepared DMMB Dye (see next page). 
2. Have prepared Chondroitin Sulfate C stock (1µg/µL, 0.25µg/µL, 0.1µg/µL, 0.01µg/µL). 
 
Assay: 
1. Turn on plate reader approximately 20min before beginning the assay. 
2. Read blank plate. 
• Place a new 96-well plate into the plate reader. 
• Open DMMB protocol.  Read absorbance at 525nm and 595nm. 
3. For standards, add appropriate volumes of both stock solution and DI H2O per well in 
triplicate. 
• Make sure to vortex stock solution in order to obtain homogeneous aliquots. See 
next page for further notes. 
4. For each sample, vortex sample, then add 5µL of sample per well in triplicate. 
• Samples may have to be diluted depending on absorbance values relative to 
standards. 
5. Set up plate reader for reading. 
• DMMB protocol should be already open. 
• Add a new plate for actual sample readings. 
6. In a dark room, pour DMMB dye into multichannel pipette reservoir immediately prior to 
use, as it is light sensitive. 
7. Using a multichannel pipette, add 200µL of DMMB dye to each well for both standards 
and samples.  Mix by pipetting up and down but be careful to not introduce bubbles. 
8. Read samples at 525 and 595nm. Subtract 595 from 525 and extrapolate values. 
 
Standards µg GAG Stock Solution Amt of stock (µL) Amt of DI H2O (µL) 
1 0 N/A 0 5 
2 0.05 0.01 µg/µL 5 0 
3 0.1 0.1 µg/µL 1 4 
4 0.2 0.1 µg/µL 2 3 
5 0.5 0.1 µg/µL 5 0 
6 0.75 0.25 µg/µL 3 2 
7 1 0.25 µg/µL 4 1 
8 1.25 0.25 µg/µL 5 0 
9 2 1 µg/µL 2 3 
 
Associated spreadsheets: 








8mg DMMB (1,9 dimethylmethylene blue) 
2.5mL 100% ethanol 
1g sodium formate 
1mL formic acid 
 
Procedures: 
1. Weigh out DMMB.  Place DMMB into a 15mL conical tube, covered in aluminum foil. 
2. Add 2.5mL of 100% ethanol and vortex thoroughly to get DMMB into solution. 
3. In a 600mL beaker with a stir bar and covered in aluminum foil, add 350mL DI H2O.  
Add 1g sodium formate and 1mL formic acid.  Pour in DMMB/ethanol solution. 
4. Use a 1mL pipette and 10mL DI H2O (to bring to a total of 500mL DI H2O) to rinse out 
DMMB conical as dye gets stuck along walls and cap of conical. 
5. pH DMMB dye down to 1.5 (original dye pH ~3-3.5) using formic acid. 
• Adjusting pH may take 20-80mL of formic acid. 
6. Add appropriate amount of DI H2O to obtain a final volume of 500mL of DMMB dye. 
7. Read absorbance at 525 nm and 595nm. Subtract 595 from 525. 
• pH 1.5 and subtracting absorbances eliminates errors from non-GAG specific 
artifacts (carboxyls, DNA…) without sacrificing sensitivity, particularly for tissue 
engineered samples 
• Reference: Zheng and Levenston, “Fact versus artifact: Avoiding erroneous 
estimates of sulfated glycosaminoglycan content using the dimethylmethylene 





The stock solutions should be prepared ahead of time from Chondroitin Sulfate C (Sigma C-4384) 
and stored at -20°C until use.  The stock solutions can be refrozen and used again.  Dissolve the 
stock in a solvent applicable to your samples, or be sure to include a blank on your plate with the 
solution your samples are in. 
Note: Vortex stock solutions well and frequently so that you are taking aliquots from a 
homogenous mixture.  Also wear gloves as it is easy to contaminate the samples/standards with 
GAGs, which may be on your hands. 
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Hematoxylin and Eosin (H&E) Staining (Paraffin Embedded Slides) 
 
Materials 
• CitriSolv ® - Fisher Scientific, cat. # 22-143-975 
• Absolute Ethanol - Fisher Scientific, cat. # A406P-4 
• Hematoxylin Gill no. 2 – Sigma, cat. # GHS-2-32 
• Eosin Y Alcoholic – Sigma, cat. # HT110-1-32 
• Cytoseal-60 – Richard and Allan Scientific cat. # 8310-4 
• Coverglass – Corning - Thickness-1 22X50mm cat. # 2975-225 
 
 
Acid Alcohol (for H&E): 
Combine    95% Ethanol   495mL 
Concentrated HCl  5mL 
 
Scott’s Buffer: 
Combine    Sodium Bicarbonate  2.0g 
Magnesium Sulfate  20.0g 
Distilled Water  1Liter 
 
Staining Procedure: 
1. CitriSolv ®       3 min 
2. 100% EtOH       1 min 
Repeat steps 1-2 if necessary 
3. 95% EtOH        1 min 
4. 70% EtOH       1 min 
5. 50% EtOH       1 min 
6. Distilled H2O       1 min 
7. Hematoxylin Solution (Gill no.2)     10 min 
8. Tap H2O       3 min 
9. Acid Alcohol (for H & E)     20 sec 
10. Tap H2O       3 min 
11. Scott’s Buffer       20 sec – 1 min 
(this is the bluing step for the nuclear stain, longer incubation leads to more intense bluing 
and thus contrast between nuclei and other structures) 
12. Tap H2O       3 min 
13. Eosin Y Solution Alcoholic     1 min 
14. 95% EtOH       1 min 
15. 95% EtOH       1 min 
16. 100% EtOH       1 min 
17. CitriSolv ®       1 min 
18. Mount and coverslip with Cytoseal-60.  Seal with nail polish the next day. 
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Alcian Blue Staining (Paraffin Embedded Slides) 
 
Materials 
• CitriSolv ® - Fisher Scientific, cat. # 22-143-975 
• Absolute Ethanol - Fisher Scientific, cat. # A406P-4 
• Alcian Blue 8GX – Sigma, cat. # A-9186 
• Glacial Acetic Acid – Fisher Scientific, cat. # A38-212 
• Cytoseal-60 – Richard and Allan Scientific cat. # 8310-4 
• Coverglass – Corning, cat. # 2975-225 
 
3% Acetic Acid (500mL): 
Combine    Glacial Acetic Acid   15mL 
Distilled Water   485mL 
Acid Alcohol (for Alcian Blue): 
Combine    70% Ethanol    495mL 
Concentrated HCl   5mL 
pH to 1.0 with concentrated HCl 
 
1% Alcian Blue Dye (500mL): 
1. Dissolve 5.0 g of Alcian blue 8GX in 450 mL of 0.1N HCl by stirring for at least six 
hours at room temperature. 
2. Adjust pH to 1.0 and fill volume to 500mL. 




1. CitriSolv ®        3 min 
2. 100% EtOH        1 min 
Repeat steps 1-2 if necessary 
3. 95% EtOH         1 min 
4. 70% EtOH        1 min 
5. 50% EtOH        1 min 
6. Distilled H2O        1 min 
7. 3% Acetic Acid        3 min 
8. 1% Alcian Blue (pH 1.0)      15 min 
9. Acid Alcohol (for Alcian Blue)     3 min 
10. Acid Alcohol (for Alcian Blue)     3 min 
11. 95% EtOH        1 min 
12. 100% EtOH        1 min 
13. CitriSolv ®        1 min 
14. Mount and coverslip with Cytoseal-60.  Seal with nail polish the next day. 
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Collagen ImmunoHistoChemistry 
Materials:   
• Water resistant Pen - Silver Permanent Marker – PILOT – Staples (on shelf) 
• Hyaluronidase Type IV-S – Sigma Cat# H-4272 (stored at -20ºC) 
• Hydrogen Peroxide – Fisher Scientific Cat# H325-100 (stored at 4ºC) 
• Methanol – Fisher Scientific Cat# A412-1 (stored at room temp, in 5th floor chemical hood) 
• 10% Horse Serum – (stored at -20ºC) 
• IgG from Mouse – Sigma Cat# I8765 (stored at -20ºC) 
• Type I Collagen antibody – Sigma Cat# C-2456. (stored at -20ºC) 
• Type II Collagen antibody – Developmental Studies Hybridoma Bank Antibody #II-II6B3-S 
(stored at 4ºC) 
• Type VI Collagen antibody – Developmental Studies Hybridoma Bank Antibody 5C6-s 
(stored at 4ºC) 
• Type X Collagen antibody – Developmental Studies Hybridoma Bank Antibody X-AC9-s 
(stored at 4ºC) 
• Biotinylated secondary antibody anti-mouse anti-rabbit IgG (H+L) – VECTOR Laboratories 
BA-1400 (stored at 4ºC) 
• VECTASTAIN Universal Elite ABC Kit – VECTOR Laboratories Cat# PK-6200 (stored at 
4ºC) 
• DAB Peroxidase Substrate Kit – VECTOR Laboratories Cat# SK-4100 (stored at 4ºC) 
• CLEAR-MOUNT with TRIS Buffer – Electron Microscopy Sciences Cat# 17985-12 (stored 
at 4ºC) 
• FITC-conjugated secondary antibodies  
• Invitrogen™ Fluoromount-G™ Mounting Medium 
 
Day 1: 
1. IHC can be performed on 4-6 slides at a time. For paraffin-embedded samples: De-
paraffinize and rehydrate. 
a. CitriSolv®      3min 
b. 100% EtOH      1min 
Repeat steps a-b if necessary 
c. 95% EtOH       1min 
d. 70% EtOH       1min 
e. 50% EtOH       1min 
f. Distilled H2O      1min 
2. For 4 slides, thaw ~2mL of 0.5mg/mL hyaluronidase (in PBS, aliquots stored at -20ºC).  Turn 
on oven and set temperature to 37ºC.  
3. Use a water-resistant pen to mark around samples.  Make sure edges and corners are touching 
and boxes are complete. Each slide should have 1 non-immune control and 3 experimental 
samples. 
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4. Incubate all samples in ~300µL of 0.5mg/mL hyaluronidase for 30 min at 37°C.  Use oven in 
the backroom; add a few drops of H2O in the glass PetriDish. (Hyaluronidase step is 
necessary to expose collagen antigens) 
5. Rinse 2X with PBS.  Use gel-loading 200μL pipette tips for aspirating liquids. 
6. Incubate samples in 0.5N acetic acid for 2 hours at 4°C. (Be gentle with fridge doors; leave a 
note.)   
7. Rinse 2X with PBS.  
(Step 8 ONLY for DAB Protocol; Skip to step 11 if doing Fluorescence) 
8. Incubate samples in 3% H2O2 (hydrogen peroxide) in methanol for 10 min at room temp 
(25°C).  To prepare, perform 1:10 dilution from stock solution of 30% H2O2.  (prepare ~2mL 
for 4 slides) 
Note:  H2O2 has low surface tension.  Also cover samples during incubation so H2O2 
does not evaporate too quickly 
9. Take out 10% horse serum to thaw.  Keep on ice. 
10. Rinse 2X with PBS.  
11. Apply ~300µL of 10% horse serum to cover samples and incubate for 20 min at room temp 
(25°C). 
12. Remove horse serum (blocking solution) but do not rinse. 
13. For non-immune controls apply ~300µL of 10% horse serum with 1μg/mL IgG-from-mouse 
to cover sample and incubate overnight at 4°C. (prepare ~2mL for 4 slides) 
14. For experimental samples, apply ~300µL of primary antibody (diluted in 10% horse serum in 
PBS) to cover sample and incubate overnight at 4°C.   
a. Primary antibody dilution should have a final concentration of 1μg/mL. 
b. Prepare ~2mL for 4 slides. 
 
Day 2 (DAB): 
1. Thaw 10% horse serum. Keep on ice. 
2. Rinse 2X with PBS.  Aspirate non-immune controls first, then change tip for actual samples, 
as to eliminate chances of cross-staining.   
3. Apply ~300µL of biotinylated secondary antibody (biotinylated horse anti-mouse/anti-rabbit 
IgG (H&L)) to cover samples and incubate for 30 min at room temp.   
a. Biotinylated horse µ-mouse/µ-rabbit IgG secondary antibody dilution: 1:50 in 10% 
horse serum. 
b. Prepare ~2mL for 4 slides. 
4. While incubating: Make VECTASTAIN ABC Reagent: 1 drop Reagent A and 1 drop of 
Reagent B in 2.5mL PBS, vortex and allow to stand for 30 min prior to use. 
5. Rinse 2X with PBS. Use different tips for non-immune controls and actual samples in order 
to eliminate chances of cross-staining. 
6. Apply ~300µL of VECTASTAIN ABC Reagent to cover samples and incubate for 30 min at 
room temp.   
7. At the end of 30 min, turn on oven and set temperature to 45ºC. 
8. Rinse 2X with PBS. Use different tips for non-immune controls and actual samples in order 
to eliminate chances of cross-staining. 
9. Apply ~300µL of DAB substrate solution to cover samples for 5 min exactly.  Immediately 
remove DAB and rinse with tap water 3X.  Leave tap water on slide after 3rd rinse.  
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a. DAB: In 2.5mL DI H2O, add 1 drop of Buffer Stock Solution and vortex.  Then add 2 
drops of DAB Stock Solution and vortex.  Then add 1 drop of Hydrogen Peroxide 
Solution and vortex.   
b. Add DAB to 2 slides at a time, spaced 2 min apart in order to avoid hecticity.  
10. If counterstain desired: use hematoxylin to visualize nuclei: 
• Apply hematoxylin stain directly to slides for 5 min (submerging slides in slide box 
runs the risk of samples sliding off slide) 
• Rinse 2x with tap H2O 
• Acid alcohol (for H&E) for 20 seconds 
• Rinse 2x with tap H2O 
• Scotts buffer for ~20 seconds 
• Rinse 2x with tap H2O 
11. Aspirate tap water.  Use Kim-wipes to remove excess water.  Cover samples using Clear-
mount, use 200μL pipette tip to spread mounting medium evenly, then place slide in oven at 
45˚C for at least 30min.  
12. All DAB containing solutions must be treated with DAB Neutralizing solution.  Dispose of 
all DAB containing solutions and pipette tips in the appropriate waste containers. 
13. Remove slides from oven, leave at room temp (in plastic box) overnight to ensure that 
mounting medium is solidified before putting slides back into histology boxes. 
 
Day 2 (Immunofluorescence): 
1. Thaw 10% horse serum. Keep on ice. 
2. Rinse 2X with PBS.  Aspirate non-immune controls first, then change tip for actual samples, 
as to eliminate chances of cross-staining.   
3. Apply 100 µl of FITC-conjugated secondary antibody (diluted 1:200 in 10% goat serum in 
PBS) to cover cells and incubate for 30-60 (30) min. Protect slides from light from here 
on. 
4. Rinse cells three times with PBS, 2 min. per rinse. 
5. If using DAPI for nuclear stain.  Apply DAPI diluted at 1:15,000 in PBS for 10 minutes at 
room temperature. 
6. Rinse once with distilled water, 2 min. 
7. Mount using fluorescence protecting mounting medium (Invitrogen™ Fluoromount-G™ 
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ُمیَِلعْلٱ 	 ُعیِمَّسلٱ 	 َتَنأ 	 َكَّنِإ 	◌ۖ	 ٓاَّنِم 	 ْلََّبَقت 	 َانَّبَر 	
Rabbana taqabbal minna inaka Antas Samee’ul Aleem 
Our Lord, accept [this] from us. Indeed, You are the Hearing, the Knowing. 
 
